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Cultivars along the Ripening Stages
Reprinted from: Appl. Sci. 2020, 10, 3930, doi:10.3390/app10113930 . . . . . . . . . . . . . . . . . 37
Feng Zhao, Meng Li, Lingling Meng, Jinhan Yu and Tiehua Zhang
Characteristics of Effervescent Tablets of Lactobacilli Supplemented with Chinese Ginseng
(Panax ginseng C.A. Meyer) and Polygonatum sibiricum
Reprinted from: Appl. Sci. 2020, 10, 3194, doi:10.3390/app10093194 . . . . . . . . . . . . . . . . . 51
Federica Turrini, Paola Malaspina, Paolo Giordani, Silvia Catena, Paola Zunin 
and Raffaella Boggia
Traditional Decoction and PUAE Aqueous Extracts of Pomegranate Peels as Potential Low-Cost 
Anti-Tyrosinase Ingredients
Reprinted from: Appl. Sci. 2020, 10, 2795, doi:10.3390/app10082795 . . . . . . . . . . . . . . . . . 65
Fan Zhang, Chenglong Jin, Shiguang Jiang, Xiuqi Wang, Huichao Yan, Huize Tan and
Chunqi Gao
Dietary Supplementation with Pioglitazone Hydrochloride and Resveratrol Improves Meat
Quality and Antioxidant Capacity of Broiler Chickens
Reprinted from: Appl. Sci. 2020, 10, 2452, doi:10.3390/app10072452 . . . . . . . . . . . . . . . . . 79
Sara M. Fraga and Fernando M. Nunes
Agaricus bisporus By-Products as a Source of Chitin-Glucan Complex Enriched Dietary Fibre
with Potential Bioactivity
Reprinted from: Appl. Sci. 2020, 10, 2232, doi:10.3390/app10072232 . . . . . . . . . . . . . . . . . 93
Marta Ziaja-Sołtys, Wojciech Radzki, Jakub Nowak, Jolanta Topolska, Ewa Jabłońska-Ryś,
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Preface to ”Functional Foods and Food Supplements”
The clear relationship between the food that we eat and our well-being is widely recognized.
Today, foods are not only intended to satisfy hunger and provide necessary nutrients: they can
also confer additional health benefits, such as preventing nutrition-related diseases and improving
physical and mental well-being. Recent technological advancements, socio-economic trends, and
population lifestyle modifications throughout the world indicate the need for foods with increased
health benefits. In this view, the demand for functional foods and dietary food supplements in
the global market has increased rapidly, partially because of the popular, although sometimes
wrong, belief that ‘natural’ is healthier and safer than synthetic drugs. This Special Issue provides
a comprehensive overview of developments in the field of functional foods and food supplements.
It includes papers focused on different food matrices as innovative natural sources of bioactive
compounds endowed with health-promoting properties. The Guest Editors would like to thank all
of the colleagues and contributors who published their works in this Special Issue, as well as the
reviewers who evaluated submissions to assure that the published studies were of high quality.
The Guest Editors would also like to thank the publisher, MDPI, and the editorial staff of Applied
Sciences for their constant and professional support and for their invitation to edit this Special Issue.
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Abstract: This Special Issue aims to provide new findings and information with respect to healthy
foods and biologically active food ingredients. Studies on the chemical, technological, and nutritional
characteristics of healthy food ingredients will be taken into consideration as well as analytical
methods for monitoring their quality. New findings on the bioavailability and the mechanism of
action of food bioactive compounds will be considered. Moreover, studies on the rational design
of potential new formulations, both of functional foods and of food supplements, have been taken
into account.
Keywords: functional foods; dietary supplements; food bioactive compounds; formulations;
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It is well known that a clear relationship exists between the food that we eat and our well-being.
Nowadays, foods are not intended to only satisfy hunger and to provide necessary nutrients, but they
can confer additional health benefits to human, preventing nutrition-related diseases, and improving
physical and mental well-being [1].
The recent technological advancement, the socio-economic trends, and the population lifestyle
modifications throughout the world indicate the need for foods with increased health benefits [2].
In this view, the demand for functional foods and dietary food supplements in the global market have
increased rapidly, according also to the popular belief, although sometimes wrong, that ‘natural’ is
healthier and safer than synthetic drugs.
Functional foods are foods that, consumed as an integral part of the normal diet, can provide,
in addition to nutrients, one or more bioactive compounds, adding beneficial health effects to the
traditional nutritional ones [3]. Recent trends in the food industry show that functional foods have
become increasingly popular around the world and they are becoming a part of the daily diet of
developed countries [3]. The health benefit of functional foods derives from their composition of
bioactive compounds, which can occur naturally, form during industrial processing or be extracted from
other sources and added [4]. Examples include phytochemicals such as vitamins, peptides, polyphenolic
compounds, carotenoids, and isoflavones, which provide health benefits, mainly on development
and growth, regulation of metabolic processes, defence against oxidative stress, cardiovascular and
gastrointestinal physiology, and physical and cognitive performances [5]. These products, aimed at
the maintenance of well-being, should present the highest quality standards if compared to the
corresponding conventional products [6]. Japan, United States, and Europe have the highest amount
of functional food consumers [5].
Food supplements are concentrated sources of bioactive compounds (i.e., minerals, amino acids,
vitamins, herbs or other botanicals, and other dietary ingredients) to supplement the normal diet by
increasing the total intake of these substances, but they are not intended to treat disease [7].
Nowadays, dietary food supplements are widespread, and they play an increasingly important
role in the consumer’s awareness. According to Euromonitor International, the current sales of these
Appl. Sci. 2020, 10, 8538; doi:10.3390/app10238538 www.mdpi.com/journal/applsci1
Appl. Sci. 2020, 10, 8538
food products in the European Union are close to 7 billion Euros annually, and they are constantly
growing [8].
Food supplements are used by the population for many different purposes including health
maintenance, preventing diseases, balancing diets, improving appearance and wellness as well as to
increase sport performance [8]. Unlike functional foods, they are marketed in dosage forms (i.e., pills,
tablets, capsules, or liquids in measured doses) [9].
This Special Issue provides a good overview of the status and the developments in the field
of functional foods and food supplements. It includes papers focused on different food matrices as
innovative natural sources of bioactive compounds endowed with health-promoting properties.
Colombo et al. [10] presented an overview on botanicals as ingredients in functional foods and food
supplements. In recent decades, the interest in botanicals has grown exponentially and, consequently,
the relative market increased all over the world [11,12]. Botanicals have become among the most
popular in the food supplements category, due to the general belief that “natural” is better, healthier, and
safer than synthetic drugs. The availability of these relatively new products can positively influence
the well-being of the population, but it is essential to provide the consumers with the necessary
recommendations to guide them in their purchase and use. This review discusses some open points,
such as: the definitions and regulation of products containing botanicals; the difficulty in obtaining
nutritional and functional claims (botanical ingredients obtaining claims in the European Union are
listed and summarized); the safety aspects of these products; and the poor harmonization between
international legislations.
Zuccari et al. [13] present a review on different formulation strategies to improve the oral
bioavailability of ellagic acid. This is a polyphenolic compound contained in many fruit and berries,
endowed with antioxidant activity, which might be potentially useful for the prevention and treatment
of cancer, cardiovascular pathologies, and neurodegenerative disorders. However, ellagic acid has poor
bioavailability associated with low solubility, limited permeability, first pass effect, and inter-individual
variability in gut microbial transformations. This review described several strategies, including micro
and nano formulations, to overcome this problem and which can be exploited to produce nutritional
supplements or to include it in functional foods.
Salehi et al. [14] present an overview on habitat, cultivation, phytochemical composition,
and 14 food preservative abilities of Cucurbita plants. Cucurbita species are a natural source of
carotenoids, tocopherols, phenols, terpenoids, saponins, sterols, fatty acids, functional carbohydrates,
and polysaccharides that exert remarkable biological effects. For this reason, they have been used for
centuries in the folk medicine of many cultures and recently they have been increasingly exploited for
biotechnological applications.
Some authors also evaluated the possibility to extract functional ingredients from the by-products of
different agro-industrial chains. The development of sustainable solutions for the management of food
waste and by-products is currently one of the main challenges of our society. Indeed, in the developing
countries, the food production and processing generate large amounts of waste and by-products, with a
significant environmental, economic, and social impact [15]. On the other hand, many of these products
could represent a potential source of valuable compounds, such as proteins, amino acids, starch,
oligosaccharides, lipids (i.e., fatty acids, sterols), micronutrients (i.e., vitamins, minerals), bioactive
compounds (i.e., polyphenols, carotenoids, glucosinolates, and terpenes), and dietary fibers [15].
Turrini et al. [16] investigated the in-vitro anti-tyrosinase activity of different aqueous extracts
obtained from pomegranate juice processing by-products. One drawback in pomegranate juice
industrial production is the large amount of waste, in particular, external peels which represent a
promising source of phenolic compounds for exploitation (such as ellagic acid and ellagitannins) [17].
Different conventional and innovative eco-compatible extraction methods (such as ultrasound-assisted
extraction) are considered, and the obtained extracts have been tested in-vitro as low-cost lightening
and/or anti-browning agents.
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Fraga et al. [18] propose the use of mushroom (Agaricus bisporus) by-products as a source of
chitin–glucan complex enriched dietary fiber, as a good strategy to reduce wastes generated in the
mushroom agro-industry. In this work, a simple and environmentally friendly procedure using only
food-grade reagents was developed and optimized by Design of Experiments (DoE) to produce a
dietary fiber-based ingredient.
Some authors considered some underrated species as potential sources of components with an
important impact in health promotion. Gamba et al. [19] presented a phytochemical characterization
and a bioactivity evaluation of autumn olive (Elaeagnus umbellata Thunb.) fruits, a deciduous shrub tree
widely distributed in Asia and Southern Europe, whose fruits are locally used for human consumption.
The aim of the study was to evaluate the main bioactive compounds and nutraceutical properties
of these fruits, using high-performance liquid chromatography fingerprint and spectrophotometric
analysis, to promote their potential applications as a food supplement.
Ziaja-Sołtys et al. [20] investigated the influence of different processing methods (such as
boiling, blanching, and fermenting) on the content and the biological activity of the water-soluble
polysaccharides extracted from a Japanese mushroom (Lentinus edodes). Indeed, among all
mushroom-derived bioactive compounds, polysaccharides are known to have the most potent
antitumor, antioxidative, and immunomodulating properties. However, the biological activities of
polysaccharides differ greatly depending on the processing applied before the consumption.
Ferro et al. [21] studied the maturation evolution of olive fruits from two major traditional
Portuguese cultivars (such as ‘Galega Vulgar’ and ‘Cobrançosa’), regarding their phenolic profile.
Particularly, oleuropein and verbascoside are the most common phenolic glucoside found in
considerably high amounts in the Oleaceae family. These bioactive compounds are shown to exert
great health benefits if regularly ingested, such as the prevention of atherosclerosis and by scavenging
several reactive oxygen species in the vascular wall.
Zhang et al. [22] investigated the potential dietary supplementation with pioglitazone
hydrochloride and resveratrol on the quality of yellow-feathered broiler chickens. The study confirmed
that the combined dietary supplementation of chickens improved the meat quality prolonging its shelf
life, the growth performance, the muscle intramuscular fat content, and the antioxidant ability.
Zhao et al. [23] investigated the effect of Chinese ginseng (Panax ginseng C.A. Meyer) and
Polygonatum sibiricum on the properties of Lactobacilli effervescent tablets. The research demonstrates
that it is possible to develop an optimal formulation of lactobacilli effervescent tablets supplemented
with Chinese ginseng and P. sibiricum, combining functional benefits of lactobacilli and both herbs.
Boukhatem et al. [24] describe the potential application of Eucalyptus globulus essential oil as
a natural preservative in beverages like fruit juices. This essential oil could be used as a possible
antifungal and antibacterial agent against foodborne and food spoilage microorganisms. The chemical
composition showed the predominance of oxygenated terpenes responsible for the microbial inhibitory
effect against pathogens.
Author Contributions: Conceptualization, F.T.; P.Z. and R.B.; methodology, R.B.; data curation, F.T. and R.B.;
writing—original draft preparation, F.T.; writing—review and editing, F.T. and R.B.; supervision, R.B. and P.Z.;
project administration, R.B. and P.Z.; All authors have read and agreed to the published version of the manuscript.
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Abstract: The potential application of Eucalyptus globulus essential oil (EGEO) as a natural beverage
preservative is described in this research. The chemical composition of EGEO was determined using
gas chromatography analyses and revealed that the major constituent is 1,8-cineole (94.03% ± 0.23%).
The in vitro antioxidant property of EGEO was assessed using different tests. Percentage inhibitions
of EGEO were dose-dependent. In addition, EGEO had a better metal ion chelating effect with
an IC50 value of 8.43 ± 0.03 mg/mL, compared to ascorbic acid (140.99 ± 3.13 mg/mL). The in vitro
antimicrobial effect of EGEO was assessed against 17 food spoilage microorganisms. The diameter of
the inhibitory zone (DIZ) ranged from 15 to 85 mm for Gram-positive bacteria and from 10 to 49 mm
for yeast strains. Candida albicans, C. parapsilosis and Saccharomyces cerevisiae were the most sensitive
fungal species to the EGEO vapor with DIZ varying from 59 to 85 mm. The anti-yeast effectiveness of
EGEO alone and in association with heat processing was estimated in a real juice matrix (Orangina
fruit juices) in a time-dependent manner. The combination of EGEO-heat treatment (70 ◦C for 2 min)
at different concentrations (0.8 to 4 μL/mL) was effective at reducing S. cerevisiae growth in the fruit
juice of Orangina, compared to juice preserved with synthetic preservatives. Current findings suggest
EGEO as an effective and potent inhibitor of food spoilage fungi in a real Orangina juice, and might
be a potential natural source of preservative for the food industry.
Keywords: natural food preservative; Eucalyptus globulus essential oil; eucalyptol; antioxidant effect;
vapor phase; Orangina fruit juice
1. Introduction
Food spoilage by fungi, yeasts and bacteria is a major problem in food production, and it
considerably impacts the price and availability of the food [1]. The use of synthetic and chemical
antibacterial and antifungal compounds and food preservatives is considered as one of the ancient
methods for reducing foodborne pathogens and contamination. The addition of synthetic antioxidant
and antimicrobial food preservatives is an active way for storage to slow down food alteration and
oxidation [2]. Nevertheless, due to increasing confirmation of the dangerous properties of synthetic
food additives, there is constant pressure from consumers to decrease the quantity of these chemicals in
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food [3] and deliver minimally processed foodstuffs without compromising food preservation, safety
and quality [4].
Thus, other sources of nontoxic, bioactive and suitable natural food preservatives need to be
discovered and investigated, such as plant secondary metabolites, phytochemicals and volatile oils
or essential oils (EOs). A new approach to prevent and avoid the proliferation of microorganisms or
protect food from oxidation is the use of EOs as antifungal, antibacterial and antioxidant preservatives.
The potential application of EOs as functional components in drinks and beverages is gaining force
because of growing anxiety about possibly dangerous and toxic synthetic additives [5,6]. Within the
context of the extensive variety of the aforementioned foodstuffs, a collective need is the accessibility of
phytochemical extracts and EOs with an agreeable flavor or scent associated with a conserving effect
and that can avoid lipid alteration, oxidation and contamination by food spoilage microorganisms and
pathogens [7–9].
Therefore, there has been growing attention to the discovery and investigation of safe, effective
and natural antioxidant bioactive molecules because they can defend the human body from free
radicals and delay the development of several chronic or acute illnesses [10]. The antimicrobial
molecules found in aromatic and medicinal plants are of interest because multidrug resistant bacteria
are now becoming a global community health alarm, particularly in terms of foodborne infections
and nosocomial contaminations [11–13]. Several studies have reported antiseptic, anti-inflammatory,
wound-healing, analgesic, antioxidant and free radical-scavenging activities [14] from aromatic and
medicinal plants, herbs, spices and EOs and, in most cases, a direct food-related application has been
verified [15].
The Eucalyptus genus is a tall shrub belonging to the family of Myrtaceae. Although some
papers about Eucalyptus globulus essential oils (EGEOs) have been done [16–20], only a limited of
them estimated Eucalyptus oil’s effect against pathogens and food spoilage species [7]. In spite of the
well-reported in vitro antibacterial and antifungal effects, food manufacturing has used Eucalyptus EOs
principally as flavoring agents. Consequently, the application of EOs and phytochemical extracts as
natural food additives has been restricted [16].
Despite the great efficacy of EOs and their phytochemical compounds against food-related and
spoilage pathogens with in vitro methods, a similar result in a food matrix is only accomplished with a
greater dose of EOs [3]. This statement suggests a sensorial and organoleptic influence from changing
the ordinary flavor of the food and beverages by surpassing suitable taste thresholds [7]. Therefore,
to reduce the dose of EO in a real juice matrix, studies on the associated effect of EOs with traditional
conservation methods such as heat processing are required. In the current research, the chemical
composition of EGEO was analyzed with gas chromatography-mass spectrometry (GC-MS). Then,
the in vitro antioxidant effect was carried out using DPPH radical scavenging and metal ion chelating
activity. The inhibitory effects of Algerian EGEO against several food spoilage bacterial and fungal
strains were assessed in vitro (disc diffusion and disc volatilization tests) and in a real food matrix
(inhibition of Saccharomyces cerevisiae strain for the preservation of Orangina fruit juices) and stored at
laboratory temperature for 6 days. Further, for reducing the dose of EGEO in the Orangina fruit juice,
the associated effect of EGEO with moderate heat treatment was evaluated.
2. Materials and Methods
2.1. Material
2.1.1. Distillation of Eucalyptus globulus Essential Oil
Eucalyptus globulus EO was purchased from “Ziphee-Bio” company of essential oils (Lakhdaria,
Bouira, Algeria). EGEO was extracted from the aerial part with alembic steam distillation (SD). SD is a
method used to obtain EOs from Eucalyptus globulus by passing steam generated in a pot still through
the plant material. A quantity of fresh plant (leaves and small branches of the tree) was loaded
in the still and stacked in layers to allow the appropriate delivery of the steam. When the steam
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passed through the Eucalyptus globulus, tiny pockets that hold the EOs opened to release the volatile
compounds. This is referred to as the distillate. The distillate will contain a mix of hydrosol (aromatic
water) and EO which return to their liquid form in the condenser and are separated using a Florentine
separator. EGEO was stored in air-tight sealed glass bottles at 4 ◦C until further use.
2.1.2. Food Spoilage Microorganisms
Different food-spoilage bacterial strains (Escherichia coli, Enterobacter sakazakii, Pseudomonas aeruginosa,
Klebsiella ornithinolytica, Bacillus cereus and Staphylococcus aureus), fungal strains (Aspergillus niger,
Aspergillus flavus, Aspergillus fumigatus and Aspergillus brasiliensis) and yeasts (Saccharomyces cerevisiae,
Candida parapsilosis, Candida albicans and Trichosporon sp.) were collected and identified from different food
matrices (water, milk, juices and honey) in the Laboratory of Food Microbiology (Laboratoire d’Hygiène,
Blida, Algeria) and used to evaluate the microbial inhibitory effect of EGEO.
The identification of microorganisms was carried out using morphologic and biochemical
characterization tests. After cell identification through Gram staining and microscopic observation was
done, the traditional biochemical tests (using API 20E) were carried out to assess the tested bacteria
classification following the Gram-negative bacterial identification method [21]. Different biochemical
assays were used such as oxidase, TSI medium, gelatin hydrolysis, sugar assimilation, amino acid
degradation, hydrogen sulfide production, citrate and Voges-Proskauer.
The fungal species were identified based on their morphological arrangements such as
pigmentation, diameter of the mycelia, and microscopic determination of formation of the germ
tube, spores and chlamydoconidias. Yeast strains were identified using the AuxacolorTM kit which
is an identification method based on sugar digestion [22]. The growth of yeasts is assessed by the
color change of a pH indicator. The AuxacolorTM system contains 16 wells in a plastic microplate.
All assays with the AuxacolorTM method were carried out following the manufacturer’s guidelines.
The AuxacolorTM system was stored at 4 ◦C and was carried to laboratory temperature before use.
The fungal and bacterial species were identified with standard microbiology assays and stored in
mueller-hinton agar (MHA) and sabouraud dextrose agar (SDA) for bacteria and fungi, respectively.
2.1.3. Chemicals and Reagents
Dimethyl sulfoxide (DMSO), gallic acid, butylated hydroxyanisole (BHA), L-ascorbic acid (vitamin
C.), ethanol, tween 80, FerroZine™ iron reagent, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and iron (II)
chloride (FeCl2) were obtained from Sigma Aldrich (St. Louis, MO, USA). Isosaline (0.9% NaCl),
MHA and SDA medium were purchased from the Ideal-Labo company (Blida, Algeria). Filter paper
discs (9 mm in diameter) were provided by Schleicher and Schull GmbH (Dassel, Germany). Antibiotic
discs of amoxicillin-clavulanic acid (AMC, 20/10μg), erythromycin (E, 15μg), chloramphenicol (C, 30μg)
(Bio-Rad Laboratories, France) and antiseptic solution of Isomedine® 0.1% (Hexamidine dermal solution,
Isopharma, Algiers, Algeria) were used to assess the sensitivity of isolated microorganism species.
2.2. Methods
2.2.1. Chemical Composition of Eucalyptus globulus Essential Oil by GC-MS Analysis
Analysis of Eucalyptus globulus volatile oil was done using GC-MS. Analyses were carried out on
an HP 6890 gas chromatograph (Agilent Technologies, Wilmington, DE, USA) fitted with an HP-5MS
fused silica column (30 m × 0.25 mm, 0.25 μm film thickness), interfaced with an HP mass selective
detector 5790A (Agilent Technologies) operated by HP Enhanced ChemStation software. The oven
temperature program was 45–280 ◦C (2 ◦C/min). The injector temperature was 250 ◦C; the carrier
gas was helium, adjusted to a linear velocity of 30 cm/s; the splitting ratio was 1:20 and the detector
temperature was 250 ◦C. Separate peaks were recognized by comparison of their Retention Index (RI)
to RI of authentic models, and by comparing their mass spectra with the NIST 2007 (National Institute
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of Standards and Technology, Gaithersburg, MD, USA) and Wiley 6.0 library (New York, NY, USA)
mass spectral database and the literature [23].
2.2.2. In Vitro Antioxidant Activity
DPPH Radical Scavenging Assay
The radical scavenging effect was evaluated with a spectrophotometric assay based on the
reduction of an ethanol solution of DPPH [24]. Briefly, a series of dilutions of EGEO was made. Then,
1.5 mL of each concentration was mixed with 1.5 mL of a 30 μg/L ethanoic DPPH solution that was
incubated at laboratory temperature in a dark storeroom for 40 min. Afterward, the absorbance at
520 nm (maximum absorbance of DPPH) was noted spectrophotometrically. Separately, a negative
control was made comprising all reagents except the EGEO. The free radical scavenging effect of each
solution was then measured and calculated as percentage inhibition in accordance to the following
equation:





where DPPHs corresponds to the absorbance of DPPH with the sample and DPPHb to the absorbance
of DPPH without sample (blank).
The antioxidant ability was recorded as the IC50 (medium inhibitory concentration). The IC50
is defined as the quantity of antioxidant required to reduce the primary DPPH quantity by 50%.
The results are expressed as the mean ± standard deviation (SD) of three tests. Ascorbic acid and BHA
were used as positive standards.
Metal Chelating Activity
Briefly, different concentrations of 1 mL of EGEO were dissolved in DMSO and added to a solution
of 0.05 mL of 2 mM FeCl2 in H2O. The reaction was started by adding 0.02 mL of 5 mM ferrozine.
The mixture was vigorously shaken and incubated at room temperature for 15 min. The absorbance
of the EGEO sample was then estimated and determined at 565 nm using a spectrophotometer [24].
The metal chelating activity was expressed according to the following formula:






Gallic acid, ascorbic acid and BHA were used as positive standards. The amount of inhibition by
the test samples was expressed as the percentage of concentration required to do 50% inhibition (IC50).
2.2.3. In Vitro Antimicrobial Effect of EGEO
Disc Diffusion Method
Microbial media used for culture and growth of bacterial and fungal strains were MHA and
SDA, respectively. Inoculum of each bacterial and fungal species to be tested was prepared with fresh
cultures by suspending the strain in isosaline (0.9% NaCl). In the first step, the antimicrobial potential
of EGEO was explored with the disc diffusion assay [7]. Antibiotic discs of amoxicillin-clavulanic
acid, erythromycin, chloramphenicol and antiseptic solution of hexamidine were used to control the
antibacterial of isolated micro-organisms strains according to the NCCLS guidelines [25]. Discs without
EGEO were considered as a negative control. Filter paper discs (diameter 9 mm) were saturated with
three different quantities (20, 40 and 60 μL per disc) of Eucalyptus EO and sited in the inoculated
microbial media (MH for bacteria and SDA for fungi). After keeping at laboratory temperature
for 40 min, the Petri dishes were incubated at 37 ◦C/24 h for bacterial strains and at 25 ◦C/72 h
for fungal strains. The microbial inhibitory effect was calculated by measuring the diameter of the
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growth-inhibition zone (DIZ) in mm (including filter diameter of 9 mm) for the tested species and
compared to the antibiotic standards.
Disc Volatilization Assay
The usual assay setup as designated by Tyagi et al. [7] was followed. Briefly, a 0.1 mL portion of
each suspension was spread over the surface of MHA (bacteria) or SDA (fungi) plates. A filter disc
was placed on the inside external of the upper lid and 10 μL EGEO was placed on each disc. The Petri
dish inoculated with strains was directly overturned on top of the lid and wrapped with parafilm to
avoid the escape of EGEO vapor. Petri dishes were incubated at 37 ◦C/24 h for bacterial strains and at
25 ◦C/72 h for fungal strains. The microbial inhibitory effect of Eucalyptus volatile oil was estimated
by calculating the DIZ of bacterial and fungal growth above the disc. Blank discs were used as a
negative control. The quantity of EGEO used was varied (20, 40 or 60 μL) by using a suitable number
of sterile discs.
2.2.4. Orangina Juice Preservation by Eucalyptus globulus Oil and Moderate Heat Processing
Preparation of Orangina Juice Inoculated with a Yeast Strain (Saccharomyces cerevisiae)
Orangina fruit juices were purchased from a local company (Djgaguen Company, Blida city,
Algeria). The suspension of Saccharomyces cerevisiae was added to Orangina beverage, and the inoculated
juices were moved into 250 mL sterilized glass flasks.
Orangina juice is a lightly carbonated beverage made from carbonated water, 12% citrus juice (10%
from concentrated orange, 2% from an association of concentrated grapefruit, lemon, and mandarin
juices), as well as 2% orange pulp. Orangina juice is sugared with high fructose corn syrup and natural
orange flavors are added. Preservatives such as benzoate sodium (E211), potassium sorbate (E202) and
citric acid (E330) are also added. All Orangina bottles were kept at 4 ◦C.
Influence of Eucalyptus globulus Essential Oil Alone
Tween 80 solution (0.5%) of EGEO was added in the inoculated Orangina at different doses (0.8, 2
and 4 μL/mL). The Orangina sample inoculated with Saccharomyces cerevisiae alone was considered as
a positive standard. Afterward, the flasks were kept at laboratory temperature for up to 6 days and
juices were drawn on days 0, 2, 4, and 6.
The microbiological method used for yeast counts was the standard plate count (SPC) agar method.
This method is used by the food industry for estimating the microbial populations in most types of
juices products and samples and for determining the quality and sources of contamination at successive
stages of processing. All Orangina fruit juices were successively diluted and plated on SDA medium.
The petri dishes were incubated for 48 h at 25 ◦C and CFU counts were estimated. The effect of different
doses of EGEO treatment was measured in a time-dependent way by the difference in log CFU/mL of
the inoculated S. cerevisiae [7].
Influence of Eucalyptus globulus Essential Oil and Moderate Heat Processing: Combined Action
Three different doses (0.8, 2 and 4 μL/mL) of EGEO were added and mixed to inoculated Orangina
fruit juice vials and were exposed to a medium heat treatment (70 ◦C) for 2 min [7]. Then, the flasks
were deposited at laboratory temperature for up to 6 days and juices were drawn on day 0, 2, 4, and 6.
All Orangina fruit juices were successively diluted and plated on SDA medium. The Petri dishes were
incubated for 48 h at 25 ◦C and CFU counts were estimated. The effects of different doses of EGEO in
association with medium heat treatment were measured in a time-dependent way by the difference in
log CFU/mL of the inoculated S. cerevisiae.
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2.3. Statistical Analysis
The significance of variances was analyzed using the test of one-way ANOVA followed by Tukey’s
post hoc multiple comparison test. Differences with p < 0.05 between experimental groups were
considered statistically significant. Statistical data analysis was performed using XLstat 2014 software,
Addinsoft, Paris, France. For all tests, three replicates were done and the final results represent the mean
of these repeats with standard deviation. The IC50 (median inhibitory concentration) was calculated
from the dose-response curve obtained by plotting percentage inhibition versus concentrations.
3. Results
3.1. Chemical Composition of Eucalyptus globulus Essential Oil
Six compounds were identified with GC-MS (Table 1). The major constituent of the EGEO was
1,8-cineole or eucalyptol (94.03% ± 0.23%), followed by α-pinene (94.03% ± 0.23%) and γ-terpinene
(94.03% ± 0.23%). The concentration of other compounds in the EGEO was less than 1%.
Table 1. Chemical profile of EO from Eucalyptus globulus analyzed with GC-MS.
Retention Time (RT, min) RI § Name # Concentration (%)
8.777 925 α-Pinene 2.93 ± 0.1
9.685 969 β-Pinene 0.20 ± 0.02
10.110 983 Myrcene 0.19 ± 0.07
10.282 1000 α-Phellandrene 0.59 ± 0.02
10.886 1033 Eucalyptol (1,8-Cineole) 94.03 ± 0.23
11.282 1053 γ-Terpinene 1.93 ± 0.17
Oxygenated monoterpenes 94.03
Monoterpene hydrocarbons 05.86
# Compounds listed in order of elution from a non-polar column. § RI (retention index) calculated relative to
C6–C17 n-alkanes.
3.2. Antioxidant Effect of the EGEO
The antioxidant effect was determined by DPPH radical scavenging and metal ion chelating
activity (Table 2). The capacity of the EGEO to scavenge DPPH radical and its reducing ability was
assessed on the basis of its dose giving 50% inhibition (IC50). In addition, its ability to chelate Fe2+
metal ions was evaluated and calculated using different doses. The radical scavenging activities of
positive controls (BHA and ascorbic acid) were more active than those obtained from EGEO. However,
EGEO had a superior metal ion chelating activity with an IC50 value of 8.43 ± 0.03 mg/mL, followed by
BHA (104.73 ± 7.30 mg/mL) and gallic acid (136.97 ± 9.09 mg/mL). Current results show that EGEO
has the best chelating activity.






Eucalyptus globulus Essential Oil 2.48 ± 2.24 C 8.43 ± 0.03 A
Positive Control (BHA) 0.13 ± 0.05 B 104.73 ± 7.30 B
Positive Control (Ascorbic acid) 0.018 ± 0.004 A 140.99 ± 3.13 C
Positive Control (Gallic Acid) — 136.97 ± 9.09 C
IC50 =medium inhibitory concentration; values are given as mean ± SD (n = 3). Means within the same column
followed by the same capital letters are significantly not different (p > 0.05) from one another according to the
ANOVA test followed by Tukey’s comparison tests.
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3.3. In vitro Antibacterial and Antifungal Effects
3.3.1. Disc Diffusion Assay
The microbial inhibitory effect of EGEO was assessed against different food spoilage
microorganisms: six yeast, six bacteria and five fungal strains. The results of the antibacterial
tests of EGEO are presented in Table 3. The EGEO displayed a dose-dependent inhibition effect.
EGEO was found to be active against all the Gram-positive bacteria species. The EGEO inhibited the
growth of Staphylococcus aureus, Bacillus cereus and Escherichia coli with DIZ ranging from 11 to 18 mm
at the lower volume of EGEO (20 μL/mL) and from 19 to 85 mm at the higher amount (60 μL/mL).
The DIZ increased with the increasing quantity (20, 40 and 60 μL) of EGEO in each paper disc. However,
no inhibitory action was found in the case of Pseudomonas aeruginosa. For the fungal strains, the DIZ
varied from 10 to 49 mm (Table 4). The highest DIZs were shown by Candida albicans ATCC (40 mm)
and Saccharomyces cerevisiae (49 mm) at a greater volume of EGEO (60 μL). The sensitivity of these
bacteria to chloramphenicol and EGEO can be explicated by the fact that they have a similar mechanism
of action on Gram-negative strains.
The highest susceptible yeast was Saccharomyces cerevisiae (49 mm), followed by Candida albicans
ATCC (40 mm), Trichosporon sp. (39 mm) and Candida parapsilosis (20 mm) (Table 4). Further, the DIZ
due to the Eucalyptus volatile oil was bigger for yeast and Gram-positive strains than for mycelial
species and Gram-negative bacteria.
3.3.2. Disc Volatilization Method
The in vitro antifungal and antibacterial effects of EGEO were assessed according to the absence
or the presence of inhibition zones. The DIZ resulting from the exposure to EGEO vapors is shown
in Tables 3 and 4. The DIZ due to the same quantity of EGEO was larger for yeast than for mycelial
species (Figure 1A,B).
Table 3. Susceptibility of bacterial strains to Eucalyptus globulus essential oil and to classic antibiotics
(positive controls).
DIZ (mm) a
Disc Diffusion Technique Disc Vapor Technique
Bacterial Strains Volume of EGEO (μL) per Disc Positive Control b
Gram-negative bacteria 20 40 60 20 40 60 AMC E C
Pseudomonas aeruginosa - - - - - - - 16 14
Enterobacter sakazakii 12 15 25 - 85 85 - 19 27
Klebsiella ornithinolytica - 10 19 - - - - 22 12
Escherichia coli 11 19 34 - - 36 12 19 7
Gram-positive bacteria
Bacillus cereus 15 35 50 24 40 59 25 35 24
Staphylococcus aureus 18 48 85 41 85 85 26 R 16
a Diameter of inhibition zone (mm) comprising a disc diameter of 9 mm; b Amoxicillin-clavulanic acid (AMC,
20/10 μg), erythromycin (E, 15 μg) and chloramphenicol (C, 30 μg) were tested as a positive control for microbial
species. EGEO: Eucalyptus globulus essential oil. (-) No activity.
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Table 4. Susceptibility of fungal strains to Eucalyptus globulus essential oil and antiseptic solution.
DIZ (mm) a
Disc Diffusion Assay Disc Volatilization Assay
Fungal Strains Quantity of EGEO (μL) per Disc Hex b
Yeasts 20 40 60 20 40 60 40
Candida albicans ATCC - 11 40 - - - 30
Candida albicans (Ca1) 10 25 27 - - 53 85
Candida albicans (Ca2) 14 19 24 85 85 85 13
Candida parapsilosis 12 17 20 85 85 85 30
Saccharomyces cerevisiae 11 37 49 - - 59 -
Trichosporon sp. 16 34 39 21 85 85 42
Molds
Aspergillus niger (An1) 12 21 29 - - - -
Aspergillus niger (An2) - 10 15 - - - -
Aspergillus fumigatus - - - - - - -
Aspergillus flavus - - - - - - -
Aspergillus brasiliensis
ATCC - - 14 - 43 85 14
a Diameter of inhibition zone (mm) including a disc diameter of 9 mm; b Antiseptic solution (Hoxamidine 0.1%)
used as a positive control for fungal strains. EGEO: Eucalyptus globulus essential oil; (-) No inhibitory effect; ATCC:
American Type Culture Collection.
 
Figure 1. In vitro inhibitory activity of Eucalyptus globulus essential oil against bacterial and fungal
species: Disc diffusion (A) versus vapor diffusion (B) methods using three different quantities of EO
(20, 40 and 60 μL/disc). Red arrows are the diameter of the inhibitory zone (DIZ).
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As detected in the previous analyses using EGEO in the liquid phase, the DIZ due to EGEO vapors
augmented with an increasing amount of the EGEO and followed a similar tendency with respect to
the different microbial species. Nevertheless, in comparison with the liquid phase, the EGEO vapors
resulted in considerably superior DIZ in all the yeast strains tested, except Candida albicans ATCC.
In addition, a total inhibitory effect (85 mm) of EGEO vapors was found in the case of Staphylococcus
aureus and Enterobacter sakazakii bacterial strains. However, no inhibitory action was found for
Aspergillus species, Pseudomonas aeruginosa and Klebsiella ornithinolytica. Candida albicans (Ca2) and
Candida parapsilosis were the most sensitive yeasts to EGEO vapors because total inhibition zones were
generated using 20, 40 and 60 μL of EO per disc.
3.4. Orangina Fruit Juice Preservation
3.4.1. Effect of Varying Dose of EGEO
As EGEO was active to inhibit different food-borne spoilage bacteria and fungi in in vitro methods,
its effect in a fruit juice matrix (Orangina juice) was also studied (Figure 2). The reduction in viability
of Saccharomyces cerevisiae due to EGEO use in a concentration-dependent way (0.8, 2 and 4 μL/mL)
and a time-dependent manner (i.e., 0, 1, 2, and 6 days) was evaluated. Complete growth inhibition
was observed in Orangina fruit juice only when a high concentration of EGEO (4 μL/mL) was used.
However, the doses of 2 and 4 μL/mL did not show an important decrease in the final amount of yeasts






























HT: Heat Treatment 
PG: Positive Control 
EGEO 0.8 μL/mL 
EGEO 2 μL/mL 
EGEO 4 μL/mL 
Figure 2. Effect of different doses of EGEO (0.8, 2 and 4 μL/mL) on the viability of Saccharomyces
cerevisiae cells in Orangina beverage during storage. The fungal growth was followed up to 6 days
after the application. HT: Heat treatment at 70 ◦C for 2 min; PG: Positive control or juice with synthetic
antimicrobial additives (sodium benzoate and potassium sorbate); EGEO: Eucalyptus globulus essential
oil; CFU: Colony-forming unit. * significant difference (p < 0.05) according to ANOVA one-way analysis
followed by Tukey’s post hoc multiple comparison tests.
3.4.2. Combined Effect of EGEO and Moderate Heat Processing
The log decrease in CFU count of the Saccharomyces cerevisiae due to the associated action of
EGEO at different doses along with medium heat treatment at 70 ◦C for 2 min of Orangina juices was
calculated for a specific time interval (0, 1, 2 and 6 days). In juices treated using an association of
medium heat processing and all EGEO doses, total fungal inhibition of Saccharomyces cerevisiae was
recorded on first sampling after 2 days (Figure 3). Therefore, the association of medium heat processing
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with EGEO reduced the EGEO concentration requirement considerably. Even in the Orangina juices
treated with a lower quantity of EGEO, the association of medium heat processing at 70 ◦C for 2 min
improved the log reduction by 3.5 log CFU/mL in comparison to EGEO-treated juices. Therefore, the


























HT: Heat Treatment 
G: Positive Control 
EGEO 0.8 μL/mL 
EGEO 2 μL/mL 
EGEO 4 μL/mL 
Figure 3. Effect of EGEO at different doses (0.08, 0.2 and 0.4 μL/mL) in association with moderate
heat processing (70 ◦C for 2 min) on the viability of Saccharomyces cerevisiae cells in Orangina beverage
during storage. The fungal growth was followed up to 6 days after the heat processing. HT: Heat
treatment at 70 ◦C for 2 min; PG: Positive control or juice with synthetic antimicrobial additives (sodium
benzoate and potassium sorbate); EGEO: Eucalyptus globulus essential oil; CFU: Colony-forming unit.
* significant difference (p < 0.05) according to ANOVA one-way analysis followed by Tukey’s post hoc
multiple comparison tests.
4. Discussion
As published in previous reports, the EO of the Eucalyptus genus was described by a great quantity
of 1,8-cineole (eucalyptol). Current data are in accordance with those published by Elaissi et al. [18]
and Goldbeck et al. [26], who found that the principal chemical element of EGEO was eucalyptol.
The chemical composition of a diversity of other Eucalyptus species have been reported [7,19,27] and
are also in accordance with our data.
Different percentages of eucalyptol in Eucalyptus globulus leaf EO have been shown: 53.7% in
Tunisia, 14.5% in Germany, 33.6% to 66.7% in India and 71% in Brazil. The majority of EO extracted
from Eucalyptus trees contains at least 10% to as high as 97% eucalyptol (1,8-cineole). Ecological
position (Table 5), climatic conditions and extraction methods have been invoked as reasons for the
chemical composition disparities and variations [18,20].
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Table 5. Comparison of the chemical composition of Eucalyptus essential oil from different countries.
Plants Country Period Method Composition (%) Authors
E. globulus Spain
Hydrodistillation of leaves and
small branches of the tree.
Certified as biological products to































































































A few investigations have been completed to study the antioxidant activity of different Eucalyptus
EO such as E. globulus [28,30,34–37]. Our IC50 values are not in agreement with those published for
the DPPH radical scavenging method [34]. The scavenging activity on the DPPH radical reported as
IC50 value was 57 μg/mL for Tunisian EGEO, but this result is inferior as compared to the BHT value
obtained with the same test (11.5 μg/mL) [34]. E. tereticornis EO presented powerful DPPH, OH and
O2− radical scavenging activity [35]. In opposition, E. camaldulensis and E. radiata EOs have been
reported to display a medium DPPH scavenging effect [38]. This variance in antioxidant power may
be related to the variation in chemical composition, distillation methods and environmental aspects,
age of the trees, storage conditions and geo-climatic situations [12].
In addition, Singh et al. [35] tested the Eucalyptus EO and its three main oxygenated terpenes
(isopulegol, β-citronellol and citronellal) for antioxidant and scavenging effect. The authors reported
that the EO extracted from Eucalyptus displayed medium to powerful antioxidant effect in terms of metal
chelating (877.3% ± 9.27% inhibition), DPPH radical (IC50 = 425.4 ± 6.79 mg/mL) and lipid peroxidation
inhibition. This research revealed that Eucalyptus EO leaves contain oxygenated monoterpenes rich EO
presenting antioxidant action.
The chelating property on metal ions is one of the important mechanisms of antioxidant activity.
Eucalyptus EO showed a better chelating effect (8.43 ± 0.03 mg/mL) on ferrous ions in comparison
with standards (BHA = 104.73 ± 7.30 mg/mL and ascorbic acid = 140.99 ± 3.13 mg/mL). Analysis of
metal ion chelating activities revealed that all EOs extracted from Eucalyptus species were capable of
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chelating iron (II) in a dose-dependent way [9]. Another study reported that the antioxidant action of
phytochemicals in lemon eucalyptus oil may be due to their redox activities of the phenolic compounds
and oxygenated terpenes and that make them good reducing, scavenging and chelating EO [8]. One of
the probable modes of action of the antioxidative effect is the chelation of transition metals.
There are very limited published studies about the antioxidant property of eucalyptol as the
principal chemical compound of the EGEO [36]. Consequently, antioxidant property detected for the
volatile oil could be linked to the remaining compounds [35]. El-Ghorab et al. [37] revealed a medium
antioxidant property by preventing the oxidative alteration of linoleic acid (20%) for 12 days for the EO
of Eucalyptus camaldulensis. Instead, EOs extracted from aerial parts of Eucalyptus camaldulensis, growing
wild in different regions of Sardinia Island (Italy), have exhibited an in vitro antioxidant potential
that varied between 0.5 and 5.8 mM [38]. The mode of action involved in the lipid peroxidation and
inhibition of DPPH assay is not analogous, thus, the results of the current experiment are not similar to
those formerly published by El-Ghorab et al. [37] and Barra et al. [38] because the positive controls and
units used in both assays for the determination of the IC50 values are not identical.
Numerous published reports have assessed and confirmed the in vitro antibacterial, anti-yeast
and antifungal potential of EGEO against a varied collection of pathogens [39,40]. For example,
Eucalyptus citriodora EO has been demonstrated to have a wide range of anti-yeast action. Moreover,
Eucalyptus urophylla and Eucalyptus camaldulensis EOs are also recognized for their microbial inhibitory
effect [38]. Though much research has been dedicated to the antifungal and anti-yeast effects of
EGEO [40], only a limited number of studies have estimated their bio-activity against foodborne
bacteria and fungi [7]. Damjanović-Vratnica et al. [41] reported 85.8% of eucalyptol in EGEO from
Montenegro and demonstrated its important and significant effect in the inhibition of different yeast
and bacteria growth. Furthermore, another study [18] revealed powerful antiviral, antiseptic and
antimicrobial activities of eight EGEOs from Tunisia.
The microbial inhibitory action of EGEO has been shown to diverge considerably within
microorganisms and species. The higher antiseptic potential could be directly linked to their main
chemical constituents detected in the EGEO (such as eucalyptol and α-pinene) or with the interaction
among the minor and major components [18]. Previously published studies revealed that Gram-positive
strains are more vulnerable than Gram-negative bacteria; the inhibitory effect against yeasts (C. albicans
and S. cerevisiae) and fungi (Aspergillus, Mucor, and Penicillium species) has also been investigated [7].
According to one of the reports, Eucalyptus odorata volatile oil presented the strongest in vitro inhibitory
effect against micro-organisms and Eucalyptus bicostata EOs possess the greatest antiviral action [18].
The EGEO vapor could be extremely active against food spoilage microorganisms in minor doses
in comparison with the liquid diffusion, thus producing less influence on the organoleptic and sensorial
food properties [42]. Hence, estimating the in vitro antifungal and antibacterial actions of EGEO vapor
might open up a promising dimension with many possible uses, especially in the food industry.
Current data obtained by both vapor diffusion and agar disc diffusion tests were not similar.
The efficiency of the EGEO had previously been described but their use in the vapors phase requires
an advanced approach [20]. This could be related to the variance in the chemical composition profile
of the vapors and liquid oil because the oil must be enriched in terms of its volatile compounds [7].
A supplementary clarification that has been proposed for the vapor phase being more active is that
the hydrophobic compounds in the aqueous phase associate to create micelles and thus restrain that
connection of the EO to the microorganism, while the vapor phase permits free attachment [43]. Despite
published papers on the in vitro antibacterial and antifungal properties of EGEO, few published articles
exist on the bioactivity of EGEO vapors. The research done by Goni et al. [44] showed that the in vitro
antibacterial activity of a combination of cinnamon and clove volatile oils presented a greater inhibitory
action with less active doses in the vapor phase in comparison to the liquid phase.
Current results revealed that Algerian EGEO was effective against all yeast and Gram-positive
bacteria strains. Previous data already showed that EGEO has in vitro inhibitory activity against
several microorganisms [7,18]. For example, EGEO displayed powerful action (with 14.3 to 18.2 mm
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DIZ) against different bacterial species (S. aureus, E. coli, and A. faecalis) and no inhibitory effect was
reported against yeast strain (C. albicans) [45]. Vilela et al. [42] tested the in vitro antifungal property of
both the EGEO and its main compound (eucalyptol) against two Aspergillus strains. They obtained
complete inhibition when using the EGEO, while less antifungal activity was obtained when testing
eucalyptol alone. This proves that the potential synergistic influence of minor and main chemical
compounds defines the final in vitro inhibitory potential of the volatile oils [3]. Based on the chemical
profile of EGEO, it can be suggested that the in vitro antiseptic potential is seemingly due to its great
concentration of oxygenated monoterpenes (94.09%).
Tserennadmid et al. [46] assessed the antifungal activity of different volatile EOs such as lemon,
clary sage, marjoram and juniper in fruit juices. The minimum inhibitory concentration (MIC) of these
EOs in fruit juices was considerably greater than in vitro MIC values. As great doses of several EOs are
necessary to accomplish a suitable fungal inhibitory activity, undesirable levels of unsuitable tastes
and smells may exist [47]. To more decrease the necessary EGEO dose for monitoring the S. cerevisiae
load in Orangina juices, the interaction between EO and heat processing was evaluated.
To avoid the development of spoilage bacteria and yeasts in foods, numerous protection methods,
such as thermal processing, the additions of acids or salts, and drying have been investigated in food
production [48–52]. In this background, several volatile molecules and EOs containing oxygenated
monoterpenes (linalool, geraniol, citronellol, citral, limonene and pinene), combined with moderate
thermal processing, were tested to decrease the growth of S. cerevisiae in beverages [48].
In the last decade, numerous reports have revealed the incidence of additional activities when
associating EOs with moderate heat and high hydrostatic pressure actions [49,50,53,54]. Synergistic
effects between EOs with high hydrostatic pressure or moderate heat have been linked to the existence
of lethal damages in the external membrane of surviving microorganisms, which may help the entrance
of oil’s compounds into the cells.
The research of Cherrat et al. [50] revealed the superior effect of EOs extracted from Myrtus communis
and Laurus nobilis in association with medium thermal processing and high hydrostatic pressure
to accomplish a greater level of bacterial inhibition of food spoilage microorganisms, and as result,
decrease undesirable effects on sensorial food properties. Belletti et al. [48] have proved that the
addition of citral and Citrus EO to soft juices in association with moderate heat processing can avoid
yeast spoilage in beverages. In addition, the bacterial growth of Listeria innocua in orange juice was
inactivated by the addition of vanillin in relation to the entity of heat processing [51].
As the required EO concentration against foodborne and spoilage bacteria and yeast is affected
by the interactions of the EO chemical constituents with the food medium and ingredients, higher
quantities are necessary to achieve appropriate food preservative action. This undesirably influences
the organoleptic and sensorial properties of the foodstuff [7,52]. To resolve this problem, an interesting
alternative is the application of an association of moderate heat treatment with EOs, which improves the
antibacterial and antifungal effects of the EO influencing the vapor pressure of the compounds [55–57].
Consequently, the association of EOs with medium heat processing can be investigated for emerging
food conservation technologies. Few studies have focused on the association of EOs (Eucalyptus
and Mentha) with thermal processing at 55 ◦C [7,52]. This approach considerably decreases the EOs
concentration necessity, offers a very valuable interaction, as the rise of heating increases the quantity
of EO in the vapor phase, thus it improves its anti-yeast effect.
Belletti et al. [58] detected that neither the presence of the EO at their greater doses alone nor the
heat treatment alone, was able to maintain or decrease the yeast and fungal stability of the drinks
against Saccharomyces cerevisiae. In opposition, when applied in association, moderate heat processing
(55 ◦C, 15 min) improved the activity of EO compounds (pinene, linalool and citral) and made an
increase in their vapor pressure, which in turn amplified their chance to solubilize in the fungal cell
membrane. The current research also revealed the improvement in the antifungal effect of EGEO
on association with moderate heat action. The association of medium heat treatment with EGEO
application has not been formerly published for avoiding Orangina juice contamination. Current
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findings demonstrated that EGEO can be used with moderate heat action for the food protections of
Orangina juices.
5. Conclusions
Current findings revealed that EGEO could be used as a possible antifungal and antibacterial
agent against foodborne and food spoilage microorganisms. The chemical composition of the different
compounds characterizing the EGEO showed the predominance of oxygenated terpenes responsible
for the microbial inhibitory effect against pathogens. The use of the EGEO in association with moderate
heat processing effectively reduced the growth of spoilage yeast strain in Orangina fruit juices. Current
data offer an outstanding record of EGEO as an antifungal agent and propose its possible use for
beverage preservation. Supplementary research should be done to determine the effectiveness of
EGEO in order to use it as a natural additive in different food matrices and/or improvement of food
shelf life.
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From Eucalyptus globulus Labill. From Montenegro. Czech J. Food Sci. 2011, 29, 277–284. [CrossRef]
42. Vilela, G.R.; de Almeida, G.S.; D’Arce, M.A.B.R.; Moraes, M.H.D.; Brito, J.O.; da Silva, M.F.D.G.; da Gloria, E.M.
Activity of Essential Oil and its Major Compound, 1, 8-Cineole, from Eucalyptus globulus Labill., Against the
Storage Fungi Aspergillus flavus Link and Aspergillus parasiticus Speare. J. Stored Prod. Res. 2009, 45, 108–111.
[CrossRef]
43. Inouye, S.; Takizawa, T.; Yamaguchi, H. Antibacterial Activity of Essential Oils and Their Major Constituents
Against Respiratory Tract Pathogens by Gaseous Contact. J. Antimicrob. Chemother. 2001, 47, 565–573.
[CrossRef]
44. Goni, P.; López, P.; Sánchez, C.; Gómez-Lus, R.; Becerril, R.; Nerín, C. Antimicrobial Activity in the Vapour
Phase of a Combination of Cinnamon and Clove Essential Oils. Food Chem. 2009, 116, 982–989. [CrossRef]
45. Wilkinson, J.M.; Cavanagh, H.M. Antibacterial Activity of Essential Oils From Australian Native Plants.
Phytother. Res. 2005, 19, 643–646. [CrossRef] [PubMed]
46. Tserennadmid, R.; Takó, M.; Galgóczy, L.; Papp, T.; Pesti, M.; Vágvölgyi, C.; Krisch, J. Anti Yeast Activities
of Some Essential Oils in Growth Medium, Fruit Juices and Milk. Int. J. Food Microbiol. 2011, 144, 480–486.
[CrossRef] [PubMed]
47. Gutierrez, J.; Barry-Ryan, C.; Bourke, P. Antimicrobial Activity of Plant Essential Oils using Food Model
Media: Efficacy, Synergistic Potential and Interactions with Food Components. Food Microbiol. 2009,
26, 142–150. [CrossRef] [PubMed]
48. Belletti, N.; Kamdem, S.S.; Patrignani, F.; Lanciotti, R.; Covelli, A.; Gardini, F. Antimicrobial Activity of Aroma
Compounds against Saccharomyces cerevisiae and Improvement of Microbiological Stability of Soft Drinks as
Assessed by Logistic Regression. Appl. Environ. Microbiol. 2007, 73, 5580–5586. [CrossRef] [PubMed]
49. Espina, L.; Gelaw, T.K.; de Lamo-Castellvi, S.; Pagán, R.; Garcia-Gonzalo, D. Mechanism of Bacterial
Inactivation by (+)-Limonene and its Potential Use in Food Preservation Combined Processes. PLoS ONE
2013, 8, 0056769. [CrossRef] [PubMed]
50. Cherrat, L.; Espina, L.; Bakkali, M.; García-Gonzalo, D.; Pagán, R.; Laglaoui, A. Chemical Composition
and Antioxidant Properties of Laurus nobilis L. and Myrtus communis L. Essential Oils from Morocco and
Evaluation of Their Antimicrobial Activity Acting Alone or in Combined Processes for Food Preservation.
J. Sci. Food Agric. 2014, 94, 1197–1204. [CrossRef] [PubMed]
22
Appl. Sci. 2020, 10, 5581
51. Char, C.; Guerrero, S.; Alzamora, S.M. Survival of Listeria innocua in Thermally Processed Orange Juice as
Affected by Vanillin Addition. Food Control 2009, 20, 67–74. [CrossRef]
52. Tyagi, A.K.; Gottardi, D.; Malik, A.; Guerzoni, M.E. Anti-Yeast Activity of Mentha Oil and Vapours Through
In Vitro and In Vivo (Real Fruit Juices) Assays. Food Chem. 2013, 137, 108–114. [CrossRef]
53. Somolinos, M.; García, D.; Pagán, R.; Mackey, B. Relationship Between Sublethal Injury and Microbial
Inactivation by the Combination of High Hydrostatic Pressure and Citral or Tert-Butyl Hydroquinone.
Appl. Environ. Microbiol. 2008, 74, 7570–7577. [CrossRef]
54. Ait-Ouazzou, A.; Espina, L.; Gelaw, T.K.; de Lamo-Castellví, S.; Pagán, R.; García-Gonzalo, D. New Insights
in Mechanisms of Bacterial Inactivation by Carvacrol. J. Appl. Microbiol. 2013, 114, 173–185. [CrossRef]
55. Hyldgaard, M.; Mygind, T.; Meyer, R.L. Essential Oils in Food Preservation: Mode of Action, Synergies, and
Interactions with Food Matrix Components. Front. Microbiol. 2012, 3, 12. [CrossRef] [PubMed]
56. Gottardi, D.; Bukvicki, D.; Prasad, S.; Tyagi, A.K. Beneficial Effects of Spices in Food Preservation and Safety.
Front. Microbiol. 2016, 7, 1394. [CrossRef] [PubMed]
57. Boukhatem, M.N. Scientific Findings: The Amazing Use of Essential Oils and Their Related Terpenes as
Natural Preservatives to Improve the Shelf-Life of Food. Food Sci. Nutr. Technol. 2020, 5, 00021.
58. Belletti, N.; Kamdem, S.S.; Tabanelli, G.; Lanciotti, R.; Gardini, F. Modeling of Combined Effects of Citral,
Linalool and β-Pinene Used Against Saccharomyces cerevisiae in Citrus-Based Beverages Subjected to a Mild
Heat Treatment. Int. J. Food Microbiol. 2010, 136, 283–289. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution






Phytochemical Characterization and Bioactivity
Evaluation of Autumn Olive (Elaeagnus umbellata
Thunb.) Pseudodrupes as Potential Sources of
Health-Promoting Compounds
Giovanni Gamba 1,*, Dario Donno 1, Maria Gabriella Mellano 1, Isidoro Riondato 1,
Marta De Biaggi 1, Denis Randriamampionona 2 and Gabriele Loris Beccaro 1
1 Dipartimento di Scienze Agrarie, Forestali e Alimentari, Università degli Studi di Torino,
10095 Grugliasco (TO), Italy; dario.donno@unito.it (D.D.); gabriella.mellano@unito.it (M.G.M.);
isidoro.riondato@unito.it (I.R.); marta.debiaggi@unito.it (M.D.B.); gabriele.beccaro@unito.it (G.L.B.)
2 Mention Agriculture Tropicale et Développement Durable—Ecole Supérieure des Sciences Agronomiques,
Université d’Antananarivo, 101 Antananarivo, Madagascar; denisr07@yahoo.fr
* Correspondence: giovanni.gamba@unito.it; Tel.: +39-011-670-8646
Received: 11 May 2020; Accepted: 22 June 2020; Published: 25 June 2020
Abstract: Autumn olive (Elaeagnus umbellata Thunb.) is a deciduous shrub tree widely distributed in
Asia and Southern Europe and grown as ornamental species. It is locally used for human consumption,
as relevant medical value is attributed to the berries. Information about its composition, especially
concerning the characterization of bioactive and health-promoting compounds, is limited. The aim of
the present study is to evaluate the main bioactive compounds and nutraceutical proprieties of autumn
olive fruits, via high-performance liquid chromatography (HPLC) fingerprint and spectrophotometric
analysis, in order to strengthen the knowledge about this underrated species and promote potential
applications as a food supplement. Concerning nutraceutical traits, total polyphenolic content
(325.366 ± 13.019 mg of gallic acid equivalents (mg GAE)/100 of fresh weight (g FW)) and total
anthocyanin content (194.992 ± 0.817 mg of cyanidin-3-O-glucoside (mg C3G)/100 g FW) recorded
considerable values. The phytochemical fingerprint revealed the presence 23 bioactive compounds.
Polyphenols (65.56%) were the largest class, followed by monoterpenes (27.40%) and vitamin C (7.04%).
Anthocyanins were the most represented compounds among polyphenols (71.9%). The antioxidant
capacity (20.031 ± 1.214 mmol Fe2+/kg) was similar to that recorded for other small fruits with
proven health-promoting properties. The present work underlined the potential of E. umbellata as a
source of health-promoting bioactive compounds. Further studies should deepen the knowledge of
nutraceutical aspects, which turned out to be interesting.
Keywords: berry fruit; antioxidant activity; anthocyanins; HPLC fingerprint; underrated species;
multipurpose tree
1. Introduction
The genus Elaeagnus includes 98 species belonging to the Elaeagnaceae family [1]. This family
includes shrubs and small trees that produce fruits with a nutritional and ornamental value. Japanese
silverberry (Elaeagnus umbellata Thunb), also known as autumn olive or goumi, is a deciduous small
tree widely used along highways, as the hedges provide a protective screen against wind, and to
prevent soil erosion [2]. Due to its ornamental value, drought tolerance, adaptability to different
environments, and compact structure, it is grown in urban areas as a hedge [3]. Locally, it is employed
for making artefacts such as fencing, fodder, and baskets and as a fuel wood [4]. Originally from
Southern Europe, Central and Meridional Asia, it grows wild in its native range as a shrub, where the
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topographic features of the area limit the cultivation of extensive crops [5]. The autumn olive produces
almost spherical fruits called pseudodrupes: 7 mm long and deep-red at fully ripening stage, highly
attractive to birds, and locally used for human consumption. The fruit is astringent until ripe, when it
acquires a sweet-tart flavor. Pseudodrupes can be consumed fresh or processed for preserves, juices,
fruit rolls, and condiments [6]. They are composed of 69.4% moisture, 14.5% total soluble solids,
8.34% total sugars, and 1.51% acids. The content of ash, expression of the total mineral content, is
1.045% [7]. The berries are rich in oil, 7.43–8.11 g/100 g and 5.84–6.11 g/100 g, respectively, in pulp and
seed. The composition of these oils contains vitamin E (tocopherol) and phytosterols, which could
have significant values in medicine [4].
In the native range of the species, relevant medical value is attributed to the berries. Inhabitants
used to eat them, either raw or cooked, as a remedy to reduce blood pressure, against coughs, and for
pulmonary infections [7]. Recent studies have shown the antibacterial activity of aqueous extracts from
fruits of E. umbellata in inhibiting the growth of Staphylococcus aureus and Escherichia coli [8]. In some
areas of China, Japan, and Korea the fruits of E. umbellata are incorporated into the local diet, due to
their putative health benefits [9].
Little information is available regarding the cultivation of E. umbellata. It is considered an invasive
exotic species in multiple American states [3]. Until the early 1990s, there were only four recognized
cultivars in the US, that mainly differed due to their adaptations to different climatic regions [10]. In the
last few years, new cultivars were selected based on the color of the berries.
In Italy, this species is mainly used for ornamental purposes, as it can easily grow over 2 m, has little
white flowers with intense scent, and does not require specific plant care. Indeed, autumn olive is a
very rustic tree, resistant to cold temperatures and drought, and highly tolerant to pruning. Cultivation
areas also include coastal zones, since autumn olive can grow at high soil salt concentrations [11].
The berries are consumed fresh, a tradition derived from tropical and temperate Asia, the native
area of the species [12]. Few cultivars are available on the market, mainly selected and registered in
North European regions over the last years, which underlines the marginal role of the cultivation of
E. umbellata.
Thus far, few studies have explored the antioxidant and bioactive compounds of autumn olive.
Berries are a valuable source of carotenoids such as lycopene, α-cryptoxanthin, β-cryptoxanthin,
β-carotene, lutein, phytoene, and phytofluene. Regarding lycopene (15–54 mg/100 g), the concentration
is rather higher than in fresh tomato fruits [13]. Scientific research has reported on the anticancer
efficacy of lycopene, represented by a high singlet oxygen quenching ability, twice that of β-carotene
and 10 times that of α-tocopherol [5]. The total phenolic content, ranging from 190 to 275 mg of gallic
acid equivalents (mg GAE)/100 g of fresh weight (g FW), falls within the range of many other berry
fruits with proven health-promoting effects [14]. Furthermore, it is a source of vitamin C, whose content
ranges between 14–17 mg/100 g FW [4].
However, at the European and national level little information is yet available on E. umbellata,
due to the limited consumption of its berries. Several aspects of its composition and potential health
benefits need to be further explored, in particular regarding the polyphenol composition.
The objective of the present work is to enhance the knowledge of the autumn olive
(Elaeagnus umbellata Thunb.), evaluating its fruits as a potential source of bioactive and
antioxidant compounds. The main phytochemical compounds, selected on the basis of their
health-promoting demonstrated efficacy, were measured through the use of high-performance liquid
chromatography (HPLC).
2. Materials and Methods
2.1. Plant Material, Harvesting Site, and Sample Preparation
E. umbellata fruits were collected in the germplasm collection of the Department of Agricultural,
Forest and Food Sciences of the University of Turin (DISAFA), located in Chieri (45◦02′26.3” N,
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7◦50′16.8” E, at 305 m a.s.l.), Piemonte (northwest Italy). Berries were harvested manually (500 g for
each replication) at the beginning of November 2018 and randomized from three different trees, so
that each tree represented one biological replication. The ripening evaluation was based on pericarp
color and fruit development. This work is a preliminary research on the autumn olive; therefore,
the investigation did not focus on a single genotype, but rather on the entire E. umbellata species.
The climate of the area is temperate and for 2018 the average precipitation recorded a value of
approximately 770 mm. The soil at the germplasm repository is loam-clay.
After the harvest, berries were immediately stored in refrigerated containers and sent to the
laboratory at the DISAFA in Grugliasco (Province of Turin). Then, selection was performed in order to
discard any defective fruits from analysis. Finally, the samples were separated into two equal portions.
The same day of harvest, physio-chemical parameters were assessed using one portion. The other
portion was stocked for one day at 4 ◦C and 95% relative humidity and further used to extract the
bioactive compounds.
2.2. Chemicals
The solvents and chemicals used for extractions and analysis are described in more detail in the
Supplementary Materials. All the references (Company, City, State Abbr. and Country) are reported.
2.3. Determination of Morphological and Quality Parameters
One portion of the samples (250 g each replication) was used for the measurement of the fruits’
physio-chemical parameters. To assess width and length, a 0.01 mm sensitive digital caliper was used
(Traceable Digital Caliper-6”, VWR International, Milan, Italy). Weight was measured to the nearest
0.01 g (Mettler-Toledo AG, Greifensee, Switzerland). For the assessment of pH, total soluble solids
(TSS) and titratable acidity (TA), samples were firstly homogenized in a blender (Ultra-Turrax model
T25, Ika, Staufen, Germany) and later centrifuged at 4000 rpm for 10 min. The remaining samples were
stored at 4 ◦C and 95% relative humidity for further analysis.
The pH was determined on the fruit juice with the support of a potentiometric pH-meter (Crison,
Alella, Spain). The TSS, expressed as ◦Brix, was quantified with the aid of a digital refractometer
(Tsingtao Unicom-Optics Instruments, Laixi, China). Finally, the TA (meq L−1) was measured by
titration of a mixture of autumn olive juice (10 mL) diluted in Milli-Q water (90 mL) with the addition
of 0.2 M NaOH solution using an automatic titrator (Crison, Alella, Spain) to an end-point of pH 8.2.
2.4. Spectrophotometric Analysis
A single-beam UV–Vis spectrophotometer (1600-PC, VWR International, Milan, Italy) was used
to determine the total polyphenolic content (TPC), total anthocyanin content (TAC), and antioxidant
capacity (AC). The Folin–Ciocalteu colorimetric method was performed to assess the TPC [15].
The results were expressed as mg of gallic acid equivalents (GAE) per 100 g of fresh weight (FW).
Standard solution of gallic acid was prepared at 0.02–0.10 mg mL−1. The pH-differential method was
used for the evaluation of TAC [16,17], and results were reported as cyanidin-3-O-glucoside (C3G) per
100 g of FW (mg C3G/100 g FW). Anthocyanins demonstrate maximum absorbance at 515 nm at pH 1.0
and at 700 nm at pH 4.5. The colored oxonium form of anthocyanin predominates at pH 1.0, and the
colorless hemiketal form at pH 4.5. The pH-differential method is based on the reaction producing
oxonium forms. Finally, the AC was determined through the ferric reducing antioxidant power (FRAP)
assay [18], expressing results as millimoles of ferrous iron (Fe2+) equivalents per kilogram (solid food)
of FW. The standard curve was plotted using FeSO4·7H2O at 100–1000 μmol/L.
2.5. HPLC Fingerprint: Bioactive Compound Extraction
Polyphenolic compounds, organic acids, monoterpenes, and vitamin C were extracted following
effective protocols used in previous works [19,20]. The full description of the protocols used to extract
each compound class is fully explained in the Supplementary Materials.
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2.6. Chromatographic Analysis
2.6.1. Sample Preparation and Chromatographic Analysis
Before the HPLC-DAD (diode array detector) analysis, circular pre-injection filters were used
to filter methanolic extracts (0.45 μm, polytetrafluoroethylene membrane, PTFE). For the absorption
of the polyphenolic fraction for the vitamin C analysis, a C18 cartridge was applied for solid phase
extraction (Waters, Milford, MA, USA). Then, for dehydroascorbic acid (DHAA) derivatization into the
fluorophore 3-(1,2-dihydroxyethyl)furo(3,4-b)quinoxaline-1-one (DFQ), 750 μL of each sample were
diluted with o-phenylenediamine (OPDA) solution (18.8 mmol L−1). After 37 min in the dark, samples
were ready to be analyzed using HPLC-DAD [21].
Concerning the chromatographic analysis, an Agilent 1200 High-Performance Liquid
Chromatograph combined to an Agilent UV–Vis diode array detector (Agilent Technologies, Santa Clara,
CA, USA) was used. To separate the bioactive substances, a Kinetex C18 column (4.6 × 150 mm, 5 μm;
Phenomenex, Torrance, CA, USA) was used. The samples were analyzed using five chromatographic
methods and different mobile phases were used in order to separate and identify the compounds,
while UV spectra were recorded at different wavelengths [22] (the mobile phases are listed in Table S1).
In order to obtain a phytochemical fingerprint with all the relevant information on the chemical
composition, with a proper resolution and a reasonable analysis time, the chromatographic conditions
were set. To optimize the molecule separation, different linear gradients in different slopes were
used. Indeed, the same chemical class had similar compounds in term of structure. Since most
of the compounds were also weakly acidic, we added formic and phosphoric acid to enhance the
resolution and eliminate peak tailing. The selection of the wavelengths was essential to develop a
reliable fingerprint. As a matter of fact, only the selected wavelengths achieved more specific peaks, as
well as a smooth baseline after a full-scan on the chromatogram from 190 to 400 nm.
2.6.2. Identification and Quantification of Bioactive Compounds
For the quantitative determination of bioactive compounds, the external standard calibration
method was used. This is an effective method already performed with success in previous studies [19,20].
A more detailed description is reported in the Supplementary Materials (Table S2).
2.7. Statistical Analysis
The results were subjected to variance analysis (ANOVA) for comparison of means, followed by
Tukey’s honest significant different (HSD) multiple range test (p < 0.05). The samples were prepared
and analyzed in triplicate (three samples for three biological repetitions). Statistical analysis was
performed with SPSS Statistics 22.0 (IBM, Armonk, NY, USA, 2013).
3. Results and Discussion
3.1. Morphological and Quality Parameters
Japanese silverberry produced almost spherical fruits (6.92 ± 0.11 mm in width and 6.46 ± 0.08
mm in length) with a mean weight of 0.32 ± 0.02 g for each berry at fully ripe stage (Table 1). Results
are in accordance with previous research [6,7,11], except for the weight, which turned out to be slightly
higher [4].
Analysis on quality traits revealed a TSS mean value of 16.23 ± 0.15◦ Brix (Table 1). These findings
are partially confirmed in the literature: a study on Elaeagnus umbellata berries cultivated in five
different localities showed lower values of TSS [23], while the results of six autumn olive genotypes
grown in Cookeville (TN, USA) recorded TSS values ranging from 10.6 to 18.4◦ Brix [5].
28
Appl. Sci. 2020, 10, 4354
Table 1. Morphological, quality, and antioxidant traits of autumn olive fruits.
Parameter Unit of Measurement Mean Value ± SD
Weight (g) 0.32 ± 0.02
Width (mm) 6.92 ± 0.11
Length (mm) 6.46 ± 0.08
Total soluble solids (◦Brix) 16.23 ± 0.15
Titratable acidity (meq/L) 342 ± 79.37
pH (pH units) 3.53 ± 0.20
Total polyphenolic content (TPC) (mgGAE/100 gFW) 325.366 ± 13.019
Total anthocyanin content (TAC) (mgC3G/100 gFW) 194.992 ± 0.817
Antioxidant capacity (AC) (mmol Fe2+/kg) 20.031 ± 1.214
Mean value and standard deviation are given for each sample (n = 3).
Free sugars are among the principal constituents and are essential to determine the quality of
fruits [24]. Within the sugar class, many studies have reported fructose and glucose as the major
contributors of fruit flavor. As proof of this, fructose turned out to be 1.8 time sweeter than sucrose [25].
Many studies on oleaster fruits revealed fructose and glucose as the main sugars during ripening
stage [5,26], highlighting the palatability of Elaeagnus fruits.
Autumn olive berries had a pH mean value of 3.53 ± 0.20, falling within the range found in a
previous study (3.30–3.90) [23], although in contrast with the study of Khattak on the same species [27].
TA ranged from 252 to 402 meq/L, with a mean value of 342 ± 79.37 meq/L (Table 1). In order to make
this value comparable, it was converted in percentage of malic acid equivalent. Therefore, titratable
acidity was found to be 1.64% (equal to 1.64 g of malic acid/100 g), considerably lower than the findings
of Hussain [23] and Khattak [27], which were 2.20–2.94% and 3.1 ± 0.1%, respectively. The differences
in terms of TA could be due to many factors, among which locality, weather conditions, genotype
(cultivar), and agronomic techniques play a key role. Considering the non-climacteric attitude of the
berries, the time of the harvest is also essential in determining the TSS:TA ratio. All of these aspects
have to be taken into account when comparing fruits grown in tropical or sub-tropical areas rather
than in temperate regions [28].
The TSS:TA ratio of 9.90 observed in this study further emphasized the large intraspecific variability
of the E. umbellata fruits, partially confirming previous studies [5,23,27].
3.2. Antioxidant Potential Properties
Berry fruits have considerable amounts of health-promoting compounds, such as phenolic
compounds like phenolic acids, anthocyanins, tannins, and flavonoids [28]. Natural phenolic
compounds exert healthy actions by reducing oxidative stress and inhibiting macromolecular oxidations,
thus counteracting the risk of degenerative diseases [29].
Autumn olive is a multipurpose plant, whose fruits have been consumed over the centuries for
many uses. Among these, especially in the native range of the species, the berries have a relevant
medical value. To partially support the effectiveness of these local remedies, a study on E. umbellata
conducted in 2007 reported the capacity of the plant extracts to inhibit the growth of E. coli, S. aureus,
P. aeruginosa, and B. subtilis [8].
The TPC value is expressed in milligrams of gallic acid equivalents and recorded a considerable
value (Table 1), higher than other studies on the same species [5,14]. These results make autumn
olive berries comparable to other small fruits such as red raspberry (357.83 ± 7.06 mg GAE/100 g
FW), blueberry (305.38 ± 5.09 mg GAE/100 g FW), and cherry (314.45 ± 5.95 mg GAE/100 g FW) [28].
Regarding TAC, no values have been reported so far in this species. The clear identification of the
different Elaeagnaceae species and cultivars is often difficult; moreover, it is hard to find specific
information on the different species. However, the observed value of total anthocyanins (Table 1),
expressed as milligrams of cyanidin-3-O-glucoside (C3G) per 100 g of fresh weight, was higher than
those found on other berry fruits such as blackberry, strawberry, blueberry, and red currant, but lower
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than the values detected in black currant and black chokeberry [28,30]. The present results are in
accordance with previous research on different genotypes of Russian olive (Elaeagnus angustifolia L.),
where values ranged from 115.45 to 260.52 mg C3G/100 g FW and from 116.84 to 630.1 mg C3G/100 g
FW [31,32]. Genetic and environmental factors contribute to determining a large intraspecific variability
on these parameters, as confirmed by the results in literature.
Ferric reducing antioxidant power (FRAP), a technique based on the ability of antioxidants to
reduce ferric (III) ions to ferrous (II) ions, was performed to assess the antioxidant activity. There are
several techniques to estimate this parameter. Among them, FRAP methodology represents a fast,
low-cost, and comparable in vitro method widely used for screening. Despite the abundance of
phenolic and antioxidant compounds, only a few studies report the antioxidant capacity of Elaeagnus
berries. The value obtained in this study (Table 1) is very close to the ones observed for similar
berries with demonstrated health-promoting properties, such as cornelian cherry (Cornus mas L.)
and jostaberry (Ribes x nidigrolaria Rud. Bauer & A. Bauer) at 20.41 mmol Fe2+/kg and 24.09 mmol
Fe2+/kg, respectively [33,34], but lower than other common berries such as blackberry (Rubus ulmifolius
L.) 79.17 mmol Fe2+/kg, highbush blueberry (Vaccinium corymbosum L.) 49.45 mmol Fe2+/kg, black
currant (Ribes nigrum L.) 58.43 mmol Fe2+/kg, and white currant (Ribes rubrum L.) 85.97 mmol
Fe2+/kg [35]. The results of nutraceutical compounds are in accordance with a previous study on
Elaeagnus angustifolia (L.), member of the Elaeagnaceae family with berries similar to the E. umbellata
species [31]. The FRAP value was highly correlated with TAC (r = 0.929) and flavonols content
(r = 0.962), pointing out the main role of these compounds in antioxidant activities.
3.3. Organic Acids
Organic acids are located in the fleshy parts of fruits and can affect sensory properties and consumer
acceptability. A study conducted on juices of six cultivars of sea buckthorn (Elaeagnus rhamnoides L.),
a berry tree of the Elaeagnaceae family, found that titratable acidity had a positive correlation with the
intensity of sourness and astringency [35]. The quantity of organic acids can vary depending on many
factors; for example, in a study on two blueberry species native to Turkey (Vaccinium arctostaphylos
and V. myrtillus), the amount of malic, citric, and quinic acids changed significantly during different
ripening stages [36]. Other factors include cultivar choice, soil, and climate conditions. Organic
acids were the most represented secondary metabolites (1890 ± 182.02 mg/100 g FW) in E. umbellata
berries. The compounds detected were citric, malic, oxalix, quinic, succinic, and tartaric acids (Table 2).
Succinic was the primary organic acid (490.78 mg/100 g FW) accounting for about 25% of the total acid
concentration, followed by quinic (468.83 mg/100 g FW) and citric (370.15 mg/100 g FW). Results are in
accordance with previous studies on the autumn olive, where the main organic acids detected were
malic, quinic, and citric acids, although in smaller quantities [5,6]. Among the acids, citric was the one
with the higher correlation to titratable acidity (r = 0.932).
Table 2. Organic acids composition of autumn olive berries.
Citric Acid Malic Acid Oxalic Acid Quinic Acid Succinic Acid Tartaric Acid
Mean value 370.15 382.43 60.69 468.83 490.58 117.77
SD 14.28 15.65 6.34 39.76 18.20 22.48
The results are reported as mg/100 g FW (FW = fresh weight). Mean value and standard deviation are given for each
sample (n = 3).
3.4. Phytochemical Composition
Phytochemicals are secondary metabolites produced by plants. These bioactive non-nutritive
compounds may provide desirable health benefits to contrast the development of chronic diseases.
Indeed, the regular consumption of phytochemicals (antioxidant compounds) help to prevent or
slow oxidative stress caused by free radicals [37]. There is currently little available research on the
phytochemical composition of E. umbellata species.
30
Appl. Sci. 2020, 10, 4354
Several factors are relevant in determining the composition of bioactive compounds, such as
genetic and environmental factors. Among the environmental ones, soil composition, agronomic
management, and weather are the most influential variables. Nevertheless, the composition can change
due to oxidative reactions during processing and storage [38]. In addition, the analytical method
is discriminatory.
The phytochemical fingerprint of autumn olive berries was carried out via HPLC-DAD and
results on bioactive compounds are summarized in Table 3. The total bioactive compound content
(TBCC), expressed as the sum of the most important biologically active molecules detected in the
extracts and reported as mg/100 g of fresh weight, showed a mean value of 413.64 ± 39.96 mg/100 g
FW, considerably lower than commercial berries such as goji [39], but close to the value of cornelian
cherry [33]. The analysis revealed the presence of 23 compounds, grouped in three different classes
to evaluate each class contribution. Polyphenols, with a percentage of 65.56%, were the largest class,
followed by monoterpenes (27.40%) and vitamin C (7.04%).












ascorbic acid 5.66 0.70
dehydroascorbic acid 23.46 2.75
Cinnamic acids
caffeic acid 0.78 0.02
chlorogenic acid 10.93 0.13
coumaric acid 5.82 0.02








ellagic acid 5.50 1.17








The results are reported as mg/100 g FW (FW = fresh weight). Mean value and standard deviation are given for each
sample (n = 3).
Polyphenols are compounds derived from secondary plant metabolism, present at high levels in
several edible species. They perform many essential roles in plant physiology and as health-promoting
compounds. Their healthy properties in humans were first linked to their antioxidant activity. In
the last few years, recent findings have challenged this view, through the investigation of more
complex actions [40]. As discussed above, very little is known about the polyphenolic composition of
autumn olive berries. Among polyphenols, anthocyanins represent the most important compounds
(71.9%), followed by tannins (10.9%), cinnamic acids (6.9%), flavonols (6.3%), benzoic acids (2.1%),
and catechins (1.8%). Recently, a strong interest has been paid to the anthocyanins class, which may
be among the principal polyphenols responsible for health benefits [41]. Indeed, they show strong
anti-oxidant activity that helps to prevent several diseases such as cardiovascular illnesses, diabetes,
cancer, and inflammation [42].
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Monoterpenes, a class of volatile chemicals found in many fruits, were the second class of bioactive
compounds in terms of quantity detected (27.40% of TBCC). Among them, limonene was the most
represented compound found in autumn olive berries (34.34 mg/100 g FW). Many studies had focused
on the anticancer properties of limonene, highlighting the positive role of monoterpenes in fighting the
course of breast cancer [43].
The amount of vitamin C in E. umbellata berries was assayed as the sum of ascorbic and
dehydroascorbic acids, shown as the average value of 29.12 ± 3.46 mg/100 g FW. This was in line with
the findings of a previous study [27], but rather higher than previous research on E. umbellate [4,7].
Considering the ascorbic acid, berries recorded significantly lower values (5.66 ± 0.70 mg/100 g FW)
compared to other super fruits (strawberry 90.13 ± 2.24 mg/100 g FW, blueberry 73.21 ± 0.35 mg/100 g
FW, blackberry 52.41 ± 11.31 mg/100 g FW) [28]. However, autumn olive represents a good source of
vitamin C. The consumption of 100 g of berries may cover from 30% to 50% of the recommended daily
intake (60–90 mg/d) [44].
4. Conclusions
The preliminary results of this work allowed to contribute to the knowledge of E. umbellata fruits,
especially concerning their nutraceutical aspects. Little information is yet available on the properties of
this underutilized fruit. In addition, several factors make it difficult to recognize the different species
and genotypes of Elaeagnus.
Concerning the results of phytochemical traits, phenolic is the larger class, mainly represented
by anthocyanins. Although no comparable values are recorded yet for this species, studies on the
Russian olive (Elaeagnus angustifolia L.) confirm the high content of anthocyanins. The importance of
anthocyanins as health-promoting compounds is also represented by the positive correlation between
total anthocyanin content (TAC) and antioxidant capacity (r = 0.929). The total polyphenolic content
(TPC) is higher if compared to other studies on the same species, and similar to the values recorded for
other known superfruits such as red raspberry, blueberry, and cherry. The autumn olive berries also
contain a high percentage of organic acids, monoterpenes, and vitamin C.
To conclude, this work contributes to highlighting the potential of autumn olive as a source of
valuable bioactive compounds, both for fresh consumption and fruit-derived products. However,
further studies on E. umbellata will be fundamental to improve the knowledge of important aspects
such as phytochemical fingerprint, health benefits, and antioxidant activity.
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Abstract: The phenolic composition of olive fruits represents a vast and unique source of health
beneficial molecules due to the presence of specific phenolic compounds (PCs), such as verbascoside
(VERB), oleuropein (OLE) and its derivative molecules. Despite of being some of the most critical
compounds regarding olive oil quality, these PCs are mostly abundant in olive fruits and leafs due to
their hydrophilic nature. In olives, the phenolic profile suffers a deep and constant change along fruit
ripening being the phenolic alcohols, such as hydroxytyrosol (HT), mainly formed by OLE, and/or
OLE aglycone molecules degradation. The present work aims to study the maturation evolution
of olive fruits from two major traditional Portuguese cultivars, ‘Galega Vulgar’ and ‘Cobrançosa’,
in regard to their specific phenolic profile, as well as caliber (C), moisture (H), fat content in dry matter
(OPDW) and maturity index (MI). Results show that both cultivars present distinct phenolic profiles
along their ripening, with ‘Galega Vulgar’ reaching a high MI and OPDW at a much earlier ripening
stage (S3), in agreement with the moment when a maximum OLE accumulation was registered.
On the other hand, ‘Cobrançosa’ cultivar reached its higher MI and OPDW at S6 (harvest period),
coinciding also with high OLE concentrations. MI may be used as a prediction tool for ’Galega Vulgar’
optimal harvesting time evaluation, associated with higher OLE and VERB concentrations, which will
confer an additional protection towards diseases, that normally affect olive orchards.
Keywords: ‘Cobrançosa’ and ‘Galega Vulgar’ olive cultivars; phenolic compounds; oleuropein;
verbascoside; hydroxytyrosol; ripening stage; maturity index
1. Introduction
Oleuropein (OLE) represents the major phenolic compound (PC) found in olive fruit, ranging from
a wide spectrum of concentrations. Belonging to the secoiridoids class, a group of monoterpenoids
typical of the Oleaceae family [1], this class of compounds is, in general, glycosidically bound and
their biosynthesis occurs from the secondary metabolism of terpenes as precursors of various indole
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alkaloids [2]. In Oleaceae, secoiridoids usually derive from the oleoside type of glucosides, which are
characterized by the combination of elenolic acid and a glucosidic residue. In particular, OLE is an
ester of hydroxytyrosol (HT) with the oleosidic skeleton that is common and specific to the secoiridoid
glucosides of Oleaceae [3]. Besides OLE, verbascoside (VERB) is also a common phenolic glucoside
found in considerably high amounts and almost exclusively in the Oleaceae family [3]. This phenolic
compound is the main hydroxycinnamic derivative of the olive fruit, and is structurally composed
by a heterosidic ester of caffeic acid and HT [4]. The presence of these specific and unique phenolic
compounds (PC) in olive fruit, as well as their degradation derivatives, has been widely studied
and their strong antioxidant activity reported [5,6], showing to possess great health benefits upon its
regular ingestion, such as the prevention of atherosclerosis by inhibiting the oxidation of low density
lipoproteins and by scavenging several reactive oxygen species in the vascular wall [7–10].
Virgin olive oil (VOO) phenolic profile is mainly derived from the amount of phenolic glycosides
originally found in olive fruit, as well as the activity of specific oxidative and hydrolytic enzymes
during VOO processing [11], such as the highly specific β-glucosidases. These enzymes work in the
OLE degradation pathway as a physiological function of a defensive mechanism, which specifically
generates OLE-derived compounds with established antimicrobial activities, such as OLE aglycones
and, to an extent, HT and tyrosol [12]. HT is undoubtedly one of the most relevant PCs naturally
present in VOO [13–15]. Exhibiting a key role in the oxidative stability of VOOs, HT is responsible for
helping to maintain both organoleptic singularity and nutritional value of a specific VOO during its
shelf time [16].
The specific presence and abundance of olive fruits PCs has been proved to be cultivar
specific [11,17,18], as well as dependent from other factors, such as the ripening stage [19,20]. During the
maturation process, three main stages may be usually distinguished in olive fruit: a growth stage,
where main accumulation of OLE occurs; a green maturation stage, where fruit develops to its final size
and a reduction in OLE concentrations may start to be observed; and a black maturation stage, which is
characterized by the appearance of anthocyanins and where OLE levels continue to decrease [2,21].
Lipid biosynthesis and accumulation in olive fruit mainly occurs during the growth stage and is
generally concluded with the beginning of ripening [22]. For different olive cultivars also differences
in lipid accumulation may be observed, as García et al. [22] confirmed for two Spanish cultivars,
the lipidic biosynthesis of ‘Gordal’ cultivar was interrupted 2 weeks earlier when compared with
‘Picual’. Therefore, harvesting at an early ripening stage does not directly imply a loss of oil yield.
To date, the optimal harvesting period for VOO production has been mainly selected by traditional
ideologies rather than scientific criteria.
Regarding traditional Portuguese olive cultivars, not much information is available in terms of
the phenolic profile evolution along the ripening stages. Sousa et al. [23] evaluated the phenolic profile
of ‘Cobrançosa’ cultivar, but only two maturation stages were considered, semi-ripe and ripe, within a
three week interval. Gouvinhas et al. [24] studied the polyphenolic content along three ripening
periods for two Portuguese cultivars, ‘Galega Vulgar’ and ‘Cobrançosa’, however, only total phenolic
content was evaluated, instead of a more component specific approach.
Being both lipidic and phenolic biosynthesis cultivar specific and ripening related, we considered
of high relevace the PCs evaluation along the maturation process of two of the most relevant traditional
Portuguese olive cultivars, ‘Galega Vulgar’ and ‘Cobrançosa’. From an early ripening stage until
harvest, within a total of 70 days for ‘Galega Vulgar’ and 84 days for ‘Cobrançosa’, this study aims to
establish the best harvesting period for these two cultivars, when maximum lipidic concentration and
most favorable phenolic profile occurs, for best VOO quality production.
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2. Materials and Methods
2.1. Chemicals and Reagents
All reagents were of analytical or HPLC (High Performance Liquid Chromatography) grade, and used
as received. Methanol (MeOH) and acetonitrile were acquired from Merck (Darmstadt, Germany) and
acetic acid from Sigma-Aldrich (St. Louis, MO, USA). Double-deionized water was obtained with
a Milli-Q water purification system (Millipore, Bedford, MA, USA). Standard compounds such as
tyrosol, HT, and OLE were purchased from Molekula (Gillingham, Dorset, UK), while vanillic acid, rutin,
VERB, ferulic acid, luteolin, and cinnamic acid were acquired from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Olive Orchard Characterization
Olive samples from both ‘Galega Vulgar’ and ‘Cobrançosa’ cultivars were provided by Torre
das Figueiras—Sociedade Agrícola (Monforte, Portugal). These olive orchards were installed in 2006
within the characteristics of an irrigated intensive olive orchard with a distance between trees of
7 m × 5 m (286 tree/ha).’Cobrançosa’ cultivar was implemented in a total area of 3.44 ha with an
average field slope of 8%, with rows oriented in the northwest-southeast direction. ‘Galega Vulgar’
cultivar was implemented in a total area of 9.1 ha with an average field slope of 11%, with rows
orientation towards southwest-northeast.
2.3. Olive Sample Collection
Olive sampling was conducted during the year of 2019 and scheduled for every two weeks,
starting at an early ripening stage, 12 September, until 7 November. Additionally, another sampling
point was considered, for each cultivar, corresponding to the selected harvesting day, which was on
20 November for ‘Galega Vulgar’ and 4 December for ‘Cobrançosa’ (Table 1).
Table 1. Temporal distribution of sampling dates for each cultivar, ‘Galega Vulgar’ (Gal) and
‘Cobrançosa’ (Cob).
Sampling Reference Date Cultivar
S1 12-09-2019 Gal + Cob
S2 26-09-2019 Gal + Cob
S3 10-10-2019 Gal + Cob
S4 24-10-2019 Gal + Cob
S5 07-11-2019 Gal + Cob
S6 20-11-2019 Gal (harvesting day)
S6 04-12-2019 Cob (harvesting day)
Through all ripening periods, olive samples were always collected from the same trees, which were
distributed along four different blocks of the olive orchard (Figure 1). From each block, four consecutive
trees were selected for sampling, where olives were randomly handpicked at an average height of
1.80 m ± 0.20. Blocks were randomly selected along the geographical area of the olive orchards.
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(a) (b) 
Figure 1. Geographical distribution of sampling blocks (total of four different blocks, from B I to B
IV) considered for both ‘Cobrançosa’ (a) and ‘Galega Vulgar’ (b) cultivars. Both olive cultivars were
collected at Torre das Figueiras—Sociedade Agrícola (Monforte, Portugal).
2.4. Basic Physical Characterizations on Olive Fruit Samples
Fruit caliber (C) was measured by calculating the average weight of 20 randomly selected olives.
Maturity index (MI) was calculated according to the International Olive Council guidelines [25],
where 100 fruits were randomly collected and scored from 0 to 7, according to the coloring stage of both
skin and flesh, ranging from 0 as skin color deep green, to 7 as skin color black with all the flesh purple
to the stone. Then, by applying Equation (1), where the number of fruits (from A to H) is pondered for
each category (From 0 to 7), a MI value was obtained for each ripening stage.
MI =
A0 + B1 + C2 + D3 + E4 + F5 + G6 + H7
100
(1)
Humidity (H) and fat content (F) analyses were determined by NIR technology (FOSS Olivia™,
Denmark), which has been demonstrated to be a very reliable and comparable technique for olive
paste analysis [26]. For sample preparation, 300.0 ± 5.0 g of olives were crushed in a laboratory scale
mill (ALREN™, Spain) through a 4 mm pore grid. All samples were prepared and analyzed within a
maximum period of 8 h from sample collection. Oil content in the olive paste on a dry weight basis
(OPDW) was calculated according to Equation (2), where OPDW (%) represents the paste oil fraction




100−H × 100 (2)
2.5. Hydrophilic Phenolic Extraction
For the hydrophilic extraction of olive fruits, the pulp of 20 olives was randomly collected and
cut into fine pieces. The pulp (2.0 ± 0.1 g) was weighted in a 50 mL falcon tube and 20 mL of
MeOH added. The mixture was then homogenized on the Ultra Turrax® (IKA® T25 digital Ultra
Turrax, Germany) for 5 min at 20,000 rpm. Phase separation was made by centrifugation (10 min at
6000 rpm). Methanolic fraction was collected, and solid fraction re-extracted following the same process,
as described, for two more times. The hydrophilic extract was then evaporated to dryness in a rotary
evaporator under low pressure at 35 ◦C. The final extract was dissolved in 2 mL of methanol and
filtered through a Polytetrafluoroethylene (PTFE) 0.22 μm syringe filter before HPLC. Triplicates were
performed in three independent experiments.
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2.6. HPLC Analyses
For the chromatographic separation of HPC a previously published method by Ferro et al. [27] was
followed. The HPLC (Merck Hitachi LaChrome, Tokyo, Japan) consisted of a L7000 interface module,
a L7200 auto sampler, a L7350 column oven, a L7100 pump andaL-7420 UV detector, controlled by the
D-7000 HSM software. Compounds separation was monitored at a wavelength of 280 nm.
2.7. Statistical Analysis
For the statistical analyses and evaluation of the experimental data, one-way analysis of variance
(one-way ANOVA) was applied, for a confidence interval of 95%. All analyses were performed using
the software STATISTICA™ (version 8, StatSoft Inc., Tulsa, OK, USA).
3. Results
3.1. Basic Sample Characterization
Along the olive fruit ripening, measurements regarding C, OPDW, H and MI were conducted.
In Table 2, results for these parameters are presented in regard to both ‘Cobrançosa’ and
‘Galega Vulgar’ cultivars.
Table 2. Evaluation of olive fruit caliber (C), fat content in dry matter (OPDW), moisture (H) and
maturity index (MI) along ripening, for ‘Cobrançosa’ and ‘Galega Vulgar’ (mean ± standard deviation).
Cultivar Ripening Stage C (g) OPDW (%) H (%) MI
‘Cobrançosa’
S1 2.96 ± 0.90 a 18.74 ± 0.18 a 60.75 ± 0.64 a,b 0.070 ± 0.030 a
S2 3.2± 1.0 a,b 26.20 ± 0.54 b 61.04 ± 0.29 b 0.88 ± 0.02 b
S3 3.41 ± 0.69 b 29.56 ± 0.26 c 57.44 ± 0.22 c 1.03 ± 0.07 c
S4 3.2 ± 1.2 a,b 32.45 ± 0.11 d 57.215 ± 0.035 c 1.24 ± 0.11 d
S5 4.3 ± 1.1 c 36.27 ± 0.66 e 59.99 ± 0.33 a 2.16 ± 0.23 e
S6 3.8 ± 1.0 d 38.65 ± 0.72 f 56.91 ± 0.31 c 3.16 ± 0.17 f
‘Galega Vulgar’
S1 0.99 ± 0.33 A,C 26.920 ± 0.042 A 45.855 ± 0.049 A 0.090 ± 0.030 A
S2 1.10 ± 0.23 B 28.83 ± 0.20 B 47.28 ± 0.12 B 1.50 ± 0.20 B
S3 1.00 ± 0.22 C 34.59 ± 0.25 C 41.53 ± 0.23 C 3.670 ± 0.070 C
S4 1.68 ± 0.34 D 30.86 ± 0.86 D 52.68 ± 0.39 D 3.900 ± 0.030 D
S5 2.05 ± 0.35 E 34.69 ± 0.81 C 54.55 ± 0.33 E 3.990 ± 0.010 E
S6 2.04 ± 0.35 E 34.28 ± 0.63 C 53.27 ± 0.20 D 4.040 ± 0.030 F
a–f: Mean values of ‘Cobrançosa’ cultivar with a different superscript differ significantly (p-value < 0.05)
(comparison between ripening stages); for ‘Galega Vulgar’ capital letters were used.
Olive C was measured along the ripening process of the fruit. For ‘Galega Vulgar’, from S1 to S6
about 1 g of fruit mass was accumulated, maintaining constant mass from S5 forward, since no significant
differences (p-value > 0.05) were found between mass registered at S5 and S6. ‘Cobrançosa’ olives
registered a considerably higher caliber than ‘Galega Vulgar’, reaching its maximum weight at S5
ripening stage, with a total amount of 4.3 ± 1.1g. From S5 to S6 a significant loss of mass was registered
(p-value < 0.05), which may be related to the significant moisture loss register between these two
ripening stages. Regarding OPDW, ‘Cobrançosa’ showed a constant and significant oil increment
along ripening time (p-value < 0.05), presenting its maximum accumulation (38.65 ± 0.72%) at harvest
time (S6), with an increment of about 20% since the first sampling period (S1). With a comparatively
different behavior, ‘Galega Vulgar’ presented higher OPDW values at an earlier ripening stage (S1).
Highest OPDW accumulation was recorded at S5, with 34.69± 0.81%, but with no significant differences
from earlier ripening stage (S3) and harvest period (S6) (p-value > 0.05). Regarding moisture (H),
while ‘Cobrançosa’ presented a general decrease of fruit humidity over ripening, with a loss of about
3.84% from S1 to S6, ‘Galega Vulgar’ showed an opposite behavior, with a total moisture accumulation
of about 7.42%, for the same period.
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In agreement with OPDW, for both cultivars, highest MI increase was achieved when oil content
was at its maximum accumulation (Figure 2a,b). For ‘Galega Vulgar’, most significant increase on
MI was achieved at S3, with a score of 3.670 ± 0.070, and increasing a total of 2.17 from S2 to S3.
Its maximum MI was observed at S6 since maturity is a constantly evolving parameter, but from
S3 to S6 only a 0.41 increment was registered, and as it was observed (Figure 2a), the slope of MI
kinetics reduces greatly from S3 forward. On the other hand, ‘Cobrançosa’ greatest MI increase was
registered from S5 to S6, with a total increment of 1.00, where also maximum OPDW accumulation was
registered. Along the ripening process ‘Cobrançosa’ presented a more constant and linear evolution
in regard to MI and OPDW, when compared with ‘Galega Vulgar’. In fact, as Figure 2 illustrates,
both cultivars presented quite distinct kinetics in regard to MI, OPDW and H, with ‘Galega Vulgar’
reaching considerably high OPDW and MI at a much earlier ripening stage (S3).
(a) (b) 
Figure 2. Maturity index (MI) evaluation (a), and fat content in dry matter (OPDW) and moisture
(H) content evaluation (b) for cultivars ‘Cobrançosa’ (Cob) and ‘Galega Vulgar’ (Gal), along ripening
stages (S).
3.2. Phenolic Compounds Identification in Olive Fruit
Analysis of single PCs was carried by means of HPLC-RP, considering the specific retention
time of the reference compounds. For both cultivars, a total of nine PCs were identified (Figure 3).
Among these, VERB, and OLE were the most abundant PCs measured in both cultivars.
Figure 3. Chromatographic phenolic profile of ‘Cobrançosa’ (black) and ‘Galega Vulgar’ (red, thickener
line) olive fruits, belonging to block I at S1 sampling period. Identified phenolic compounds (PCs):
(1) hydroxytyrosol (HT); (2) tyrosol; (3) vanillic acid; (4) rutin; (5) verbascoside (VERB); (6) ferulic acid;
(7) oleuropein (OLE); (8) luteolin; (9) cinnamic acid.
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Considering that Figure 3 represents the overlapping chromatographic profile of ‘Cobrançosa’
(black) and ‘Galega Vulgar’ (red) at an early ripening stage (S1), it was clear that, at this ripening stage,
single PCs present a very distinct distribution regarding the cultivar. A much higher peak intensity
was registered for both VERB and OLE in ‘Galega Vulgar’, whereas rutin and ferulic acid were present
with higher intensity in ‘Cobrançosa’ profile.
3.3. Phenolic Profile Evolution over Ripening
Along the olive fruit maturation process, a total of six sampling periods were evaluated. OLE and
HT were the main PCs of interest, due to their bioactive properties and oxidative protection conferred
to the VOOs, as well as VERB, due to its relatively high amounts. The evolution of these specific PCs
was measured along the ripening process of both cultivars (Table 3).
Table 3. Quantification of hydroxytyrosol (HT), oleuropein (OLE) and verbascoside (VERB) (mg/Kg
of olive pulp) over six different ripening stages (S), for ‘Cobrançosa’ and ‘Galega Vulgar’ cultivars
(mean ± standard deviation).
Cultivar Sampling Reference HT VERB OLE
Cobrançosa
S1 105 ± 24 a 4514 ± 712 a 1236 ± 684 a
S2 108 ± 11 a 3604 ± 421 b 1689 ± 880 a,c
S3 118 ± 23 a,b 3394 ± 481 b 1619 ± 527 a,c
S4 130 ± 35 a,b,c 3179 ± 458 b 1790 ± 1084 a,c
S5 157 ± 46 c,d 2979 ± 473 b 1387 ± 652 a
S6 156 ± 46 b,d 2886 ± 618 b 3268 ± 2731 b,c
Galega
Vulgar
S1 98 ± 30 A 3043 ± 645 A 16,763 ± 15,173 A,B
S2 93 ± 22 A 3210 ± 494 A,B 7976 ± 1867 B
S3 71 ± 28 B 4247 ± 361 B 26,304 ± 10,930 A
S4 61 ± 30 B 2454 ± 379 A 4141 ± 1338 C
S5 82 ± 28 A,B 2559 ± 202 A 1582 ± 115 D
S6 126 ± 31 C 2448 ± 112 A 1908 ± 468 E
a–f: Mean values of ‘Cobrançosa’ cultivar with a different superscript differ significantly (p-value < 0.05)
(comparison between ripening stages); for ‘Galega Vulgar’ capital letters were used.
Regarding HT, for both cultivars considerably lower amounts were registered during ripening.
Highest values were observed for ‘Cobrançosa’ starting at S4 (130 ± 35 mg/kg) until the last collection
point (156± 46 mg/Kg). ‘Galega Vulgar’ also presented higher HT amounts at harvest (126 ± 31 mg/Kg).
Since HT mainly results from an enzymatic hydrolysis of OLE, the increase of HT towards harvest could
be expected. On the other hand, VERB was present at considerably higher amounts during ripening for
both cultivars. With a general decreasing tendency over time for both cultivars, ‘Cobrançosa’ registered
its maximum VERB accumulation at S1, with an average of 4514 ± 712 mg/Kg, while ‘Galega Vulgar’
showed it at S3, with an average amount of 4247 ± 361 mg/Kg. OLE presented the most distinguished
profile along the ripening stage regarding both cultivars. Within much lower concentrations, OLE was
registered with its higher amounts at S6 for ‘Cobrançosa’ (average value of 3268± 2731 mg/Kg) and S3 for
‘Galega Vulgar’ (average value of 26,304 ± 10,930 mg/Kg). While for ‘Cobrançosa’ OLE was maximum
at S6, ‘Galega Vulgar’ showed its minimum concentration (average value of 1908 ± 468 mg/Kg) at the
same time, affirming the distinct particularity that OLE profile presented for each cultivar. The range of
variability, registered for these quantifications, is also noteworthy. As shown, both cultivars presented
a notorious variability among sampling periods, mainly regarding OLE, which registered standard
deviations in the extreme ranges of ±2731 mg/Kg for ‘Cobrançosa’ at S6 (Figure 4a) and ±15,173 mg/Kg
for ‘Galega Vulgar’ at S1 (Figure 4b).
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(a) (b) 
Figure 4. Mean value± standard error (SE) and mean value± standard deviation (SD) representation for
oleuropein (OLE) concentrations regarding ‘Cobrançosa’ (a) and ‘Galega Vulgar’ (b) along ripening (S).
As described, samples were collected from four different blocks randomly selected within the
olive orchards (Figure 1). Results showed a great variability on PCs, mainly OLE concentrations,
within the different sampling blocks, despite of belonging to the same cultivar, in a similar water
regime and being subjected to the same agronomic practices and edaphoclimatic conditions.
To better visualize the sampling block effect on OLE variability, a discriminate approach
was applied, where distinct sampling blocks (I to IV) were analyzed separately for both





Figure 5. Ripening stage (S) profile of oleuropein (OLE) concentration regarding maturity index (MI)
for ‘Cobrançosa’ (a) and ‘Galega Vulgar’ (c), and fat content in dry matter (OPDW) for ‘Cobrançosa’
(b) and ‘Galega Vulgar’ (d).
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‘Cobrançosa’ showed block I to present the highest OLE concentrations at S6, with more than
6000 mg/Kg, while block II, for the same period, registered values below 1000 mg/Kg. Notably, within all
‘Galega Vulgar’ sampling blocks, a positive OLE peak and maximum, was registered at S3. Block III
showed its maximum OLE accumulation at S1 but no significant differences were found when compared
with S3 (p-value > 0.05). Concentrations ranged greatly among blocks for S3, with block III showing
the highest amount with values as high as 35,000 mg/Kg, while bock IV did not go higher than about
9000 mg/Kg. After this, a general OLE decrease until S6 was observed for all blocks.
Furthermore, regarding ‘Cobrançosa’ MI (Figure 5a) and OPDW (Figure 5b), maximum values
occured at S6 in agreement with the general maximum OLE concentration registered for this cultivar.
For ‘Galega Vulgar’ most relevant MI (Figure 5c) increase was reached at S3, with a score of 3.63,
coincident with highest OLE concentrations for all blocks. A similar tendency was observed with
OPDW accumulation (Figure 5d).
4. Discussion
‘Galega Vulgar’ and ‘Cobrançosa’ are two of most recognized Portuguese cultivars for VOO
production. From the six Protected Designation of Origin (PDO) products for olive oil registered in
Portugal, both ‘Galega Vulgar’ and ‘Cobrançosa’ are present in five of them, revealing their unique
quality and sensory characteristics when Portuguese VOO are considered. Olive fruit ripening is
a well-known variable that influences the presence and respective structural availability of specific
PCs [28]. As demonstrated by Peres et al. [29], PCs present an important role on the organoleptic
evaluation and nutritional value of the VOO derived from these two cultivars, being the phenolic
profile deeply related with the ripening stage. Therefore, harvesting date will influence the presence
of different taste notes and functional value of the produced VOO. As our results show, along the
ripening period, olive fruits from ‘Galega Vulgar’ achieved comparatively higher MI levels and OPDW
accumulation content at a much earlier stage (Figure 5c,d), in agreement with a previously reported
study regarding VOO derived from the same cultivars [30]. For both cultivars, a high correlation
between MI and OPDW was observed (r = 0.925 and r = 0.899, respectively for ‘Cobrançosa’ and
‘Galega Vulgar’), which confirms the MI as a good preliminary visual tool to predict appropriate
harvesting time for olive oil production [31]. However, when a high quality and functional VOO is
desired, other variables such as the phenolic fraction should be considered.
‘Galega Vulgar’ olive orchards are generally highly susceptible to diseases such as anthracnose [32],
which is the main phytopathological limiting factor affecting olive production in Portugal. This disease
may be caused by several fungus species belonging to the genus Colletotrichum and mainly affects
mature olive fruits, starting to be observed during the autumn [33]. Considering the MI and OPDW
reported in this study for S3 ripening stage of ‘Galega Vulgar’, aligned with the highest OLE and
VERB registered concentrations (respectively, 26,304 ± 10,930 and 4247 ± 361 mg/Kg), harvesting at
this considerably early stage (middle of October) could help reducing the susceptibility of anthracnose
occurrence for this cultivar, with no loss in the oil yield and taking advantage of a considerably high
phenolic content. As observed in Table 1, the harvesting day occurred approximately one month later,
which does not represent any significant increment (p-value > 0.05) in OPDW values (34.59 ± 0.25% at
S3 and 34.28 ± 0.63% at S6). Therefore, the MI can be a pmay be viewed as a good predictor for ‘Galega
Vulgar’ optimal harvesting time, associated with OLE and VERB higher concentrations, which might
confer an additional protection towards diseases that normally affect olive orchards. To the best of our
knowledge, there is no reported information related to defensive mechanisms for ‘Galega Vulgar’ in
relation to phenolic compounds, but since OLE is associated with an endogenous defensive system
against invasive species [34], such as Bactrocera oleae [35], the high OLE values registered for this
cultivar, especially at S3, should confer it a relatively good natural resilience against infestations.
By itself, OLE will not confer any considerable bioactive protection to the fruit, but when exposed to the
highly specific β-glcosidase enzymes, caused by cellular membrane rupture, its enzymatic hydrolysis
will produce highly reactive aldehyde molecules [36,37]. In conjugation with OLE, β-glcosidase
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activity also suffers changes along fruit ripening. As reported by Mazzuca et al. [36], the levels of
β-glucosidase activity tend to be in accordance with OLE content in olive fruit, higher before the fruit
is fully ripe, and gradually decreasing when the fruit turns mature, mainly due to the senescence
of cellular tissues that will put β-glucosidase in contact with OLE, promoting its natural hydrolysis
until their amounts turn merely residual. So, if not accelerated by external factors, OLE hydrolysis
will naturally occur along fruit ripening, which was showed for ‘Galega Vulgar’ from S3 forward,
inducing a gradual increase on HT values. For ‘Cobrançosa’ this could not be observed since at harvest
time (S6) OLE concentration was still showing an increasing trend, and also ‘Cobrançosa’ at S6 was
still presenting a lower MI, when compared to ‘Galega Vulgar’ at the same period; therefore, it is
possible that for ‘Cobrançosa’ at S6 stage olive fruits were yet not presenting signs of cellular tissue
senescence. In regard to VERB, since its formation is metabolically linked to the conjugation of HT
with caffeic acid [38], the observed decrease of VERB concentrations along ripening is supported by
the sequential HT increase. In fact, ‘Galega Vulgar’ registers it highest VERB levels at S3, the period
when HT was registered as minimum (with no significant differences from S4). Previously, Markakis
et al. [39] reported for ‘Koroneiki’ cultivar a correlation between the enhanced levels of VERB and the
resistance of this cultivar towards Verticillium dahlia, a soil borne fungus responsible for Verticillium wilt,
a serious diseases affecting olive trees. Therefore, in conjugation with OLE degradation metabolites,
the high VERB concentrations found in both cultivars also present significant relevance in the olive
tree defensive mechanism.
When compared to ‘Galega Vulgar’, ‘Cobrançosa’ registered a much different behavior, considering
both MI and OPDW, which only reached considerably higher values at a latter ripening period
(early December). As the results suggested, the maximum OPDW and OLE quantity should probably
be achieved on a latter ripening, comparatively to ‘Galega Vulgar’, and hence, for ‘Cobrançosa’ cultivar,
the harvesting time should be delayed in order to better evaluate the studied kinetics.
Several studies have previously reported great changes in the phenolic profile during olive
fruit maturation for different cultivars. Arslan et al. [40] showed for the Turkish ‘Sarıulak’ cultivar,
OLE concentrations ranging from 2981 to 375 mg/Kg, respectively, from an early-ripe to ripe stages.
Regarding two other Turkish cultivars, Dagdelen et al. [41] showed the highest OLE content to be
at an early ripening stage for ‘Ayvalık’ cultivar, with 210 mg/Kg, and at a latter ripening stage for
‘Gemlik’, with an average concentration of 147 mg/Kg. Regarding the Tunisian cultivar ‘Chemlali’,
Bouaziz et al. [28] showed that higher OLE concentrations were registered during the early ripening
stage, ranging from about 6500 mg/Kg to less than 1000 mg/Kg when full maturation was achieved.
Different cultivars reveal specific and unique phenolic profiles that overcome a constant change during
fruit ripening, as showed as well for the Portuguese cultivars ‘Cobrançosa’ and ‘Galega Vulgar’ with
the present study. As VOO phenolic content is highly related to the presence and concentration of PCs
in olive fruit, among other factors, such as β-glucosidade activity [11,42,43], the high OLE and VERB
concentrations present on the studied cultivars represent a great potential for a standout nutritional
quality VOO production.
Results have demonstrated that for both ‘Cobrançosa’ and ‘Galega Vulgar’ different harvesting
periods should be considered. In respect to studied variables, ‘Cobrançosa’ presented (within the total
of 84 sampling days) the optimal harvest period at S6, when both MI and OPDW were at their maximum
and OLE accumulation also showed an increasing trend. In contrast, ‘Galega Vulgar’ presented its
optimal harvest period at S3, when the most significant MI increase was registered and also the highest
OPDW was reached. At S3 ‘Galega Vulgar’ also presented its highest OLE accumulation, as well as a
considerably higher VERB concentration, which may predict a final VOO with a richer PCs fraction
and improved nutritional value.
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Featured Application: Chinese ginseng (Panax ginseng C.A. Meyer) and Polygonatum sibiricum are
two medicine food homology herbs widely used in many countries, which have many functional
benefits. This study demonstrated that it is possible to develop a formulation of lactobacilli
effervescent tablets supplemented with Chinese ginseng and P. sibiricum, which provides new
ideas for the development of functional probiotic products.
Abstract: Development of probiotic products has always been popular in the food industry.
Considering the advantages of effervescent tablets, developing probiotic products in effervescent
tablet form was conducted in this study. Besides three Lactobacillus species, whole root powders of two
medicine food homology herbs, Chinese ginseng (Panax ginseng C.A. Meyer) and Polygonatum sibiricum,
were added to the formulation in equal amounts for multiple health care functions. Using the plate
counting method, the viability of lactobacilli was measured. After tabletting, lactobacilli viability
in tablets containing the two herbs, L-group (20 mg herbs/tablet), M-group (60 mg herbs/tablet),
and H-group (100 mg herbs/tablet) was higher than that in the control (containing no herbs). After
tablet disintegration, the survival rate of lactobacilli after gastrointestinal fluids treatment was
measured; it was higher for the L-group and the H-group than for the control. After incubation
with dissolved tablets for 1 h, the lethal rate of Staphylococcus aureus and Escherichia coli O157:H7 for
tablets containing the herbs was lower than that for the control. In the organoleptic assessment test,
the L-group and the control were preferred to the M-group and the H-group. During storage at 25 ◦C
for two months, the viability of lactobacilli in tablets containing the herbs was similar to that in the
control. In conclusion, the formulation of the L-group has the best characteristics.
Keywords: lactobacilli effervescent tablets; Chinese ginseng; Polygonatum sibiricum; lactobacilli
viability; antibacterial activity; organoleptic assessment; storage stability
1. Introduction
Probiotics are defined as “live microorganisms which when administered in adequate amounts
confer a health benefit on the host” (FAO/WHO 2002), such as stimulation of the immune system,
maintenance of mucosal integrity, production of important digestive enzymes and others [1]. Most
probiotics belong to the genera of Bifidobacterium and Lactobacillus [2]. Lactobacillus species are normal
inhabitants of the human gastrointestinal tract, and some of them are generally recognized as safe
because of a long history of human consumption [3]. Many pieces of research have led to the conviction
that certain strains from the genera Lactobacillus can promote health in humans and animals. Among
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them, Lactobacillus acidophilus and Lactobacillus rhamnosus have been successfully used in restoring the
imbalances associated with inflammatory bowel diseases (IBD) [4,5]. Meanwhile, Lactobacillus plantarum
has the potential to alleviate aluminium toxicity [6] and inhibit pathogenic fungi [7]. Therefore, these
lactobacilli might be useful as supporting therapeutic agents. Considering their probiotic properties,
some isolates of these lactobacilli, such as L. acidophilus LA1, L. rhamnosus GG, and L. plantarum Lp01
are already widely used as food supplements and produced on an industrial scale [8].
Due to the beneficial health properties, functional foods have been playing an outstanding role in
the food market [9]. As one kind of functional foods, probiotic-supplemented food products are more
and more popular for their favorable impact on consumer health. Probiotic products available on the
market are mainly fermented dairy products, and fruit drinks and powders containing probiotics can
be seen in the marketplace in recent years. However, the most popular forms of probiotic products,
liquid, semi-solid, and powder, require more space for transportation and storage, which may increase
the price of end products. To overcome such problems, compaction of powders containing probiotics
in the shape of tablets is a more suitable strategy [10]. In addition to reducing the bulk volume of other
forms, products in tablet form are extremely stable, surpassing the stability of liquid form [11]; thus
they lead to prolonged shelf life.
At present, the demand for ready-to-eat food and drinks is increasing day by day. Ready-to-drink
effervescent tablets can meet consumer demands. Meanwhile, effervescent tablets containing probiotics
can be added to any liquid product, which would provide a pleasant taste and facilitate the daily
ingestion of probiotics. They are especially suitable for children, the elderly, and people who have
difficulty in swallowing pills. Additionally, carbon dioxide gas released during effervescent tablet
dissolving could stabilize the gastric mucosa and promote absorption, resulting in benefits to consumer
health [12]. Therefore, water-soluble effervescent tablets are a good choice for probiotic-supplemented
food products.
To our knowledge, effervescent tablets containing probiotics are usually used for the prevention
of vaginal infections [13,14], but little research has been done on the development of effervescent
tablets supplemented with probiotics for application in the food industry. Using L. acidophilus and
Saccharomyces boulardii as probiotics supplements, Nagashima, Pansiera, Baracat and Gómez [12]
had developed probiotic effervescent tablets for ready-to-drink. Considering the health needs of
consumers and the good properties of probiotics, more studies should be conducted to develop a wider
variety of effervescent tablet products supplemented with probiotics, especially with multiple health
care functions.
Chinese ginseng (Panax ginseng C.A. Meyer) is the medicine food homology plant, which has
been used for over 2000 years as a medicine in China and is popularly used in more than 35 countries
as food, a health supplement, and a natural remedy [15]. Ginseng possesses many beneficial health
properties, such as the alleviation of menopause symptoms and some neurological disorders, regulation
of cardiovascular disease and hyperglycemia in type 2 diabetes, and improvement of the immune
function [16]. Polygonatum sibiricum is another traditional herbal medicine and foodstuff widely
used in China, Korea, and Japan for hundreds of years [17]. The dried root of P. sibiricum shows
anti-inflammatory, immunoregulatory, and anti-diabetic activities [18]. Hence, the present work aimed
to develop effervescent tablet products containing both probiotic lactobacilli and Chinese ginseng and
P. sibiricum for more health care functions. Characteristics of the effervescent tablet products were
investigated, especially the effect of Chinese ginseng and P. sibiricum on the properties of lactobacilli
effervescent tablets.
2. Materials and Methods
2.1. Strains
Three lyophilized strains of lactobacilli obtained from Clerici Sacco Co. (Italy) were used
in the preparation of effervescent tablets. They were L. acidophilus LA3, L. rhamnosus IMC501,
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and L. plantarum BG112. These strains are often used in functional foods as probiotic strains and
dietary supplements [19–21]. In the antibacterial experiment, Staphylococcus aureus NCTC 8325-4 and
Escherichia coli O157:H7 NCTC 12900 were used. S. aureus NCTC 8325-4 belongs to the gram-positive
bacterium, which was kindly donated by Professor Baolin Sun working in the University of Science and
Technology of China. E. coli O157:H7 NCTC 12900, one of the gram-negative bacteria, was obtained
from the National Culture Type Collection (Colindale, London, UK).
2.2. Preparation of Effervescent Tablets
In order to maintain high probiotic activity, probiotics used in product production should possess
high cell viability. According to the viability of three kinds of Lactobacillus in lyophilized powder under
the same culture condition as in our preliminary experiment, the proportion of three lactobacilli strains
in the mixed lactobacilli powder for effervescent tablet preparation was achieved, which was 5:4:1
for L. plantarum: L. rhamnosus: L. acidophilus. As citric acid and sodium bicarbonate are the common
effervescent agents used in pharmaceutical and nutraceutical industries to produce fast dissolving
effervescent tablets, the two agents were added to the effervescent tablets in this study. Additionally,
the formulation of effervescent tablets contained povidone as a tablet binder and polyethylene glycol
6000 (PEG6000) as a lubricating agent. To determine the effect of Chinese ginseng and P. sibiricum on
the properties of lactobacilli effervescent tablets, effervescent tablets containing different contents of
Chinese ginseng and P. sibiricum were prepared. Whole root powders of the two herbs were obtained
from Changchun Huacheng Biological Co., Ltd. (Changchun, China). The composition formulas
for the lactobacilli effervescent tablets are given in Table 1. Each ingredient for tablet preparation
was calibrated through an 80-mesh screen, and then the weighed ingredients were mixed thoroughly
according to the formulation. A single punch tabletting machine (Hebi Innovative Instruments Co.,
Ltd., Henan, China) equipped with a 12-mm flat-faced round punch was used for the preparation of
the effervescent tablets.
Table 1. Formulations of lactobacilli effervescent tablets supplemented with different contents of
Chinese ginseng and Polygonatum sibiricum.
Ingredients
Tablets Formulations (Quantity in mg/Tablet)
Control L-Group M-Group H-Group
Lactobacilli mixed powder 150 150 150 150
Citric acid 350 350 350 350
Sodium bicarbonate 350 350 350 350
Povidone 30 30 30 30
PEG6000 20 20 20 20
Chinese ginseng powder 0 10 30 50
Polygonatum sibiricum powder 0 10 30 50
2.3. Measurement of Weight and Thickness of Tablets
For each kind of tablet, ten tablets were individually and randomly weighed on an analytical
balance (OHAUS International Trade (Shanghai) Co., Ltd., Shanghai, China) to determine their weight,
and their thickness was also measured by a ruler.
2.4. Determination of Disintegration Time
According to the method for measurement of disintegration time of effervescent tablets in Chinese
Pharmacopoeia (2015 Edition), the disintegration time of the effervescent tablets prepared in this
study was tested. For each kind of effervescent tablet, the disintegration time of six tablets was
individually determined in 200 mL of distilled water at 20 ± 5 ◦C. Disintegration time within 5 min is
considered acceptable.
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2.5. Change of Viability of Lactobacilli Cells after Tabletting and Tablet Disintegration
In order to determine survival rates of lactobacilli cells after the tablets preparation, the number
of viable lactobacilli cells in the mixed lactobacilli powder before tabletting and in the tablets was
measured using the pouring plate method. Firstly, the mixed lactobacilli powder or the tablets were
dissolved in sterile distilled water. Then, the dissolved sample was ten-fold diluted with a 0.90% NaCl
solution, and pour-plated on de Man-Rogosa-Sharpe (MRS) agar (Oxoid Ltd., Basingstoke, Hants, UK).
Each dilution sample was measured in triplicate. After incubation at 37 ◦C for 48 h, the number of
colonies was counted. Two independent experiments were performed. The survival rate of lactobacilli
cells after tablet preparation equals to the ratio of viable cells in the tablets to those in the mixed
lactobacilli powder.
Furthermore, to investigate the viability change of lactobacilli cells after tablet disintegration,
the remaining tablet solution after counting was placed at 25 ◦C for 48 h, then the number of viable
lactobacilli cells was measured using the pouring plate method. The survival rate of lactobacilli
cells after tablets disintegration was calculated by the ratio of viable cells in tablet solution after
disintegration for 48 h to those for 0 h.
2.6. Effect of Gastrointestinal Fluids on the Viability of Lactobacilli Cells
Firstly, one effervescent tablet was dissolved in 15 mL of sterile distilled water. Then, 0.1 mL
and 1.0 mL samples from the same solution were added to 9.9 mL and 9.0 mL of sterile simulated
gastric fluid (0.045 M HCl, 1% pepsin, pH 1.7), respectively. After incubation at 37 ◦C for 30 min,
1.0 mL aliquot was removed and added to 9.0 mL of sterile simulated intestinal fluid (0.05 M KH2PO4,
pH 6.8, added with 0.6% of bile salts), which was further incubated at 37 ◦C for 150 min. The number
of viable lactobacilli cells before and after gastrointestinal fluids treatment was determined using
the pouring plate method. Meanwhile, the survival rate after gastric or enteric fluid treatment was
calculated respectively, which equals the ratio of viable cells after treatment to those before treatment.
Two independent experiments were performed.
2.7. Analysis of the Antibacterial Activity of the Tablets
Antibacterial studies were performed against S. aureus and E. coli O157:H7. After activation from
the stocked strain, cultures of S. aureus or E. coli O157:H7 were inoculated into sterile distilled water,
and the initial cell counts were measured by the pouring plate method using tryptic soy agar (TSA).
Each sample was measured in duplicate. Then one effervescent tablet was added to 15 mL of the
bacterial solution, and the dissolution time was recorded. After incubation for one hour (including
dissolution time) at room temperature, the number of S. aureus or E. coli O157:H7 was determined by
the staph express count plate or E. coli/Coliform count plate of 3M PetrifilmTM (3M Center, St. Paul,
MN, USA). Each sample was measured in duplicate. The testing slips were incubated at 37 ◦C for 48 h.
Two independent experiments were performed. The antibacterial activity of the tablets was assessed
by the following equation:
antibacterial ratio =
(
1− Cell counts of bacteria after incubation with tablets for one hour
Initial cell counts of bacteria
)
× 100%
Meanwhile, the pH of the solution was measured, including pH before adding tablets, pH at the
end of dissolving tablets, and pH after incubation with tablets for one hour. The pH measurement was
performed for three independent experiments.
2.8. Organoleptic Assessment
Twenty panelists (10 males and 10 females) aged between 22 and 25 years participated in the
organoleptic assessment. The panelists were selected from students at the College of Food Science and
Engineering at Jilin University, China. The study was reviewed and approved by the college of Food
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Science and Engineering at Jilin University. All participants were familiar with basic organoleptic
assessment techniques, and all of them agreed to participate in the test. Before the organoleptic
assessment, the panelists participated in briefing sessions to familiarize themselves with the specific
vocabulary used to describe the effervescent tablet solution attributes and with the evaluation scales.
Each kind of sample solution was prepared by adding one tablet into 200 mL distilled water at
room temperature. After disintegration, the panelists were presented with 20 mL of each sample in
see-through polypropylene cups. Different samples were labeled with random numbers and presented
to each panelist in random order. Between samples evaluation, panelists were asked to cleanse
their palate with water. In addition, panelists were required to have a break before starting the next
evaluation [22].
Attributes of appearance, color, aroma, flavor, and overall liking were evaluated in a 9-point
hedonic scale ranging from 1 (“dislike extremely”) to 9 (“like extremely”). Afterwards, the products
were ranked and evaluated by the Friedman test [23] to verify differences between samples.
2.9. Stability of the Tablets during Storage
In order to study the stability of tablets during storage, the tablets were stored individually in
vacuum packages (Sealed Air Co., Charlotte, NC, USA), which are transparent multi-layer co-extruded
cross-linked vacuum shrinkable bags with high oxygen barrier, high sealing strength, and good wear
resistance and shrinkage properties, and then incubated at 25 ◦C for two months. At a certain storage
time (0, 15, 30, 45 and 60 days), one tablet of each kind of tablets was dissolved in 15 mL sterile distilled
water, and then the number of lactobacilli in the solution was measured in triplicate using MRS agar
by the pouring plate method. Two independent experiments were performed.
2.10. Statistical Analysis
One-way analysis of variance (ANOVA) and student’s test were used to analyze possible
statistically significant differences among the samples. The significance level was 0.05. All the analyses
were performed using IBM SPSS Statistics 22 (Chicago, IL, USA). The figure was produced by Microcal
Origin 9.2 (Northampton, MA, USA).
3. Results and Discussion
3.1. Physical Properties of the Tablets
Round, flat disc-shaped tablets were obtained in this study. As powders of Chinese ginseng and
P. sibiricum are yellow, and other raw materials are white powders, the color of tablets without Chinese
ginseng and P. sibiricum (Control) was white, while tablets supplemented with the two herbs showed
pale yellow. Besides the color, weight and thickness of tablets prepared by different formulations
were different. As shown in Table 2, the mean weight of the control was 0.82 g per tablet, which was
increased with an increase in the content of the two herbs. Except for the H-group (100 mg herbs/tablet),
the thickness of the other three tablets showed similar results (Table 2). After adding the tablets to
distilled water, the effervescence was mediated by the presence of citric acid and sodium bicarbonate.
The disintegration time of the control was short, at about 3.19 min. Interestingly, this parameter was
influenced by the presence of the herbs, showing prolonged disintegration significantly with increasing
content of the two herbs (p < 0.05). It was 4.48, 6.92, and 9.70 min for the L-group (20 mg herbs/tablet),
the M-group (60 mg herbs/tablet), and the H-group, respectively (Table 2). The result indicated
that the presence of the two herbs has a slow-releasing effect on the disintegration of effervescent
tablets. A disintegration time within 5 min for oral effervescent tablets is considered acceptable in the
pharmacopoeia of several countries. The disintegration time depends on the disintegrating solvent,
solvent temperature and solvent volume, thus suitable disintegrating conditions should be studied for
the M-group and H-group tablets.
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Table 2. Weight, thickness and disintegration time of the lactobacilli effervescent tablets supplemented
with different contents of Chinese ginseng and Polygonatum sibiricum.
Tablets Weight (g) Thickness (mm) Disintegration Time (min)
Control 0.82 ± 0.02 a 7.05 ± 0.37 a 3.19 ± 0.41 a
L-group 0.85 ± 0.03 b 6.90 ± 0.39 a 4.48 ± 0.31 b
M-group 0.88 ± 0.02 c 7.40 ± 0.61 a 6.92 ± 0.33 c
H-group 0.92 ± 0.02 d 8.15 ± 0.24 b 9.70 ± 0.42 d
All data show the means ± SD. Different letters in the same column indicate a significant difference.
3.2. Change of Viability of Lactobacilli after Tabletting and Tablet Disintegration
In order to achieve benefits from probiotics, probiotic products must contain at least 106 CFU
(Colony Forming Unit)/g or be eaten in sufficient amounts to yield a daily intake of 108 CFU [24].
Therefore, the number of viable lactobacilli cells in tablets was investigated. As shown in Table 3,
at least 1.55 ± 0.80 billion viable cells per tablet were found after disintegration, which meets the intake
requirement for probiotics. However, compared with the mixed lactobacilli powder before tabletting,
the number of viable cells in tablets decreased remarkably for four kinds of tablets. Nagashima,
Pansiera, Baracat and Gómez [12] had also found that there was up to 2.3 logarithmic cycles reduction
in the number of viable L. acidophilus in effervescent probiotics tablets after tabletting. Chan and
Zhang [25] had observed that cellular viability decrease was related to the applied compression force
in tabletting. Under mechanical stress, some cells cannot tolerate such compression, which caused
damages to the cell walls and membranes or even loss of viability [12]. But it is worth noting that
the survival rate of lactobacilli cells was higher for tablets containing the herbs than that for the
control, and the survival rate enhanced significantly with the increase of the herbs content in tablets
(p < 0.05) (Table 3). This result demonstrated that Chinese ginseng and P. sibiricum can protect the
viability of lactobacilli cells in the tablets. Perhaps some active ingredients in the herbs, such as
polysaccharides, might maintain the viability of the lactobacilli. As we know, prebiotics supply a
fermentable carbohydrate for probiotic bacteria in the colon, stimulating the growth and activity [26].
Thus, we further speculated that the two herbs may have similar functions with prebiotics, which
would protect or promote the viability of beneficial bacteria after consumption. Therefore, the viability
of lactobacilli cells after gastrointestinal juices treatment for four kinds of tablets was investigated,
which will be discussed in a later part in this study.
Table 3. Viability of lactobacilli cells in the mixed lactobacilli powder before tabletting and in different
kinds of lactobacilli effervescent tablets.
Samples Number of Viable Cells The Survival Rate after Tabletting
Mixed lactobacilli powder (7.14 ± 0.52) × 1010 CFU/g powder
Control tablet # (1.55 ± 0.80) × 109 CFU/Tablet a 14.50%
L-group tablet (5.18 ± 3.71) × 109 CFU/Tablet b 48.37%
M-group tablet (7.00 ± 1.14) × 109 CFU/Tablet b,c 65.36%
H-group tablet (9.03 ± 1.77) × 109 CFU/Tablet c 84.31%
All data show the means ± SD. # ANOVA was performed among different kinds of effervescent tablets. Different
letters in the same column indicate a significant difference.
What is the change of lactobacilli viability after tablet disintegration? Do the herbs protect viability
or stimulate the growth of lactobacilli after tablet disintegration? Surprisingly, after disintegration
for 48 h, the number of lactobacilli cells for the control tablet increased more than 2-fold, while the
survival rate for tablets containing the herbs decreased by 10.5%–23.75% (Table 4). In fact, besides
polysaccharides, saponins are another main active component in ginseng and P. sibiricum which have
antimicrobial activity [27–29]. Battinelli, Mascellino, Martino, Lu and Mazzanti [29] found that a total
extract of ginseng had lower antimicrobial activity than some pure ginsenosides (saponins in ginseng),
56
Appl. Sci. 2020, 10, 3194
and ascribed this lack of antimicrobial activity of the whole plant to possible antagonist effects between
ginsenosides and other ginseng components. Considering the protective effect of the herbs on the
viability of lactobacilli after tabletting, the changes of the viability of lactobacilli after tabletting and
tablet disintegration for tablets containing the herbs may be due to possible antagonistic effect between
saponins and other components in the herbs.
Table 4. The survival rate of lactobacilli cells after tablet disintegration for 48 h.
Tablets The Survival Rate after Tablet Disintegration for 48 h
Control 216.61% ± 0.86 b
L-group 76.25% ± 0.13 a
M-group 89.50% ± 0.21 a
H-group 77.62% ± 0.16 a
All data show the means ± SD. Different letters in the same column indicate a significant difference.
3.3. Effect of Gastrointestinal Fluids on the Viability of Lactobacilli Cells
As shown in Table 5, the survival rate of lactobacilli cells after gastric juice treatment for each
kind of tablets was remarkably different with the different initial amounts of tablet solution inoculated
into gastric juice. It was increased 23-, 350-, 186- or 482-fold for tablets of control, L-group, M-group,
or H-group, respectively, when the initial inoculum increased from 0.1 mL to 1.0 mL. With a 10-fold
increment in the initial inoculum, the survival rate of lactobacilli cells after gastric juice treatment
increased more than 10-fold for all the kinds of tablets, which demonstrated that more intake of the
probiotic product would greatly increase the levels of probiotics reaching the intestine. Meanwhile,
it can be seen that the effervescent tablets supplemented with the herbs have a higher survival rate
of lactobacilli cells after gastric fluid treatment than the control at 1.0 mL initial inoculum, but this
phenomenon cannot be found at 0.1 mL initial inoculum (Table 5). This result indicates that the herbs
supplemented in tablets have a protective effect on the viability of lactobacilli during gastric fluid
treatment, and this protective effect of the herbs is dose-dependent. This protective effect caused by
the herbs should also be a comprehensive effect of antimicrobial activity and probiotic activity derived
from components in the herbs. However, in the gastric juice environment, antimicrobial components in
the herbs may not play their role effectively, and/or probiotic activity of components may be improved,
thus the protective effect is prominent.
Table 5. The survival rate of lactobacilli cells after contact with gastric juice for 30 min followed by
exposure to enteric juice for 150 min for different kinds of lactobacilli effervescent tablets.
Tablets













Control 0.1 mL 0.0369 0.0000 0.0000
L-group 0.1 mL 0.0063 0.3992 0.0000
M-group 0.1 mL 0.0077 0.0000 0.0000
H-group 0.1 mL 0.0155 0.0000 0.0000
Control 1.0 mL 0.8660 0.1167 0.0009
L-group 1.0 mL 2.2162 0.3444 0.0076
M-group 1.0 mL 1.4232 0.0442 0.0006
H-group 1.0 mL 7.4842 0.3239 0.0294
# N0 is the number of viable lactobacilli cells before gastric fluid treatment (CFU/Tablet). Ng is the number of viable
lactobacilli cells after gastric fluid treatment (CFU/Tablet). Ne is the number of viable lactobacilli cells after enteric
fluid treatment (CFU/Tablet).
After enteric juice treatment, there were no viable lactobacilli cells at 0.1 mL initial inoculum for
three kinds of tablets, while viable cells could be examined in all the kinds of tablets at 1.0 mL initial
inoculum (Table 5). This result also confirmed that more intake of the product would significantly
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increase the levels of probiotics in the intestine. However, compared with the control, the survival rate
of lactobacilli cells after intestinal juice treatment only increased 2.95-, 0.13- and 2.77-fold for L-group,
M-group, and H-group, respectively. Meanwhile, there was no dose-dependent protective effect of the
herbs on the viability of lactobacilli cells after enteric juice treatment when compared to the gastric
fluid treatment. Nagashima, Pansiera, Baracat and Gómez [12] had also found that the number of
L. acidophilus decreased significantly after effervescent probiotics products contact with artificial enteric
juice; they ascribed this decline to the sharp change in the pH from 2.0 in the gastric juice to 6.8 in the
enteric juice, and the presence of bile salts. Therefore, the presence of bile salts in enteric juice and the
pH variation from 1.7 to 6.8 might greatly destroy the viability of lactobacilli and thus weaken the
protective effect of the herbs in this study. Additionally, an increase of antimicrobial activity and/or
a decrease of probiotic activity of components in the herbs in the enteric juice environment may be
another reason for the reduced protective effect of the herbs.
Generally, after gastrointestinal fluids treatment, the survival rates of lactobacilli for the L-group
(0.0076%) and the H-group (0.0294%) were both higher than that for the control (0.0009%), while it was
similar between the M-group (0.0006%) and the control. It is confirmed that the herbs supplemented in
the lactobacilli effervescent tablets have a certain protective effect on the viability of lactobacilli during
gastrointestinal fluids treatment, but for the better protective effect the optimal concentration of the
herbs in probiotic products should be further investigated.
3.4. Antibacterial Activity of the Tablets
The goal in administering probiotic products is to induce a balanced enteric microbiota, which will
have a favorable impact on consumer health. Enteric microbiota include both beneficial and harmful
microflora. As mentioned above, the tablets supplemented with Chinese ginseng and P. sibiricum have
a certain favorable effect on the activity of some lactobacilli. In order to investigate the antibacterial
activity of the lactobacilli effervescent tablets, an in vitro bacteriostatic experiment against S. aureus and
E. coli O157:H7, two common pathogens in clinical infection and food contamination, was conducted.
After incubation with the control tablet for one hour, about 95.11% and 97.86% of S. aureus and E. coli
O157:H7 were killed, respectively (Table 6). While the antibacterial ratio against both bacteria was
decreased significantly with an increase in the content of the two herbs in the tablets (p < 0.05), there
was still a high antibacterial ratio for these tablets, which was more than 78% for the H-group. Because
the treatment time of the antibacterial experiment was relatively short, which was 1 h, we considered
that the disintegration progress of tablets may be an important factor affecting the antibacterial activity.
As shown in Table 6, the dissolution time of the tablets was prolonged with increasing content of the
two herbs (p < 0.05), which is opposite to the change trend of antibacterial activity. The effervescence
mediated by the citric acid and sodium bicarbonate ensures a rapid and complete distribution of the
active ingredients in products to solutions [14], and can rapidly create an anaerobic microenvironment
by released CO2 [30], which can also decrease pH of the solution (Table 6). These features are harmful to
bacteria which cannot withstand the environment. As the dissolution time of the tablets was prolonged
with increased content of the two herbs (Table 6), this would decrease release rates of active ingredients
and CO2 with an increase in the content of the herbs, which may lower the antibacterial activity of
the tablets with increased content of the herbs. Additionally, under the condition of the antibacterial
experiment in this study, antagonist effects between antimicrobial and probiotic components of the
herbs may lead to weak antibacterial activity of the tablets containing the herbs in a dose-dependent
manner. Therefore, the antibacterial activity was highest for the control, which decreased significantly
with an increase in the content of the two herbs in tablets under the condition of the antibacterial
experiment in this study (Table 6). According to the previous results on the change of viability of
lactobacilli after tablet disintegration for 48 h (Table 4), we deduced that the antibacterial activities of
the four kinds of tablets against S. aureus and E. coli O157:H7 would be different when prolonged the
treatment time.
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Table 6. Antibacterial activity of different kinds of lactobacilli effervescent tablets against Staphylococcus

















Control 95.11% ± 0.01 d,A 97.86% ± 0.01 c,B 1.99 ± 0.36 a 6.38 ± 0.09 β 5.61 ± 0.03 α 5.71 ± 0.08 α
L-group 90.00% ± 0.01 c,A 97.39% ± 0.00 c,B 2.28 ± 0.26 a 6.42 ± 0.06 β 5.56 ± 0.08 α 5.58 ± 0.08 α
M-group 83.16% ± 0.02 b,A 90.96% ± 0.02 b,B 3.27 ± 0.28 b 6.59 ± 0.05 β 5.57 ± 0.04 α 5.60 ± 0.03 α
H-group 78.27% ± 0.03 a,A 83.87% ± 0.04 a,B 4.45 ± 0.04 c 6.72 ± 0.11 β 5.52 ± 0.03 α 5.53 ± 0.03 α
All data show the means ± SD. Different lowercase English letters in the same column indicate a significant
difference; different uppercase English letters or lowercase Greek letters in the same row indicate a significant
difference, respectively.
Meanwhile, the antibacterial activity of each kind of tablet was significantly higher against E. coli
O157:H7 than against S. aureus (p < 0.05) (Table 6). Xue, Yang, Zhao, Hou, Zhang, Zhang and Ren [28]
had found that ginsenosides cause bacterial death by directly destroying the membrane system. As we
know, the cell wall of S. aureus is thicker than that of E. coli O157:H7, which will reduce the speed and
content of CO2 and active ingredients (such as saponins) reaching the cell membrane, causing higher
antibacterial activity against E. coli O157:H7 than against S. aureus for each kind of tablet.
3.5. Organoleptic Assessment
An organoleptic assessment was performed to measure the acceptability of the four kinds of
effervescent tablets. As shown in Table 7, except for appearance and overall liking attributes, there
was no significant difference among different kinds of tablets. In respect of the appearance of the
tablet solution, panelists evaluated the L-group as largely like (7.30 ± 1.17), while the H-group was
considered slightly appreciated (5.90 ± 1.86). After disintegration, a small amount of light-yellow foam
was floating on the solution of the H-group, resulting in a lower appearance score for it. The overall
liking classified the H-group as slightly like (5.30 ± 1.56) and the L-group and the control as moderately
like (6.45 ± 1.43 and 6.05 ± 1.39, respectively), while the evaluation for the M-group (5.70 ± 1.45) was
between them. Besides the appearance attribute, the flavor was also a main reason for a lower overall
liking score for the H-group solution, although there was no significant difference in the flavor attribute
between the four kinds of tablets (p > 0.05). As can be seen from Table 7, the lowest score of flavor
attribute was found for H-group solution (5.70 ± 1.34), as most panelists felt relatively high bitterness
in the H-group solution. Panelists participated in the organoleptic assessment aged between 22 and
25 years, do not like consuming bitter foods. Perhaps these effervescent tablets may be evaluated
differently if older people participate in the organoleptic assessment. According to the preference
ranking test results (Table 8), the L-group received the highest value in the sum of the orders (59),
but its preference did not present statistical difference (p > 0.05) for the control and the M-group.
The H-group was the less preferred along with the M-group, reinforcing the results obtained in the
organoleptic assessment.
Table 7. Organoleptic assessment of the lactobacilli effervescent tablets supplemented with different
contents of Chinese ginseng and Polygonatum sibiricum.
Tablets Appearance Color Aroma Flavor Overall Liking
Control 7.10 ± 1.41 a,b 7.25 ± 0.97 a 6.15 ± 1.31 a 6.30 ± 1.49 a 6.05 ± 1.39 a
L-group 7.30 ± 1.17 b 7.20 ± 0.95 a 6.40 ± 1.39 a 6.40 ± 1.43 a 6.45 ± 1.43 a,b
M-group 6.20 ± 1.58 a,b 6.75 ± 1.37 a 6.35 ± 1.22 a 6.10 ± 1.71 a 5.70 ± 1.45 a
H-group 5.90 ± 1.86 a 6.55 ± 1.54 a 6.40 ± 1.23 a 5.70 ± 1.34 a 5.30 ± 1.56 a
All data show the means ± SD. Different letters in the same column indicate a significant difference.
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Table 8. Results of the preference ranking test of the lactobacilli effervescent tablets supplemented with
different contents of Chinese ginseng and Polygonatum sibiricum.
Tablets Control L-Group M-Group H-Group
Control - 1 ns 10 ns 23 *
L-group - 11 ns 24 *
M-group - 13 ns
H-group -
* Significant critical difference (5%) minimum of 21, for four samples and 20 panelists, according to the Friedman
test. ns non-significant.
3.6. Stability of the Tablets during Storage
Figure 1 shows the survival of lactobacilli in different kinds of lactobacilli effervescent tablets
after storage at 25 ◦C for 60 days. After storage for 15 days, the number of lactobacilli cells was
reduced by 1.20, 1.79, 2.08, and 2.35 logarithmic cycles for the control, L-group, M-group, and H-group,
respectively. This result demonstrated that the viability of lactobacilli decreased significantly with the
increase of the content of the herbs in tablets in the early stage of storage (0–15 days). Nevertheless,
in the later stage of storage (15–60 days), the viability of lactobacilli in the tablets supplemented with
the herbs was similar to that in the control (Figure 1). Considering the diversity of drug-resistance
ability of microorganism cells to antimicrobial substances, we speculated that some sensitive cells in
the tablets may be inactivated by the herbs in a dose-dependent manner in the early stage of storage,
while the cells that can tolerate the herbs could maintain their viability throughout the storage period.
Nagashima, Pansiera, Baracat and Gómez [12] had also reported that the number of L. acidophilus in
effervescent probiotics tablets decreased from 5.18 to 2.91 logarithmic cycles after storage for 60 days at
25 ◦C. In this study, the number of viable lactobacilli cells was about 5.80 logarithmic cycles in all kinds
of tablets at the end of storage (Figure 1). In order to obtain more probiotic properties, it should be
considered to add protectants for lactobacilli viability to the formula.
 
Figure 1. Viability of lactobacilli in different kinds of lactobacilli effervescent tablets stored for 0, 15, 30,
45 and 60 days at 25 ◦C. All data show the means ± SD. At the same storage period, different letters
indicate a significant difference.
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4. Conclusions
Our findings demonstrate that it is possible to develop an optimal formulation of lactobacilli
effervescent tablets supplemented with Chinese ginseng and P. sibiricum, combining functional benefits
of lactobacilli and both herbs. In terms of form, the effervescent tablet product exceeds the stability of
the liquid form, thereby prolonging the shelf life. Compared with the capsule product, the effervescent
tablet has the advantages of simple processing, rapid disintegration, dissolving in water, and easy to
take. The effervescent tablet is more suitable for children, the elderly, and people who have difficulty
in swallowing pills. According to the results in this study, the formulation of the L-group (60 mg
herbs/tablet) would be the best choice for industrial production, which can effectively protect the
viability of lactobacilli after tabletting and gastrointestinal juices treatment, together with the high
antibacterial ability and the preferred organoleptic characteristics. Meanwhile, the L-group was
relatively stable during storage. For a better probiotic effect of the L-group, consumers should drink
it in time after disintegration, which would be conducive to retaining higher viability of lactobacilli
reaching the intestine and help to create better antibacterial activity in the intestine, leading to a more
beneficial enteric microbiota. The main purpose of this study was to investigate the effect of Chinese
ginseng and P. sibiricum on the properties of effervescent tablets, thus no sweetener was added to the
formulations of the lactobacilli effervescent tablets. Considering the younger consumer perspective,
manufacturers can add some beneficial sweeteners, such as the prebiotic fiber inulin, to the formula.
Additionally, an in vivo experiment should be studied for understanding more health care functions of
the lactobacilli effervescent tablets supplemented with Chinese ginseng and P. sibiricum.
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Featured Application: The recycling of the external peels of pomegranate represents an important
goal for pomegranate juice manufacturers, since their disposal is expensive and not eco-friendly.
Traditional decoction and an innovative ultrasound-assisted method of extraction of pomegranate
peels using just water have both led to obtaining aqueous extracts rich in polyphenolic compounds
and endowed with anti-tyrosinase activity. Although these aqueous extracts may require a further
formulation step for preservation, these findings suggest the possibility of using them as low-cost
lightening and/or anti-browning agents, even extemporarily.
Abstract: The aim of the study is to evaluate the anti-tyrosinase activity of different aqueous extracts
obtained from pomegranate juice processing by-products. External pomegranate peels of two
certified cultivars (Akko and Wonderful), were extracted using only water as the extraction solvent.
A traditional decoction and a pulsed ultrasound-assisted extraction (PUAE), both 10 min long, were
performed and compared. All the aqueous extracts proved to be rich in bioactive compounds.
In particular, the total phenolic content (TPC) ranged from 148 to 237 mg gallic acid equivalent
(GAE)/g of dried peels (DW), the radical-scavenging ability (RSA) ranged from 307 to 472 mg ascorbic
acid equivalent (AAE)/g DW, the free ellagic acid content (EA) ranged from 49 to 94 μg/mL, and the
ellagitannins (ETs) ranged from 242 to 340 μg/mL. For both cultivars, PUAE extracts had higher ET
content and a lower EC50, while the decoctions had slightly higher TPC, RSA, and free EA amounts.
Principal component analysis (PCA) highlighted the direct correlation between the ET content and
the tyrosinase enzyme inhibition (lower values of EC50). These findings suggest the potential use of
both these natural extracts as low-cost lightening and/or anti-browning ingredients exploitable in
several formulations (e.g., cosmetics) or extemporarily usable.
Keywords: pomegranate peels; anti-tyrosinase activity; waste recovery; green extraction
1. Introduction
Pomegranate (Punica granatum L.) is one of the oldest edible fruits. Mentioned in the Bible,
the Koran and Egyptian texts, the first pomegranate crops date back to 3000–4000 BC. [1].
Native to the Middle East and North Africa, today pomegranate is spread globally due to its
high longevity, drought and salinity resistance, and adaptability to different climatic conditions [2].
In particular, pomegranate is widely cultivated in Iran, India, China, USA, several countries of the
former USSR, South Africa, and in Mediterranean countries such as Spain, Turkey, Egypt, Israel,
Morocco and Tunisia [3]. In Italy, this resilient and rustic crop recently has shown a growing diffusion,
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especially in central and southern areas, in response to increasing market demand for pomegranate
and, at the same time, with the aim of valorizing marginal land facing climatic change.
Pomegranate juice is the main industrial product obtained from this fruit. In addition to direct
consumption, fresh arils (marketed as ready-to-eat products) and pomegranate seed oil have also
recently gained an important industrial relevance [3].
One drawback in pomegranate juice industrial production is the large amount of waste, since
juice represents about only 30% of the pomegranate fruit fresh weight. External peels are the most
abundant by-products (about 50% of the total fruit weight) [4,5]. Even if they represent an expensive
disposal problem, they are at the same time a promising source of phenolic compounds for exploitation.
Ellagic acid (EA), in its free form or in the form of ellagitannins (ETs), is considered the main phenolic
compound responsible for the numerous health properties of pomegranate, and is mainly concentrated
in the peels with respect to the juice [6,7]. The functional properties of EA are largely reported in the
literature [8,9]. Among the described healthy properties of pomegranate peel extracts, a previous study
indicated that its methanolic peel extracts also inhibit tyrosinase activity [10,11].
The tyrosinase metallo-enzyme, widely distributed in nature, is fundamental in melanogenesis
and enzymatic browning. It can be reversibly or irreversibly inhibited by several molecules that
block the melanogenesis process in animals, as well as causing the undesired browning in fruits
and vegetables [12]. Anti-tyrosinase compounds can be useful both as lightening and anti-browning
ingredients in several commodities, such as cosmetics, pharmaceutics, and agri-food products.
The color of skin, as well as hair and eyes, is determined by the melanin pigment [13]. In human beings,
physiological changes in the normal production of melanin may lead to the appearance of freckles, skin
spots or, in the worst case, to the development of melanomas [14–16]. Melanin is synthesized starting
from a series of reactions controlled mainly by the activity of the tyrosinase enzyme, a monophenol
monooxygenase capable of enclosing a single oxygen atom in the phenolic substrate, oxidizing it to
o-diphenol and then transforming it into o-quinone [17,18].
EA is a cosmetic ingredient classified as a skin conditioner (CAS number: 476-66-4) [19].
In particular, it is considered an anti-aging, antiwrinkle, antimicrobial, antioxidant, astringent,
moisturizing, and lightening/whitening agent [20]. Several authors have described the action of EA on
skin pigmentation [21,22]. EA inhibits tyrosinase activity by chelation of the copper atoms present in
the active site of the enzyme itself and, for this reason, it has been approved as a lightening ingredient
in cosmetic formulations [21]. Nevertheless, there is a large interest in finding low-cost natural extracts
with efficiency and safety features as recently reported by Zolghadri et al. [12].
In previous papers, the authors described different extraction strategies to valorize both the
external peels (major waste) and the squeezing marcs (internal by-products), exploiting the cavitation
of ultrasound extraction in order to increase the mass transfer rate between the peels and the extraction
solvent in order to enhance the bioactive compounds recovery useful for a nutraceutical use [4,23].
In this paper, a simple, rapid, and low-cost strategy in the form of traditional decoction and the
more innovative pulsed ultrasound-assisted extraction (PUAE) of oven-dried pomegranate peels were
applied for the same time period, with the aim to obtain potential low-cost anti-tyrosinase ingredients
from these by-products. Water, which is a basic element of both a greener and safer chemistry approach
compared to methanol or other organic solvents [24,25], was employed alone as the extraction solvent.
PUAE is an example of ‘green’ extraction technology, widely used for the extraction of food and
natural products, and able to considerably reduce the extraction times and increase the extraction yield
maintaining high reproducibility [26].
Akko and Wonderful, corresponding to an early and a late pomegranate variety, respectively,
are some of the most wide-spread commercial pomegranate cultivars, in virtue of their soft seeds
and welcome organoleptic features [4]. Wonderful is the most cultivated commercial cultivar in the
Mediterranean region. However, the Akko cultivar, due to its early availability, has recently been
introduced in these areas to ensure a continuous offer for the market [27].
66
Appl. Sci. 2020, 10, 2795
To the best of our knowledge, no studies of the aqueous extracts of the Akko and Wonderful
varieties of pomegranate as sources of anti-tyrosinase compounds have been conducted, and this is the
object of our investigation.
2. Materials and Methods
2.1. Pomegranate Samples
Pomegranate fruits of Akko and Wonderful certified cultivars were harvested at Masseria
FruttiRossi (https://lomesuperfruit.com/it/home) in Castellaneta Taranto (Italy), which includes
250 hectares of crops and represents the major Italian pomegranate producer.
Fruits were collected at full maturity (Maturity Index, MI = 14.5 ± 2.5), during September and
November 2018, respectively, for Akko and Wonderful cultivars, and immediately processed to obtain
the corresponding juice. Peels, manually separated during the juice processing, were dried using a
traditional heating oven (Binder FED53, Goettingen, Germany) for 48 h at 40 ◦C. Before the extraction
process, dried peels were finely ground by a Grindomi × 200 M (Retsch, Haan, Germany) for 20 s at
5000 rpm and finally sieved by a 150 μm sieve to obtain a fine and homogeneous material.
2.2. Standards and Reagents
All standards and reagents used were analytical grade. DPPH (1,1-diphenyl-2-picrylhydrazyl)
and Folin-Ciocalteu reagents, gallic acid, ascorbic acid, ellagic acid, cyanidine-3-O-glucoside chloride,
and methanol were supplied by SIGMA (Steinheim, Germany). Ethanol, acetic acid, hydrochloric acid,
and sodium hydroxide were purchased from VWR Chemical (Radnor, PA, USA). L-tyrosine, kojic
acid, and mushroom tyrosinase for tyrosinase inhibition assay were supplied by SIGMA (Steinheim,
Germany). High purity water (HPW) produced with a Millipore Milli-Q system (Millipore, Bedford,
MA, USA) was used throughout. All solvents used for chromatographic purposes were HPLC grade.
2.3. Pomegranate Peel Extraction
Peel extraction, both by traditional decoction and by ‘green’ extraction exploiting the ultrasound
action, was performed. Only water was used as the extraction solvent under both methods. The same
extraction time (10 min) and the same solvent/solid ratio (40/1, considering the dried peel weight) were
used for both extraction processes. Each extraction was performed in duplicate and all the obtained
extracts were analytically analyzed.
2.3.1. Traditional Decoction (D)
The decoction of pomegranate peels was carried out by adding the milled dried materials to
40 mL of Milli-Q water in a beaker. This suspension was heated and kept boiling for 10 min. Then, it
was filtered by Buchner, using Whatman n. 1 paper, and centrifuged at relative centrifugation force
(RCF or G-force) equal to 2016 for 10 min. The final extracts (AK_D and WO_D) were kept at −20 ◦C
until further analysis.
2.3.2. Green Extraction: Pulsed Ultrasound-Assisted Extraction (PUAE)
Ultrasonication was applied directly by an Hielscher UP200St (Teltow, Germany) in pulsed
modality (PUAE). Maximum nominal output power of 200W, frequency of 26 kHz, and a titanium
probe (7 mm diameter) were employed for the sonication. The pulse duration and pulse interval refer
to “on” time and “off” time of the sonicator. The pulse duration/pulse interval ratio was 4/1 (duty
cycle 80%). The amplitude level was set to 50%. During the extraction process, temperature was
controlled to be below 65 ◦C (temperature variation during the extraction period was lower than 40◦C).
The obtained extracts (AK_PUAE and WO_PUAE), similarly to the decoction described in the previous
paragraph, were filtered, centrifuged and stored frozen until analysis.
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2.4. Characterization of the Peel Aqueous Extracts
pH was evaluated by electrochemical measurements using a pHmeter (Jenway 3510, Stone,
UK). The total soluble content (TSS), expressed in ◦Brix, was determined at 20 ◦C by a digital
refractometer (Hanna Instruments, Milano, Italy) (Table 1). The total polyphenol content (TPC) and
the Radical Scavenging Activity (RAS) of all the aqueous peel extracts (D and PUAE) were determined
spectrophotometrically. The total anthocyanin content (TAC) and the EA and ET amounts were
quantified by chromatography.
Table 1. pH, TSS, and TAC values of Akko and Wonderful pomegranate peel aqueous extracts obtained








AK_D Akko Decoction 3.92 ± 0.04 3.10 ± 0.10 0.14 ± 0.01
AK_PUAE Akko PUAE 4.04 ± 0.03 1.95 ± 0.05 0.06 ± 0
WO_D Wonderful Decoction 3.56 ± 0.02 2.05 ± 0.05 0.08 ± 0
WO_PUAE Wonderful PUAE 3.65 ± 0.03 1.80 ± 0 0.05 ± 0.02
2.4.1. Determination of Total Polyphenols
TPC was determined by an UV-Vis Agilent 8453 spectrometer (Waldbronn, Germany) following
the Folin-Ciocalteu method previously reported by Singleton et al. [28]. TPC was determined in the
peel aqueous extracts as milligrams of gallic acid equivalent in 100 mL of extract (mg GAE/100 mL)
using an appropriate gallic acid calibration curve (R2 = 0.9887) as the reference standard. Then, the
results were transformed in mg GAE/g of pomegranate peel dry weight (DW). Each sample was
analyzed in duplicate and the results were reported as mean values ± standard error (SE).
2.4.2. Determination of the Radical Scavenging Activity
RSA of the achieved extracts was spectrophotometrically determined by DPPH• (1,1-diphenyl–
2-picryl-hydrazyl) in vitro assay [29]. This method, widely used for food matrices, allowed the
detection of the antiradical activity colorimetrically based on the discoloration of the stable colored
DPPH• recorded at 515 nm. Ascorbic acid was used as the reference standard and the recorded
absorbances of the extracts were compared with the absorbance of solutions of ascorbic acid (AA) at
known concentration (y = 0.5824x − 0.0036; R2 = 0.9975; range of linearity 0.1–1 mM). The antiradical
activity was obtained as mg ascorbic acid equivalent in 100 mL of extract (mg AAE/100 mL) and then
converted as mg AAE/g of pomegranate peel DW. Two replicated determinations were performed for
each sample and data were reported as mean values ± SE.
2.5. HPLC Analysis
2.5.1. Determination of EA and ETs
The HPLC determination of EA and ETs was realized using an Agilent 1100 LC-DAD (Agilent
Technologies, Palo Alto, USA) [4]. A C-18 Kromasil 100® (Akzo-Nobel, Amsterdam, NL) column
(250 × 4 mm, 5 μm), thermostat-controlled at 30 ◦C, was used for the chromatographic separations.
Gradient elution of acetic acid/methanol/water (2:400:598) (solvent A) and methanol (solvent B), with a
1 mL/min flow rate was employed as follows: 100% A at 0 min, 0% A at 20 min, 100% A reset in 10 min
and held for 5 min. The injection volume was 10 μL, and the detection wavelengths were set between
220 and 600 nm. Free EA in the extracts was quantified at 245 nm by external standard, using an
appropriate 4-point calibration line (y = 251.58x − 204.41; R2 > 0.999; range of linearity 2.5–200 μg/mL;
LOD = 0.78 μg/mL; LOQ = 2.36 μg/mL). The total ET content was determined after the preliminary acid
hydrolysis (performed in replicate) of extracts in order to hydrolyze ETs in EA [4,30]. A quantity of
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2 mL of each extract, added to 2 mL HCl 2 M, was heated at 100 ◦C for 1 h in a boiling water bath. After
the cooling time, 1 mL of NaOH 2M and 6 mL of methanol were added. The final solution was vortexed
and filtered before the injection. Two replicated determinations of EA and ETs were performed for
each sample analyzed and data were reported as mean values ± SE. The EA chromatogram of one
pomegranate peel aqueous extract is reported in the Supplementary Materials Figure S1.
2.5.2. Determination of Total Anthocyanins
TAC identification and quantification was conducted using an HPLC–DAD method [31]. Analysis
were carried out on a C-18 core-shell column (Agilent Poroshell 120 EC, 3 mm × 150 mm, 2.7 μm particle
size) thermostat-controlled at 30 ◦C. Gradient elution of water acidified at pH 2.14 by formic acid (solvent
A) and acetonitrile (solvent B), with a 0.4 mL/min flow rate, was employed as follows: 95% A at 0 min,
70% A at 25 min, 45% A at 35 min, and 0% A at 42 min, held for 3 min. Anthocyanins were quantified
at 515 nm by external standard, using an appropriate 4-point cyanidin-3-O-glucoside calibration line (y
= 71.52x – 12.54; R2 > 0.999; range of linearity 1.5-150 μg/mL; LOD = 0.39 μg/mL; LOQ = 1.17 μg/mL).
Each sample was analyzed in duplicate and the results, expressed as μg cyanidin-3-O-glucoside/g DW,
were reported as mean values ± SE. The anthocyanin profile of one pomegranate peel aqueous extract
is reported in the Supplementary Materials Figure S2.
2.6. Tyrosinase Inhibition Property
A 25 mg/mL stock solution of each cultivar and treatment, prepared as described in the previous
paragraph, was diluted in water to obtain a series of test solutions with final concentrations of 10, 50,
100, 250, 350, and 500 μg/mL. Components of the reaction mix were added to each well of 96-well
plates in the following order: 70 μL of phosphate buffer, 60 μL of extract solutions (water for controls),
10 μL of mushroom tyrosinase (Sigma-Aldrich, T3824, 25 kU, 125 U/mL in phosphate buffer, pH 6.8),
and 70 μL L-tyrosine (0.3 mg/mL in water). Kojic acid was used instead of pomegranate solutions as a
positive control. Blank samples without enzyme were also included for all conditions. Plates were
then incubated at 30 ◦C for 60 min, and absorbance was read at 505 nm in a microplate reader (Spectra







where Aex/en = absorbance of sample mixture with extract and enzyme; Aex = absorbance of sample
mixture with extract and without enzyme; Aen = absorbance of sample mixture with enzyme and
without extract; Abk = absorbance of sample mixture without enzyme and extract (blank).
2.7. Statistical Analysis
All the measurements performed were replicated and the results are expressed as mean value
± SE. Analysis of variance (ANOVA) was performed using the Excel Data Analysis Tool (Microsoft
Corporation, Seattle, WA, USA). A p-value lower than 0.05 was statistically significant. Principal
component analysis (PCA), based on the NIPALS algorithm [32], was performed by CAT (Chemometric
Agile Tool) [33]. This chemometric software, based on R, was developed by the Chemistry Group of
the Italian Chemical Society.
3. Results and Discussion
It is known that bioactive compounds are variable in pomegranate, and generally in plant material,
according to genetic factors, different collection stages, pedoclimatic conditions of the sampling sites
(growing wild or cultivation), application of agricultural practices, and post-harvest handling [34,35].
For this investigation, pomegranates of Akko and Wonderful cultivars were grown in the same
cultivation area in Southern Italy, under the same pedoclimatic conditions, and using the same
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agro-techniques. These samples, coming from one of the biggest Italian producers, are representative
of the commercial cultivars most widespread and marketed in Italy. Fruits were harvested in different
collection periods according to the cultivar maturity but at the same maturity status.
pH, TSS, and TAC of both the aqueous extracts (D and PUAE) of Akko and Wonderful cultivar
are reported in Table 1.
One-way ANOVA, analyzing the mean differences of the pH values, showed significant differences
(p < 0.05) between the cultivars (Akko and Wonderful), but no significant differences are highlighted
between the two different extraction methods (D and PUAE) for the same cultivar (Table 2).
Table 2. One-way ANOVA results.





pH F 7.353 8.022 89.379 84.5
p value 0.113 0.105 0.011 0.012
TSS
F 105.8 25 88.2 9
p value 0.009 0.038 0.011 0.095
RSA
F 3.038 17.838 12.012 9.064
p value 0.223 0.052 0.074 0.095
TPC
F 51.789 5.184 43.586 0.798
p value 0.019 0.151 0.022 0.466
TAC
F 64 5.444 36 1
p value 0.015 0.145 0.027 0.423
EA
F 17.323 5.758 57.772 9.221
p value 0.053 0.138 0.017 0.093
ETS
F 3.959 9.755 0.542 0.236
p value 0.185 0.089 0.538 0.675
As regards TSS, one-way ANOVA highlighted significant differences (p < 0.05) between D and
PUAE extracts for both the cultivars. In particular, D extracts (AK_D and WO_D) showed higher TSS
with respect to the corresponding PUAE extracts (AK_PUAE and WO_PUAE). This is likely because
the higher boiling temperature of decoction compared to sonication allowed the partial hydrolysis of
glucosides and the release of sugar moieties [36]. No significant difference between AK_PUAE and
WO_PUAE was observed, probably because the extraction temperature was similarly maintained
under control (<65 ◦C). According to previous studies [37], extraction temperature in the range of
60–70 ◦C was optimal for the UAE of EA from pomegranate peels.
For both the extraction methods the obtained extracts can be considered almost sugar-free if
compared with the corresponding pomegranate juice (Akko: TSS = 15.20 ± 0.42; Wonderful: TSS =
17.01 ± 0.57), as previously studied by the authors [23].
Previous studies have shown that cultivar, maturity stage, and environmental factors could
significantly influence the TAC of pomegranate peel extracts [5,38,39]. Cyanidin and pelargonidin
derivatives are the most abundant anthocyanin pigments isolated from the peels. In particular, cyanidin
3-O-glucoside was considered one of the major anthocyanins detected in these by-products [38]. In all
the extracts the TAC was slightly lower compared to those reported in literature for other pomegranate
cultivars [40] even if the cited authors used methanol as an extraction solvent. One-way ANOVA,
analyzing the mean differences of the TAC, showed significant differences (p < 0.05) between the
cultivars when extracts were obtained by decoction. On the contrary, no significant differences between
AK_PUAE and WO_PUAE were observed. Different results were shown for the two cultivars by
comparing the two extraction methods (D and PUAE).
Figure 1 reports the TPC and the RSA results of the peel aqueous extracts (D and PUAE) belonging
to the two cultivars investigated.
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Figure 1. TPC and RSA of Akko and Wonderful pomegranate peel aqueous extracts obtained by the
traditional (D) and innovative extraction technique (PUAE). Bars show mean values and SE of the
replicated data.
TPC and RSA values were moderately correlated (R2 = 0.7304). The decoction demonstrated
higher TPC compared to the extract obtained by sonication (PUAE) in both cultivars. In fact, one-way
ANOVA, analyzing the mean differences of the TPCs, showed significant differences (p < 0.05) between
the extraction methods (D and PUAE) for both cultivars. Analyzing the two different cultivars, there is
a significant difference between AK_D and W_D, with a higher value for Akko. On the contrary, no
significant differences in TPC were observed between the cultivars when the extraction was performed
by PUAE.
As regards RSA, no significant differences were observed by ANOVA in Akko and Wonderful
cultivars extracted both by decoction and PUAE, although the statistical significance was very low
(Table 2).
Some previous studies, which considered aqueous extracts of pomegranate peels starting from
different cultivars, showed an extraction efficiency, expressed as TPC, lower than that obtained in
the present work; for example, El-Said et al. 2014 [41] reported a TPC equal to 16.343 mg GAE/g for
aqueous extracts obtained from similarly oven-dried peels, which is more than 10 times less than
those reported in Figure 1. Rahja et al. 2019 [24] described different ‘green’ extraction methods
using just water as a solvent to efficiently extract the bioactive fraction of pomegranate peels. From a
comparison of different aqueous extraction methods applied to pomegranate peels, such as ultrasound
(UAE), infrared, pulsed electric fields, and high-voltage electrical discharges (HVED), HVED-assisted
extraction, applied for 7 min., yielded a maximal concentration of phenolics equal to 46 mg GAE/g
DW. After the same period, the UAE method yielded phenolic recovery equal to 14.5 mg of GAE/g
DW, which is approximately 10–16 times lower than the TPCs of those reported in Figure 1. Recently,
Kaderides et al. 2019 [42], exploiting the action of ultrasound and microwave to extract the phenolic
compounds from pomegranate peels, described TPCs equal to 119.82 mg GAE/g dry peel and 199.4 mg
GAE/g dry peel, respectively, which are more in accordance with the values described in this study
(148–237 mg GAE/g DW).
Figure 2 reports the free EA and ET amounts of the peel aqueous extracts (D and PUAE) belonging
to the two different cultivars investigated.
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Figure 2. EA and ET amounts of Akko and Wonderful pomegranate peel aqueous extracts obtained by
the traditional (D) and innovative extraction technique (PUAE). Bars show mean values and SE of the
replicated data.
Free EA and ET contents were not correlated. In particular, for both cultivars, the decoction (AK_D
and WO_D) showed higher EA and lower ET contents compared to the PUAE extracts (AK_PUAE
and WO_PUAE). The PUAE extract, according to several other green strategies reported in the
literature [42–44], confirms its superiority in terms of ET recovery, even if the simplest decoction is
endowed with a higher free EA content, probably due to the highest boiling temperature, which allows
the partial hydrolysis of ETs with the consequent release of the common aglycone (EA) and some sugar
moieties [36]. The aim of this investigation was the comparison between the innovative PUAE and the
traditional decoction. For this reason, the same experimental conditions (extraction time, liquid/solid
ratio, extraction solvent) were maintained for both of the extraction strategies with the exception of the
temperature, which was the only variable that changed (PUAE < 65 ◦C and D = 100 ◦C). ETs are stable
in acidic conditions (pH = 2–4), which is their natural condition; nevertheless, they rapidly degrade in
neutral and mildly basic media, especially at higher temperatures [36]. In acidic conditions, as in the
pomegranate extracts, ETs show high stability in the range of temperature 20–60 ◦C but at 80 ◦C they
gradually degrade [36].
One-way ANOVA, analyzing the mean differences of the free EA content, showed significant
differences (p < 0.05) only between AK_D and WO_D. On the contrary, as regards the mean differences
of the ET content, one-way ANOVA did not reveal significant differences between the studied couples
as reported in Table 2.
Figure 3 reports the percentage of tyrosinase inhibition of the peel aqueous extracts (Akko and
Wonderful) obtained by the innovative (a) and the traditional (b) extraction techniques.
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Figure 3. Percentage of tyrosinase inhibition of Akko and Wonderful pomegranate peel aqueous
extracts obtained by innovative (a) and the traditional (b) extraction techniques. Bars show mean values
and SE of the replicated data as a function of concentration. The letters represent homogeneous groups
with p > 0.05 (LSD Fisher post-hoc test). Same letters denote groups that are not statistically different.
The PUAE extracts of the two cultivars showed inhibition values not significantly different at the
different concentrations tested, except for those observed at 500 μg/mL. More relevant differences were
found for traditional decoctions: in these extracts the Akko cultivar showed greater inhibitions at all
concentrations except the highest one considered. From the inhibition values obtained from the various
concentrations tested, it was possible to calculate the EC50. In general, the extracts obtained from the
innovative extraction technique had better EC50 values (AK_PUAE = 117.73 μg/mL; WO_PUAE =
159.04 μg/mL) compared to traditional extracts (AK_D = 147.38 μg/mL; WO_D = 365.91 μg/mL).
In order to analyze the data using a multivariate approach, principal component analysis (PCA),
an unsupervised pattern recognition technique, was applied to the data matrix D8,8, whose rows are
the extracts and the columns are all the determined experimental variables. In detail, the eight extracts
are those obtained by PUAE and decoction for both cultivars, in duplicate, and correspondingly
categorized. PCA was performed on the autoscaled data matrix, since autoscaling, which consists
of mean-centering followed by division of each column (variable) by its standard deviation, allows
elaboration of multivariate data characterized by different scales and units. Figure 4 a-b shows the
PCA results obtained from the above-mentioned data matrix D8,8.
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Figure 4. Biplot (score and loading plot) on PC1–PC2 obtained by principal component analysis (PCA).
(a): extracts are categorized by the different cultivar (Akko and Wonderful); (b): data are categorized
by the different extraction techniques (D and PUAE).
The first two principal components (PCs) together explain almost 90% of the total information
of the whole data set since they visualize almost 90% of the total variance of the dataset. Figure 4a,b
shows the biplot PC1 vs. PC2, which represents the scores and loadings plot, on the first two PCs,
highlighting the different categorization of the extracts (a—the extracts are categorized by the different
cultivar; and b—the data are categorized by the different extraction techniques).
PC1, the direction of maximum variance (60.9%), for both cultivars, discriminates the PUAE
extracts from decoctions which have more positive scores on the first PC (Figure 4b). Decoction could
be associated with higher ◦Brix, RSA, TPC, TAC, and EA (highest loadings on PC1). Nevertheless, as
far as anti-tyrosinase activity is concerned, PC2, whose variance is about 29%, is the most important
component, highlighting the indirect correlation between the ET content (highest loadings on PC2)
and the EC50 (lowest loading on PC2). For both cultivars, PUAE extracts could be associated with the
highest ET content (highest loading on PC2) and the highest anti-tyrosinase activity. AK_PUAE, which
represents the extract with the highest content of ETs, is the one endowed with the highest anti-tyrosinase
activity (lowest EC50). Since PCs are mathematically uncorrelated (orthogonal) variables, it seems that
ET content, among all the determined variables, is the most important to determine the anti-tyrosinase
activity, together with pH, whose highest value in the Akko cultivar could further positively influence
the anti-tyrosinase activity [10,11]. The remaining variables, having high loadings on the PC1, do not
seem correlated with the anti-tyrosinase activity.
Water was employed as an extraction solvent with the dual aim of achieving a greener and safer
chemistry approach compared to methanol or other organic solvents, and developing a low-cost
recovery strategy of these by-products. The aqueous decoction of pomegranate peels represents
the simplest and cheapest strategy to rapidly obtain extracts, and has widely been used as a folk
remedy in traditional medicine. In fact, due to its high concentration of tannins, which gives the peel
a strong astringency, the peel decoction has been used to treat dysentery and other gastro-intestinal
disorders [45]. Moreover, another advantage of decoction is that, being an extemporaneous preparation,
there is no need to stabilize the extract. This is particularly relevant in the case of the extract obtained
with ultrasound, since the stability over time of aqueous extracts is very limited.
Ultrasound-assisted extraction (UAE) is a green and energy-saving technology which is being
increasingly employed in the extraction of natural products as a simple and efficient alternative to
conventional extraction techniques. Substantial shortening of extraction time, reduction of reagent
consumption, increase of extraction yield, and faster kinetics are the most important advantages of
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UAE [4–26]. The sonication used in pulsed mode (PUAE) drastically reduces the operating temperature,
allowing the extraction of thermolabile compounds. The superiority of PUAE to produce antioxidants
from pomegranate peels has been previously demonstrated [46]. Longer times of extraction have
not been tested in the present paper in order to minimize the potential degradation of the aqueous
extracts. In fact, during the sonication process of vegetal material in water, a small amount of active
oxidizing species (i.e., HO· and hydrogen atoms) are generated, and this process is time-dependent [47].
Although these aqueous extracts may require a further formulation step for preservation over time [48],
we did not tackle this point, since our priority was to emphasize whether or not they deserve further
formulative investigations.
4. Conclusions
The results of this research highlighted that water, as an extraction solvent, was able to extract, in
a limited extraction time (10 min), significant amounts of bioactive compounds, particularly ETs, from
pomegranate peels of the commercial cultivars most widespread in Italy: Akko and Wonderful. This is
of great importance considering the need for ‘greener’ and safer extractions of natural compounds.
Compared to PUAE, traditional decoction has the advantages of being easily and extemporaneously
obtainable and leads to extracts endowed with higher values of EA, TPC, RSA, and TAC for both the
cultivars investigated. Nevertheless, PUAE has the advantage of yielding extracts endowed with a
higher content of ETs, whose content is directly correlated with enzymatic activity.
Based on the results obtained, both of the ‘green’ extraction strategies proposed proved to be
promising methods to produce low-cost anti-tyrosinase ingredients. EA is already approved as a
lightening/whitening agent in cosmetic formulations; however, considering these results, the cheaper
natural extract rich in ETs could represent a potential new cosmetic ingredient. Stabilization to
preserve the polyphenolic compounds over time and formulation of a hydrophilic gel containing the
pomegranate peel extract, as well as the tests necessary to evaluate their in vivo lightening properties,
are currently under study.
These findings represent an important aim for pomegranate juice manufacturers, since peels are
the major form of processing waste, and their disposal is expensive and not eco-friendly.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3417/10/8/2795/s1,
Figure S1: HPLC separation of EA in one pomegranate peel aqueous extract, Figure S2: HPLC chromatogram
with anthocyanin profile of one pomegranate peel aqueous extract.
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Hladnik, M.; Krapac, M.; et al. Genetic, Biochemical, Nutritional and Antimicrobial Characteristics of
Pomegranate (Punica granatum L.) Grown in Istria. Food Technol. Biotechnol. 2017, 55, 151–163. [CrossRef]
35. Fawole, A.M.; Opara, U.L. Developmental changes in maturity indices of pomegranate fruit: A descriptive
review. Sci. Hortic. 2013, 159, 152–161. [CrossRef]
36. Sójka, M.; Janowski, M.; Grzelak-Błaszczyk, K. Stability and transformations of raspberry (Rubus idaeus L.)
ellagitannins in aqueous solutions. Eur. Food Res. Technol. 2019, 245, 1113–1122. [CrossRef]
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Abstract: The study aimed to investigate the effects of pioglitazone hydrochloride (PGZ) and
resveratrol (RES) on yellow-feathered broiler chickens. A total of 500 broiler chickens were randomly
divided into four groups and fed a basic diet (control group) or a basic diet supplemented with
15 mg/kg PGZ, 400 mg/kg RES, or 15 mg/kg PGZ plus 400 mg/kg RES for 28 days. Compared with the
control group, the PGZ and PGZ plus RES groups presented a significantly higher average daily gain
and a decreased feed-to-gain ratio. Increases in the dressing percentage, semi-eviscerated yield, muscle
intramuscular fat content, and C18:1n-9c, C18:3n-6, C20:3n-3, and monounsaturated fatty acid (MUFA)
percentages were found in the PGZ plus RES group. Moreover, the diet supplemented with RES or
PGZ plus RES increased the activities of catalase, glutathione peroxidase, and superoxide dismutase,
and decreased the levels of reactive oxygen species of thigh muscle. Additionally, the mRNA
abundance of peroxisome proliferator-activated receptor γ coactivator 1α, fatty acid-binding protein
3, nuclear factor erythroid-2-related factor 2, and superoxide dismutase 1 was increased in the PGZ
plus RES group. In conclusion, this study suggested that dietary supplementation of PGZ combined
with RES improved the growth performance, the muscle intramuscular fat content, and antioxidant
ability of yellow-feathered broiler chickens.
Keywords: resveratrol; pioglitazone hydrochloride; fatty acid; meat quality; antioxidant ability;
yellow-feathered broiler chicken
1. Introduction
In recent years, the demands of consumers have shifted from quantity to quality and, as a result,
the intramuscular fat (IMF) content and fatty acid profile of poultry meat have become important
to both producers and consumers [1]. Due to its relatively higher proportion of polyunsaturated
fatty acids, poultry meat is usually better than other meats [2]. However, unsaturated fatty acids are
susceptible to oxidation, and malonaldehyde (MDA) is well known as one of the end products of
this process [3]. Thus, lipid oxidation is one of the main factors leading to the deterioration of meat
quality, which can occur both before and after death [4]. Furthermore, lipid oxidation causes adverse
changes in glycolysis that increase the drip loss and thereby lead to meat spoilage and a shorter shelf
life [5,6]. Thus, an effective approach for improving the IMF and protecting intramuscular lipids
against oxidative damage is needed.
Thiazolidinediones (TZDs) are a class of medicines currently been used to treat type 2 diabetes [7].
Although TZDs have beneficial effects on glycemic control, insulin sensitivity, inflammation and
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oxidative stress, and reduction of triglycerides [8–10], TZDs are clinically at risk for hepatic insufficiency,
thus the use of TZDs in the animal diet is prohibited in some countries [11]. However, regarding the
effects of TZDs on skeletal muscle lipid metabolism, many studies have found that intramuscular
lipid content and the proportion of unsaturated fatty acids are increased after TZD treatment [12–14].
As adipogenic compounds, TZDs play a crucial role in adipocyte differentiation and have the potential
to alter the formation of intramuscular or marbled fat [15,16]. As one of the TZDs, pioglitazone
hydrochloride (PGZ) is a high-affinity ligand for peroxisome proliferator-activated receptor gamma
(PPARγ) [17], and previous study has found that PGZ can promote adipocyte differentiation to modify
intramuscular adipogenesis [15]. More adipocytes and larger cell sizes have been observed in mice
supplemented with PGZ [13,14,18]. According to previous reports, PGZ has the potential to promote
fat deposition in animal muscle [19,20]. Consistent with these findings, our previous studies confirmed
that dietary supplementation with 15 mg/kg PGZ can increase the IMF in the longissimus thoracis
muscle of pigs [21,22]. Therefore, PGZ has potential as a new feed additive for improving meat quality
of animals. However, few studies have explored the effects of PGZ on poultry, such as chickens.
The inclusion of an antioxidant additive in broiler chicken diets is necessary to protect the PGZ
supplementation-induced increase in the IMF of the thigh muscle from oxidation. Resveratrol (RES) is
a botanical polyphenolic compound, and previous studies have indicated that dietary supplemental
with RES could promote antioxidant activity in quail eggs and broiler chickens [23,24]. Furthermore,
the impairment in the antioxidant status caused by heat stress is attenuated in chickens fed a diet
supplemented with RES [25]. As an important plant-derived bioactive polyphenol, RES can eliminate
reactive oxygen species (ROS) and thereby improve antioxidant activity [26]. Consequently, RES has
the potential to work as an antioxidant and preservative to extend the shelf life of meat and thereby
avoid huge economic losses.
Because RES can improve the antioxidant capacity and PGZ can enhance the IMF and proportions
of unsaturated fatty acids, the aim of this study was to explore whether the combination of PGZ and RES
exerts effects on the muscle antioxidant status, IMF content, and fatty acid profile of broiler chickens.
2. Materials and Methods
The protocols used for the feeding and management of broiler chickens in this study were approved
by the Animal Ethics Committee of South China Agricultural University and were in accordance to
the Guidelines for the Care and Use of Laboratory Animals of South China Agricultural University
(Guangzhou, China).
2.1. Materials
PGZ (purity≥ 99%) and RES (purity≥ 98%) was obtained from Sichuan Jisheng Biopharmaceutical
Co., Ltd. (Leshan, China).
2.2. Experimental Design, Diets and Growth Performance
A total of 500 female yellow-feathered broiler chickens, approximately 72 days of age (28 days
before slaughter), were randomly assigned to four groups: a control group (fed with basic diet, Table S1),
and the PGZ, RES, or PGZ+RES groups, which were fed the basic diet and supplemented with 15 mg/kg
PGZ, 400 mg/kg RES, or 15 mg/kg PGZ + 400 mg/kg RES, respectively, for 28 days. The basic diet was
formulated according to the Nutrient Requirements of Poultry (Ministry of Agriculture of the People’s
Republic of China 2004).
Prior to the experiment, the experimental room was cleaned and disinfected. Immunization was
performed using a routine procedure. The broiler chickens were housed in a room with a concrete
floor covered with wheat shavings and allowed access to feed and water ad libitum. The room was
illuminated for 23 h, and the temperature was maintained at approximately 25 ± 2 ◦C. Before the
experiment, the animals were pre-fed with the assigned diet for 5 days, and all weak broiler chickens
were eliminated. The weight and feed intake of weak broiler chickens were recorded, and these data
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were excluded in the final statistics. The experiment spanned 28 days, and the average daily feed
intake (ADFI) was recorded. All broiler chickens were weighed at 1, 14, and 28 days to calculate the
average daily gain (ADG) and feed/gain (F/G) ratio.
2.3. Serum Biochemical Indices
After feeding for 28 days, 3 broiler chickens were selected from each replicate (totaling 15 broiler
chickens per diet group) and fasted overnight for 12 h. The broiler chickens were bled from the
jugular vein, and the blood samples from the broiler chickens of the formal experiment were collected,
then maintained at an oblique position for 30 min. The serum samples were then collected after
centrifugation of blood samples at 3000 rpm for 10 min and stored at−20 ◦C. Various serum biochemical
indices, including total protein (TP), triglyceride (TG), cholesterol (CHO), low-density lipoprotein
cholesterol (LDL-C), serum urea nitrogen (SUN), and high-density lipoprotein cholesterol (HDL-C),
were then detected using kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The kits
and their sensitivity and detection limits used in this study were as follows: TP assay kit A045-2-2,
5.0-122.1 U/mL; TG assay kit A110-1-1; Total CHO assay kit A111-1-1; LDL-C assay kit A113-1-1; SUN
assay kit C013-2-1; and HDL-C assay kit A112-1-1.
2.4. Carcass Performance and Meat Quality
After blood was harvested and feathers were removed, carcass weights were calculated. The carcass
traits and meat quality were measured as previously described [27]. Dressing percentage was calculated
by dividing carcass weight by live weight. The semi-eviscerated yield (feet, head, and all the organs
except the lungs and kidneys were removed), eviscerated yield (lung and kidney were removed),
breast muscle yield (2 × right left muscle), thigh muscle yield (2 × left thigh muscle), and abdominal
fat were expressed relative to carcass weight.
The entire left breast muscle and thigh muscle (the skin was removed) were collected immediately
after slaughter and used for detection of the meat quality. The pH was detected using a meter (HI99161,
HANNA, Rome, Italy) equipped with an insertion glass electrode, and the color was detected at the
same part of the front of all muscle using a colorimeter (CR410, MINOLTA, Tokyo, Japan) after 45 min
and 24 h slaughter. The drip loss was determined with the muscle samples were suspended in a
zip-lock bag and stored at 4 ◦C for 24 h. The cooking loss was determined using muscle samples sealed
in a zip-lock bag; the muscle samples were cooked in a 75 ◦C water bath and maintained at 72 ◦C for
20 min. The shear force was detected using the muscle cooked in a water bath at 70 ◦C for 30 min
with a digital muscle tenderness tester (C-LM3B, TENOVO, Beijing, China) at 24 h after slaughter.
A piece of muscle from the same location on the right side of the body was obtained and stored in
liquid nitrogen for histological analysis, determination of the fatty acid composition, and RT-PCR assay.
The remaining of the thigh muscle samples of each chicken were divided into 5 sections and stored at
4 ◦C. They were then collected for the detection of the total volatile basic nitrogen (TVB-N) at 0, 3, 5, 7,
and 9 days. As a crucial indicator used for evaluating the shelf life of meat, the TVB-N values were
detected using the procedure described by Goulas [28] and expressed as mg of TVB-N/100 g.
Six sections of thigh muscle were cut at 8 μm and embedded in 4% paraformaldehyde to protect
against dehydration. The sections were then stained with Oil Red O. The whole staining procedure
lasted approximately 10 min. Specifically, the slices were immersed in isopropanol for 2 min, washed
under running tap water for 1 min, covered with working solution for 5 min, and then washed in clean
isopropanol for 2 min to adjust the slice color. A working solution composed of 0.5 g of Oil Red O
diluted with 100 mL of isopropanol was prepared and stored at 4 ◦C [29].
2.5. Determination of the Fatty Acid Composition
The fatty acid contents and compositions were measured as previously described [30,31].
Samples of 30 g thigh muscle were baked at constant temperature (at 70 ◦C). 2 g portion of each
sample was weighed and then placed in a degreasing filter paper bag and dried to constant weight for
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extraction. After extraction, 2 mL methylation reagent (DongYing HeYi Chemical Co., LTD., Shandong,
China) was taken in a 10 mL screw cap centrifuge tube, and accurately added to 200 mL of fat and
gently mixed by pipetting. After sealing, the screw cap centrifuge tube was placed in a boiling water
bath at 100 ◦C for 30 min. The upper organic phase was transferred to a 2 mL centrifuge tube for
centrifuge. The upper organic phase was transferred to a 1.5 mL gas chromatography sample vial
(Jinpu Analytical Instrument Co., Ltd., Shandong, China) for later use. The fatty acid profile was
detected by GC 7890A gas chromatograph (Agilent, Santa Clara, CA, USA). Nitrogen was used as
carrier gas (2 mL/min). Injector and detector temperature were 270 ◦C. The temperature of the column
was operated as follows: 75 ◦C for 0.5 min, from 75 ◦C to 190 ◦C at 20 ◦C/min, and from 190 ◦C to
250 ◦C at 5 ◦C/min. The types of fatty acids were identified by comparing the retention times with
FAME Mix 37 (18919–1 AMP, Supelco, Bellefonte, PA, USA). Contents of various fatty acids were
calculated by calculating retention times and peak area percentages.
2.6. Determination of Muscle Antioxidant Abilities and ROS
The MDA, catalase (CAT), total superoxide dismutase (T-SOD) activity, glutathione peroxidase
(GSH-Px), and total antioxidant capacity (T-AOC) of thigh muscle were determined using commercial
kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The thigh muscles slaughtered
within two hours were cut into frozen sections of 5 μm, washed twice with phosphate buffer saline,
and returned to room temperature for incubation with 10 μM dihydroethidium (DHE, 50102ES02,
YEASEN, Shanghai, China) at 37 ◦C for 60 min. Fluorescence intensity was measured using Varioskan
LUX (Thermo Fisher Scientific, Waltham, MA, USA).
2.7. Determination of mRNA Abundances
Total RNA from the thigh muscle was extracted using TRIzol (Ambion, Austin, TX, USA) [32].
A quantity of 50–100 mg of frozen thigh muscle tissue was cut and placed in a mortar, poured into
liquid nitrogen, and crushed. A quantity of 1 mL TRIZOL was added to separate the nucleoprotein
complex. A quantity of 0.2 mL of chloroform was then added and the upper aqueous phase was
transferred into 1.5 mL centrifuge tubes, to which were added 0.5 mL of isopropanol. A quantity of
98 μL of Rnase-free water was then added after washing the RNA pellet (GeneStar, Beijing, China).
The concentration of RNA was determined by NanoDrop 2000 (Waltham, MA, USA), and first-strand
cDNA was synthesized with Primer Script™ (GeneStar, Beijing, China) and used for PCR amplification
with T100™ Thermal Cycler (Bio-Rad, Hercules, CA, USA). The IQ5 Real-Time PCR Detection System
(Bio-Rad, CA, USA) was used to determine the mRNA abundances, and the sequences of the primers
used in this study are listed in Table S2.
2.8. Statistical Analysis
All the data are shown as means. SPSS software (version 20.0) was used for the statistical analyses,
and the statistical significance levels (p < 0.05) were determined by one-way analysis of variance
(ANOVA) followed by Duncan’s multiple range test.
3. Results
3.1. Growth Performance
The growth performances of the broiler chickens are shown in Table 1. After feeding for 28 days,
the broiler chickens belonging to the PGZ and PGZ + RES groups presented heavier weights compared
to the control group (p < 0.05). Moreover, the PGZ and PGZ + RES groups exhibited 8.92% and 9.86%
lower F/G ratios (p < 0.05) and 12.14% and 13.64% higher ADG values (p < 0.05), respectively.
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Table 1. Effects of dietary supplemental with pioglitazone hydrochloride (PGZ) and resveratrol (RES)




Control PGZ RES PGZ + RES
IBW (g) 1623.6 1624.2 1623.7 1624.1 8.24 0.303
FBW (g) 2112.3 b 2163.1 a 2119.6 b 2168.5 a 10.32 <0.05
ADFI (g) 93.4 94.2 94.8 94.9 2.01 0.647
ADG (g) 17.4 b 19.2 a 17.7 b 19.4 a 0.51 <0.05
F/G (g/g) 5.37 a 4.91 b 5.34 a 4.89 b 0.09 <0.05
a,b Values with different letters within the line mean significant differences (p < 0.05). n = 5. Abbreviations: SEM,
standard error of the means; PGZ, pioglitazone hydrochloride; RES, resveratrol; IBW, initial body weight; FBW, final
body weight; F/G, feed/gain ratio; ADG, average daily gain; and ADFI, average daily feed intake.
3.2. Serum Biochemical Indices
As indicated by the results shown in Table 2, compared with the control group, the serum LDL-C
level was significantly decreased in the broiler chickens fed with PGZ, RES, or PGZ + RES (p < 0.05).
In addition, the broiler chickens fed with PGZ and PGZ + RES presented decreased serum CHO levels
(p < 0.05) and increased HDL-C levels (p < 0.05).




Control PGZ RES PGZ + RES
SUN (mmol/L) 0.61 0.50 0.51 0.59 0.06 0.331
LDL-C (mmol/L) 0.91 a 0.71 b 0.64 b 0.36 c 0.04 <0.05
CHO (mmol/L) 3.30 a 2.97 b 3.20 a 2.86 b 0.11 <0.05
TP (g/L) 45.53 46.96 46.70 48.07 1.45 0.251
TG (mmol/L) 1.73 1.62 1.78 1.89 0.57 0.734
HDL-C (mmol/L) 1.73 b 2.31 a 1.67 b 2.56 a 0.08 <0.05
a–c Values with different letters within the line mean significant differences (p < 0.05). n = 5. Abbreviations: SEM,
standard error of the means; PGZ, pioglitazone hydrochloride; RES, resveratrol; SUN, serum urea nitrogen; LDL-C,
low-density lipoprotein cholesterol; CHO, cholesterol; TP, total protein; TG, triglyceride; and HDL-C, high-density
lipoprotein cholesterol.
3.3. Carcass Performance and Meat Quality
The results of carcass performance are shown in Table 3. The dressing percentages of the PGZ and
PGZ + RES groups were higher than that in control group (p < 0.05). Moreover, the semi-eviscerated
yield was significantly increased (p = 0.045 and p = 0.037, respectively) and the abdominal fat was
decreased in PGZ, RES, and PGZ + RES supplemental groups (p < 0.05).




Control PGZ RES PGZ + RES
Dressing percentage (%) 90.96 b 91.71 a 91.54 a 91.73 a 0.20 <0.05
Semi-eviscerated yield (%) 86.53 b 87.28 a 87.24 a 87.25 a 0.19 <0.05
Eviscerated yield (%) 69.75 69.80 70.33 70.81 0.33 0.817
Breast muscle yield (%) 14.98 14.67 14.84 14.12 0.78 0.520
Thigh muscle yield (%) 17.46 16.71 16.88 16.2 0.56 0.793
Abdominal fat (%) 11.15 a 10.13 b 10.12 b 9.40 b 0.14 <0.05
a,b Values with different letters within the line mean significant differences (p < 0.05). n = 5. Abbreviations: SEM,
standard error of the means; PGZ, pioglitazone hydrochloride; and RES, resveratrol.
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Relative to the control treatment, RES and PGZ + RES supplementation reduced the cooking loss
and drip loss of breast muscle (Table S3) and thigh muscle (Table 4) (p < 0.05). In addition, the thigh
muscle of broiler chickens fed RES and PGZ + RES exhibited an increased muscle A* (red) (p < 0.05)
and pH (p < 0.05) at 24 h after slaughter. Furthermore, the breast muscle of broiler chickens fed
RES and PGZ + RES displayed a tendency toward an improved pH (p = 0.08) at 24 h after slaughter.
As expected, increases in the IMF values of breast muscle and thigh muscle were observed in broilers
fed PGZ or PGZ + RES-supplemented diet (p < 0.01), as evidenced by Oil Red O staining (Figure 1).





Control PGZ RES PGZ + RES
Shear force (N) 23.42 23.44 23.58 23.23 0.47 0.935
Drip loss (%) 1.43 a 1.41 a 1.23 b 1.20 b 0.05 <0.05
Cooking loss (%) 22.25 a 22.85 a 19.83 b 19.35 b 0.76 <0.05
pH45 min 6.02 5.94 6.06 5.98 0.06 0.305
pH24 h 5.82 b 5.80 b 5.91 a 5.94 a 0.03 <0.05
Color at 45 min
L* 52.44 51.93 51.10 52.21 0.51 0.532
A* 12.69 12.82 12.32 12.71 0.44 0.891
B* 7.39 7.49 8.17 8.10 0.67 0.589
Color at 24 h
L* 51.01 50.33 50.11 50.36 0.78 0.354
A* 11.04 b 10.87 b 11.76 a 11.84 a 0.16 <0.05
B* 8.23 8.45 8.56 10.29 0.43 0.197
Intramuscular fat (%) 3.18 b 3.88 a 3.22 b 4.21 a 0.15 <0.01
a,b Values with different letters within the line mean significant differences (p < 0.05). n = 5. Abbreviations: SEM,
standard error of the means; L*, lightnesss; A*, redness; B*, yellowness; PGZ, pioglitazone hydrochloride; and
RES, resveratrol.
Figure 1. Effects of PGZ and RES on Oil Red O staining in thigh muscle of broilers. The sections were
visualized under a light microscope with 100×magnification. n = 5. The red areas indicated by the
arrows in the figure represent intramuscular fat.
3.4. Determination of the Fatty Acid Composition
Because of the 215.69%−240.35% higher IMF contents of thigh muscle compared to breast muscle
(Table S3 and Table 4), we determined the fatty acid compositions of thigh muscle; results are listed in
Table 5. Compared with the control group, diet supplemented with PGZ, RES, and PGZ+RES exhibited
higher proportions of C18:1ω-9 (p = 0.009, p = 0.008 and p = 0.005, respectively) and monounsaturated
fatty acid (MUFA) (p < 0.05). Meanwhile, the proportions of C20:3ω-3 were increased in PGZ and PGZ
+ RES groups (p < 0.05).
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Control PGZ RES PGZ + RES
C14:0 0.60 0.64 0.59 0.59 0.02 0.174
C16:0 23.16 23.01 22.76 23.03 0.42 0.527
C16:1 2.91 2.83 2.91 3.01 0.17 0.314
C18:0 8.58 8.39 8.18 8.16 0.33 0.937
C18:1ω9 37.25 b 38.90 a 39.03 a 39.09 a 0.37 <0.05
C18:2ω6 20.99 20.87 20.39 21.08 0.25 0.149
C18:3ω6 0.15 b 0.18 a 0.15 b 0.19 a 0.01 <0.05
C18:3ω3 1.50 1.51 1.49 1.48 0.03 0.537
C22:0 0.24 0.21 0.22 0.21 0.01 0.217
C20:3ω3 0.30 b 0.39 a 0.32 b 0.41 a 0.15 <0.05
C20:4ω6 1.73 1.69 1.74 1.67 0.15 0.111
SFA 32.59 32.25 31.75 31.99 0.28 0.218
MUFA 40.16 b 41.73 a 41.94 a 42.10 a 0.33 <0.01
PUFA 24.67 24.64 24.09 24.83 0.35 0.379
a,b Values with different letters within the line mean significant differences (p < 0.05). n = 5. Abbreviations: SEM,
standard error of the means; PGZ, pioglitazone hydrochloride; RES, resveratrol; SFA, saturated fatty acid; MUFA,
monounsaturated fatty acid; and PUFA, polyunsaturated fatty acid.
3.5. Determination of Muscle Antioxidant Abilities and ROS
The results from the analysis of the lipid antioxidant capacities are presented in Table 6. ROS levels
in RES and PGZ + RES groups were significantly decreased compared with the control group (p < 0.05),
meaning that oxidative stress in thigh muscle was attenuated by RES addition. The broiler chickens
belonging to the RES and PGZ + RES groups exhibited higher thigh muscle CAT, GSH-Px, and SOD
activities, and lower MDA values (p < 0.05) compared with the control chickens. As displayed in
Figure 2, the RES group had lower TVB-N values at 5, 7, and 9 days in thigh muscle (p < 0.05), and the
combination of PGZ with RES substantially reduced the TVB-N values of thigh muscle meat at 7 and
9 days relative to the control levels (p < 0.05).





Control PGZ RES PGZ + RES
ROS (% of Control) 1.00 a 0.83 a 0.41 b 0.35 b 0.12 <0.05
T-AOC (U/mg prot) 0.20 0.21 0.21 0.25 0.07 0.978
CAT (U/mg prot) 2.01 b 2.05 b 2.63 a 2.65 a 0.15 <0.05
GSH-Px (U/mg prot) 8.43 b 8.27 b 12.33 a 12.78 a 0.43 <0.05
T-SOD (U/mg prot) 34.01 b 33.10 b 39.26 a 40.23 a 0.37 <0.05
MDA (nmol/mg prot) 5.03 a 4.71 a 3.85 b 3.72 b 0.27 <0.05
a,b Values with different letters within the line mean significant differences (p < 0.05). n = 5. Abbreviations: SEM,
standard error of the means; PGZ, pioglitazone hydrochloride; RES, resveratrol; T-AOC, total antioxidant capacity;
MDA, malonaldehyde; T-SOD, total superoxide dismutase; GSH-Px, glutathione peroxidase; CAT, catalase; ROS,
reactive oxygen species; and prot, protein.
3.6. Determination of mRNA Abundances
The mRNA expression levels of antioxidation- and lipogenesis-related genes in thigh muscle are
shown in Figure 3. Compared with the control group, the mRNA abundances of the lipogenesis-related
genes, such as PGC-1α and FABP3, were greater in the PGZ and PGZ + RES groups (p < 0.05).
Furthermore, RES and PGZ + RES supplementation resulted in an upregulation of the mRNA
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abundances of antioxidation-related genes, such as Nrf2 (p < 0.05) and SOD1 (p < 0.05). In addition,
a trend toward an increased GPX 4 mRNA abundance (p = 0.07) was found in the PGZ + RES group.
Figure 2. Effects of PGZ and RES on the TVB-N values of the thigh muscle of broilers. a,b Values with
different letters within the line mean significant differences (p < 0.05). n = 5. Abbreviations: SEM,
standard error of the means; PGZ, pioglitazone hydrochloride; RES, resveratrol; and TVB-N, total
volatile basic nitrogen.
 
Figure 3. Effects of PGZ and RES on the mRNA abundances (× 10−4) of lipogenesis-related genes, such
as (A) PGC-1α, (B) FABP3, and (C) GLUT4, and antioxidant genes, such as (D) NRF2, (E) GPX4, and (F)
SOD1, in the thigh muscle of broilers. a,b Values with different letters within the line mean significant
differences (p < 0.05). n = 5. Abbreviations: PGZ, pioglitazone hydrochloride; RES, resveratrol; PGC-1α,
peroxisome proliferator-activated receptor γ coactivator 1α; FABP3, fatty acid-binding protein 3; GLUT4,
glucose transporter 4; SOD1, superoxide dismutase 1; GPX4, glutathione peroxidase 4; and NRF2,
nuclear factor erythroid-2-related factor 2.
86
Appl. Sci. 2020, 10, 2452
4. Discussion
The yellow-feathered broiler chicken is highly accepted in the local market of Asian countries
due to its delicious meat [33]. However, the yellow-feathered broiler chicken is a slow-growing breed.
The ADG and feed/gain of yellow feather broilers are approximately 18.0 g/d and 4.8 (feed/gain, g/g),
respectively [27,34]. Therefore, optimization of their feed nutrients is important for improving the
growth performance of these slow-growing broiler chickens.
Our previous studies in pigs showed that dietary PGZ and PGZ + RES supplementation improved
the ADG and reduced the F/G ratio, the results being consistent with this study [21,22]. The increased
ADG of pig may be due to the ability of PGZ to promote adipocyte differentiation and store more fat in
the body [35]. In the present study, we used low dose of PGZ as an adipogenic additive rather than as
a drug, and in order to minimize the impact of PGZ on the liver and prevent drug residue in chicken
products, we started to add a low dose (15 mg/kg) of PGZ to the diets one month before the chicken
was released. Furthermore, broiler chickens supplemented with PGZ + RES exhibited an increased
dressing percentage and a decreased abdominal fat percentage. Previous studies showed RES reduced
the subcutaneous fat mass of pigs and obese rats through the inhibition of fat formation and lipolysis,
which was due to the enhanced expression of silent information regulator 1 in adipocytes [36,37].
Our results show that the PGZ and PGZ + RES groups present decreased CHO and LDL-C levels
but increased HDL-C concentrations, indicating that these broiler chickens exhibit an increased lipid
utilization and an improved fat metabolism in vivo, which is more beneficial for IMF deposition rather
than simply shifting toward abdominal fat [22,38,39].
The cooking loss and drip loss are significantly decreased by PGZ + RES supplementation,
which suggests an improved water holding capacity [40]. The enhanced antioxidant capacity of the
PGZ + RES group is beneficial for reducing glycolysis and increasing the water storage capacity.
In addition, the glycogen level largely affects the pH value, and we thus find that PGZ + RES
supplementation increases A* and pH at 24 h after slaughter [21,30]. During storage, most nutrients,
such as carbohydrates, proteins, and fats, decompose into various volatile organic compounds following
microbial spoilage and biochemical reactions, and these basic nitrogenous compounds increase the
TVB-N value, which is an important index for evaluating the shelf life of meat [41,42]. We find that the
TVB-N values at 5, 7, and 9 days are decreased in the RES and PGZ + RES groups, which indicates that
PGZ+RES addition has positive effects on extending the meat shelf life and improving the meat quality.
PGZ targets the adipose tissue through PPARγ and PGC-1α, and the latter is used to measure the
effect of PGZ [12,43]. Moreover, PGZ has potential as a new feed additive for improving meat quality
because it can increase the meat IMF [30]. In this study, PGZ activates PGC-1α and its downstream
genes, such as FABP3, and may thus induce a more active fat metabolism. In addition, the Oil Red O
staining results shown in Figure 1 also confirm that increased amounts of IMF are deposited in the
muscles of the chickens belonging to the PGZ and PGZ + RES groups.
Higher unsaturated fatty acid proportions in meat are beneficial for human health [1]. Early studies
had demonstrated that PGZ could enhance the proportions of polyunsaturated fatty acids in serum
phospholipids and longissimus thoracis muscle, and MUFAs in rodent muscle [12,21,30,44]. Similar to
previous studies, our present study finds that both the PGZ and PGZ+RES supplementation can increase
the C18:1ω-9, C18:3ω-6, and C20:3ω3 proportions in thigh muscle, and the latter supplementation
results in higher proportions. The changes may be associated with the roles of PGZ as an affinity
ligand of PPARγ, and PGZ affects several specific genes, not only PPARγ, but also PGC-1α and FABP3,
to ensure its normal function [45,46]. Our results support the hypothesis that PGZ improves the IMF
contents and MUFA proportions by activating critical genes involved in fat metabolism. In addition,
free radicals in meat can attack unsaturated fatty acids, and MDA is well known as one of the end
products [3]. Our study demonstrates that dietary supplementation with RES and PGZ + RES decreases
the MDA content and enhances the proportion of MUFAs in thigh muscle, which indicates that
unsaturated fatty acids are protected from oxidation [47].
87
Appl. Sci. 2020, 10, 2452
Antioxidant enzyme defensive systems, composed of SOD, GSH-Px, and CAT, can directly
eliminate ROS in meat [36,44]. The content of ROS determines the degree of oxidative stress
response [48]. Excessive ROS can cause cholesterol peroxidation, which in turn reduces membrane
fluidity and receptor activity, thereby impairing membrane function [49]. In general, decreased lipid
peroxidation or improved antioxidant ability in muscle is beneficial to meat quality. Mujahid et al.
showed that excessive MDA accumulation could inhibit the activities of antioxidant enzymes and
accelerate oxidative damage to proteins and DNA [50]. RES is a naturally occurring polyphenol
compound, and its biological activities, including antioxidant and lipogenesis regulation, have been well
researched in vitro and in vivo [51,52]. Numerous studies on the functionality of RES in poultry and
pigs have confirmed its efficacy as a feed additive for improving animal production and health [12,29].
RES facilitates the inactivation and subsequent elimination of oxide precursors and mobilizes the
expression of antioxidation-related proteins [53,54]. In our present study, the activities of the CAT,
T-SOD, and GSH-Px enzymes are increased by RES and PGZ+RES supplementation, and ROS is
reduced in the cells of thigh muscle. The mechanism underlying this effect may involve increased
mRNA expression of NRF2, SOD1, and GPX4. NRF2 is a redox-sensitive transcription factor that can
initiate the transcription of antioxidant genes, and the synthesis of CAT, SOD, and GSH-Px is regulated
by NRF2 [55,56]. The above results of antioxidant enzyme activities are confirmed through an analysis
of the antioxidant gene expression. Indeed, a strong positive correlation is found between antioxidant
enzyme activities and the corresponding mRNA levels, which suggests that activities of antioxidant
enzymes may be mainly regulated by their transcriptional levels [43].
From the present and some previous studies [13–22], we can conclude that dietary PGZ can
increase muscle fat deposition and improve the meat quality of food animals. It has potential as a new
functional feed additive. However, in many countries PGZ is a human drug and it is not allowed to be
used in feeds or foods. Dietary supplementation with PGZ has the potential to generate residues in
animal-derived products. There is limited information on the magnitude of PGZ residue worldwide.
Therefore, extensive work has to be carried out to investigate the effects of dietary supplementation
with PGZ on food-producing animals, and to prevent the occurrence of PGZ residues.
5. Conclusions
In conclusion, this study indicated that dietary supplementation with 15 mg/kg PGZ and
400 mg/kg RES improved the growth and carcass performances, meat quality, and antioxidant ability
of yellow-feathered broiler chickens and prolonged the shelf life of the meat. Importantly, the IMF
contents and MUFA proportions were improved and oxidative stress was reduced by PGZ and RES
supplementation, and the mechanisms underlying these effects likely involve increases in the mRNA
expression of PGC-1α, FABP3, Nrf2, and SOD1.
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Featured Application: A novel, simple and environmentally friendly method was developed and
optimize to produce a dietary fiber ingredient from Agaricus bisporus by-products, with suitable
characteristics for food application and potential biological activity, as a mean for upgrading
mushroom industry wastes.
Abstract: Mushroom production generates large amounts of by-products whose disposal creates
environmental problems. The high abundance of biological active non-starch polysaccharides in
mushroom cell walls makes these by-products attractive for dietary fiber-based ingredient (DFI)
production. Traditional methods of dietary fiber preparation didn’t allow to obtain a DFI with suitable
chemical and functional properties. In this work a simple and environmentally friendly method
was developed and optimized for DFI production using a central composite design with treatment
time, hydrogen peroxide and sodium hydroxide concentration as factors and chemical composition,
chromatic and functional properties as dependent variables. The chemical composition of the DFI was
strongly influenced by the process parameters and its functional and color properties were dependent
on its fiber and protein content, respectively. The method developed is simple, uses food grade and
low-cost reagents and procedures yielding a DFI with white color, no odor and a high concentration
of dietary fiber (>60%) with an identical sugar composition to the original mushroom fiber. Due to
the high water and oil retention capacity, this DFI may be used not only for dietary fiber enrichment
and reduction of the food energy value but also as a functional ingredient with potential bioactivity.
Keywords: dietary fiber; mushroom; Agaricus bisporus; dietary fiber ingredient; chemical composition;
functional properties; optimization; central composite design
1. Introduction
Mushrooms consumption and production over the last decades has shown a phenomenal growth
with several times increase in tonnage [1]. Some of the more common cultivated mushroom species
are the button mushroom (Agaricus bisporus) which is widely cultivated in Europe and comprising
about 32% of the world mushroom production, the Shiitake mushroom (Lentinus edodes) which is
grown for centuries in China and other oriental countries and the oyster mushroom (Pleurotus ostreatus)
cultivated in several countries around the world [2]. This increase is related to the increasing awareness
of consumers for the importance of a healthy diet [3,4]. Indeed, a variety of substances present in
mushrooms have been shown to present beneficial biological effects, from these, polysaccharides
comprising the β-D-glucans and heteroglucans are the best known and most potent mushroom-derived
substances with antitumor and immunomodulating properties [5–8]. The fungal cell walls are
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composed by an alkali-insoluble structural skeleton mainly composed of β-(1→3)-glucan covalently
linked to chitin [9,10], forming a chitin-glucan complex (CGC). Chitin and CGC have been shown
to have very interesting biological activities [11–15]. In addition, several studies have shown that
polysaccharides from a variety of mushrooms, including those of A. bisporus, have been successfully
used as prebiotics [16–22].
Nevertheless, mushroom production generates a large amount of by-products including waste and
off-grade mushrooms with no suitable commercial use that ranges between 5% and 20% of production
volume [23]. Mushrooms and mushroom by-products, especially those from A. bisporus, are rapidly
perishable products [24], and they suffer rapid and deleterious transformations resulting in darker
products due to the tyrosinase activity and synthesis of melanins [25] and with an unpleasant smell,
creating environmental problems for their disposal. The European regulation of waste management,
Directive 2008/98/ EC (‘Waste Framework Directive’), focused on the reduction of waste generation
by 30% in 2025, requires that waste should be managed without endangering human health and
harming the environment, in particular without risk to water, air, soil, plants or animals, and without
causing a nuisance through noise or odors [26]. To reduce the environmental impact of the agro-food
industries and the dependence on raw materials, the implementation of valorization procedures
for these materials is stimulated. Some strategies have already been evaluated, for example, the
use of A. bisporus by-products for non-animal chitin and chitosan production [27]. Nevertheless,
most of the methods employed for the extraction of fungal cell wall polysaccharides are tedious and
time-consuming involving the use of high temperatures and high concentrated alkaline and acid
solutions or using specific enzymatic treatment in combination with synthetic detergents [28–31].
In addition, the use of concentrated reagents can deteriorate the native properties of the obtained
products [32]. The production of dietary fiber ingredients (DFI) has been successfully used to upgrade
agricultural products and by-products of cereals, fruits, and vegetables [33,34], therefore, the production
of a high added value food ingredient based on mushroom dietary fiber from by-products and off-grade
mushrooms can be an economical alternative to the simple waste disposal. Nevertheless for the food
industry, beyond their nutritional and health benefits, dietary fibers also have technological properties
that can be used in food formulations, resulting in texture modification and enhancement of food
stability during production and storage, and more importantly, added fibers cannot alter the sensorial
properties of foods where they are used. Altogether, these factors will determine their successful use
in foods.
The purpose of this work was to develop and optimize a simple and green method for the
production of mushroom CGC enriched dietary fiber from A. bisporus off-grade mushrooms and
in situation of excessive mushroom production, using a response surface methodology based on a
central composite design to evaluate the influence of the process variables in the chemical composition,
nutritional and functional properties to evaluate its suitability for use as a DFI in food formulations.
2. Materials and Methods
2.1. Materials
As the method developed in this work is intended to be used for the valorization of off-grade
mushrooms with no commercial value and the excesses of mushroom production, for reasons of
simplicity and easier management, the A. bisporus mushrooms were bought on the local market for
obtaining the DFI. Samples were stored in dark conditions at 4 ◦C until experiments began for a
maximum of one day. All reagents used were of analytical grade. All reported values, unless otherwise
stated, are expressed on a dry weight basis and are the average values of the analysis of at least two
different replicates.
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2.2. Method for Preparation of Mushroom DFI
Preliminary experiments in our lab allow concluding (detailed later) that to obtain a food ingredient
based on dietary fiber from mushrooms with good technological properties, i.e., with a white color
and no aroma, an alkaline oxidative treatment using sodium hydroxide and hydrogen peroxide was
the most appropriate, and this method was further optimized concerning the treatment time, sodium
hydroxide concentration and hydrogen peroxide concentration (Table 1). For obtaining mushroom
DFI, mushrooms (300 g) were sliced and ground in a Waring blender (3 min) and transferred to the
treatment solution (1 L) whose composition was varied according to Table 1. The material was stirred
at 300 rpm at room temperature (20–22 ◦C) during the time for each specific treatment. After the
treatment, the solution pH was neutralized with concentrated sulfuric acid to pH 6–7, and hydrogen
peroxide was destroyed by adding NaHSO3. The material was filtrated, re-suspended in water and
filtered again. The material was freeze-dried and the solid was ground and weighted. The yield,
chemical and functional properties of the prepared mushroom DFI were determined to evaluate the
impact of the studied process parameters.
2.3. Dietary Fiber, Protein, Moisture, Lipids, Ash and Caloric Value Content of the DFI
Due to the expected presence of chitin in the DFI, the content and sugar composition of dietary
fiber of the mushroom DFI was determined as non-starch polysaccharides (NSP) by the method
of Englyst et al. [35,36], being determined by the sum of sugars released after acid hydrolysis, and
quantified by anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) [37].
Protein content was determined by quantification of the nitrogen content of the mushroom DFI after
correction for the nitrogen from glucosamine present and multiplication by 6.25. The total nitrogen
content of the DFI was determined by the Dumas method. Moisture, lipids and ash content of the
mushroom DFI were determined according to AOAC [38]. Total carbohydrates were calculated
by difference. Caloric values, on a dry basis, were computed using the Attwater coefficients [39],
corrected for 2% of ash.
2.4. FTIR Analysis
A Unicam Research Series FTIR spectrometer was used. The spectra were recorded in the range
of wavenumbers 4000–450 cm−1 with 50 scans being taken at 2 cm−1 resolution. Pellets were prepared
by thoroughly mixing DFI sample or reference polysaccharides (chitin, chitosan, and curdlan) and KBr
at a 1:200 sample/KBr weight ratio in a small size agate mortar. The resulting mixture was placed in
a Perkin–Elmer manual hydraulic press, and a force of 15 tons was applied for 10 min. The spectra
obtained were background corrected and smoothed using the Savitzky–Golay algorithm using PeakFit
v4 (AISN Software Inc., Oregon, United States, 1995). Chitin from crab shells (Sigma), Chitosan 66%
deacetylation degree (Sigma) and curdlan (Sigma) were used as reference polysaccharides.
2.5. DFI Chromatic Characteristics
The chromatic characteristics of the DFI were evaluated with a Chroma Meter CR-300 Minolta
(Osaka, Japan). CIE Lab coordinates were obtained using D65 illuminant a 10 observer as a reference
system. L*, a*, and b* parameters were calculated from the average of five color measurements.
The equipment was calibrated with a white standard (L* = 97.71; a* = −0.59 and b* = 2.31).
2.6. Water Retention Capacity and Oil Retention Capacity
Water retention capacity (WRC) of the mushroom DFI obtained under the different experimental
conditions was determined under external centrifugal force using the method described by Robertson
et al. [40]. Fiber (~1 g) was hydrated in water (30 mL) for 18 h, centrifuged (3000× g; 20 min),
drained, and dried. WRC was calculated as the amount of water retained per g of dry fiber residue.
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For determination of the oil retention capacity (ORC) of the mushroom DFI, the same procedure
described previously was used, but instead of water 30 mL of corn oil were used.
2.7. Experimental Design
A rotatable central composite design of the experiments was performed with k = 3—treatment
time, hydrogen peroxide and sodium hydroxide concentrations as independent variables. Central
composite experiments consisted of three sets of experimental points [41]: (1) a factorial design with 2k
points, k is the number of xi variables (factors) with coded levels +1 and −1 for each; (2) a star for 2k
points, coded as +α and −α on the axis of the system at a distance of 2k/4 from the origin, that accounts
for non-linearity; (3) central points, which are replicated to provide an estimate of the lack of fit of the
linear statistical model obtained as well as the pure error of the experiments (due to unreliability in the
measurement of the dependent variable) [42]. The main advantage of this methodology is to decrease
the number of experimental trials needed to evaluate multiple parameters and their interactions.
The established ranges were: sodium hydroxide concentration (CNaOH) 0.1–0.5 M, hydrogen peroxide
concentration (CH2O2 )—1.5–4.5%, treatment time (T)—2–6 h. Table 1 shows the coded and uncoded
experimental design.
2.8. Statistical Analysis
Data was fit to second-order polynomial Equation (1) for each dependent Y variable, through
multiple regression analysis using Statistic® vs. 10 software.
Y=β0 + β1X1 + β2X2 + β3X3 + β4X12 + β5X22 + β5X32 + β7X1X2 + β8X1X3 + β9X2X3, (1)
βn are regression equation coefficients and Xn the independent variables. Based on the predicted
model equations surface plots were generated. The analysis of the variance was performed to determine
the lack of fit and the significance of the effects of each of the three independent factors, using the mean
square pure error as the error term. This provides a more sensitive test of model fit because the effects
of the additional higher-order terms are removed from the error.
2.9. Principal Component Analysis (PCA)
PCA is one of the most often used chemometric methods for data reduction and exploratory
analysis of high-dimensional data sets [43]. PCA decomposes the original matrix into multiplication
of loading (chemical composition, color, and functional properties) and score (dietary fiber samples)
matrices. The principal components are linear combinations of the original variables. The principal
components are uncorrelated and account for the total variance of the original variables. PCA is an
unsupervised method of pattern recognition in the sense that no grouping of the data has to be known
before the analysis. The new sub-space defined by the principal components leads to a model that
is easier to interpret than the original data set. From these results, it should be possible to highlight
several characteristics and correlate them to the chemical composition of the different DFI produced.
3. Results
3.1. Development and Optimization of a Method for Obtaining Mushroom DFI
Preliminary experiments using methods previously described for the production of DFIs from
other sources, including the simple hot water extraction [44], ethanol extraction of the low molecular
weight material [45] and enzymatic removal of protein [46], rendered a deep yellow-brown material
with an unpleasant smell (results not shown). This prompts us to develop an efficient method for
the production of mushroom DFI that could render a food ingredient with desirable characteristics
for their application in foods. This could be accomplished by using a chemical treatment with
an alkaline solution containing hydrogen peroxide at room temperature. Under these conditions,
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the product obtained presented a white color and with no perceived odor. The method developed
for the production of mushroom dietary fiber was optimized considering three process variables:
treatment time (T), hydrogen peroxide concentration (CH2O2 ) and sodium hydroxide concentration
(CNaOH). A rotatable central composite design with α = 1.68 was used for the optimization of the
parameters for the production of mushroom DFI as well as optimization of the DFI physico-chemical,
nutritional and functional properties. Table 1 shows the design matrix of factors for the rotatable central
composite design. DFI yield, chemical and nutritional composition, color, and functional properties
were measured as the output variables.
3.2. Yield of the Mushroom DFI
The yield of mushroom DFI obtained varied between a minimum of 15% to a maximum of 53%
of the mushroom dry weight (0.77% to 2.8% of the fresh mushroom weight for a mushroom water
content of 94.7%) (Table 1). Based on the central composite design, each of the three factors (T, CH2O2 ,
and CNaOH) had a significant effect on the mushroom DFI yield (Table 2). There was also observed
a significant interaction between T and CNaOH. Using multiple regression analysis, a second-order
polynomial equation model based on codded levels was used to fit the experimental results. This model
which consists of the factors found to be significant is shown in Table A1. The ANOVA results of the
model obtained indicated an adequate performance with R2 = 0.64, implying that 64% of the variations
observed for the mushroom DFI yield are explained by the factors considered. It was therefore
considered that the model provided a good description of the experimental data. Nevertheless, the
F-test for the lack of fit was also significant (p < 0.05) therefore a more complicated model or additional
factors (for example variability of the mushrooms used in each experiment) are required to a higher
fit of the experimental data [41]. Figure 1 shows the three-dimension response surface curves of
mushroom DFI yield for each pair of factors by keeping the third factor constant at the level where it
presented the maximum value. The factor T presented the highest positive effect (Table 2, Figure 1a)
on the mushroom DFI yield (maximum for the +1.682 level), followed by the factor CH2O2 were it was
observed a positive effect (Table 2; Figure 1b) for the linear effect and a negative effect for the quadratic
effect (maximum value for the CH2O2 > 0 level). The interaction between the factor T and CNaOH and
the linear effect of the factor CNaOH both had a positive effect on the DFI yield (Table 2, Figure 1a).
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Figure 1. Response surfaces for mushroom DFI yield as a function of: (a) time and hydrogen peroxide
concentration (at sodium hydroxide concentration level of 1.682); (b) time and sodium hydroxide
concentration (at hydrogen peroxide concentration level of 1); (c) hydrogen peroxide concentration and
sodium hydroxide concentration (at time level of 1.682).
These results show that during the treatment of the mushroom material with the alkaline solution
containing hydrogen peroxide there was observed an insolubilization of material with treatment time,
this insolubilization being promoted by higher NaOH concentrations. According to the response
surface analysis, the predicted maximum mushroom DFI yield in the range studied is 2.9% of the
mushroom fresh weight (95% prediction interval: 2.1–3.6%) when the factor T is+1.682, the factor CH2O2
is +0 and the factor CNaOH is +1.682, corresponding to 55% of the mushroom solids. To understand
what is being insolubilized during the treatment of the mushroom material, and as the composition of
DFIs are important from a legal perspective [47] but also for its nutritional and functional properties,
the fiber, protein, lipid and ash contents of the DFI were determined.
3.3. Fibre Content and Composition
As can be observed in Table 1, fiber was the main component of the mushroom DFI for all the
conditions employed and ranged from 45.9% to 70.4%. Only the factor T had a significant negative
effect on the DFI fiber content (Table 2), therefore although higher treatment times resulted in higher
DFI yields, there was also observed a decrease in the relative abundance of dietary fiber in the DFI.
The previously described increase in the DFI yield with T is not related to an increase in fiber retention
during the treatment as there was not observed a correlation between fiber yield and treatment time (R2
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= 0.2092). For obtaining a mushroom DFI with higher fiber contents the lower processing times assure
this value (Table 1). The yield of dietary fiber obtained ranged between 0.50% of the mushroom’s fresh
weight to 1.3%, corresponding to a yield of fiber between 31% and 81% of original mushroom fiber
content (on average 54%). This yield is explained by the fact that some of the A. bisporus polysaccharides
are water and alkali-soluble [48].
In Table 3 it is shown the sugar composition of the mushroom DFI obtained for the different
experimental conditions tested. In addition, the sugar composition of the fiber of the freeze-dried
mushrooms is shown. The method applied resulted in a relative increase of the fiber in the DFI from
1.9 to 2.9 times in comparison with the original mushroom, showing the efficiency of the method
employed for enriching the DFI with the original mushroom fiber. As can be observed, the main sugars
present in the mushroom DFI were glucose followed by glucosamine and xylose that together account
for more than 91% of the total sugars present. Smaller amounts of mannose, glucuronic acid, fucose,
and galacturonic acid were also present. This sugar composition is similar to that described in previous
works that have shown that A. bisporus cell walls are composed predominantly by β(1→3)-linked
glucan containing some β(1→6) linkages containing also chitin [27,48,49]. FTIR analysis of the DFI
confirms the presence of chitin (Figure 2). The spectra had characteristic bands at 3400–3480 cm−1 that
responded to OH-3 and CH2OH-6 intra- and intermolecular hydrogen bonds, bands at 1650 cm−1
for amide I, and 1557 cm−1 for amide II vibrational mode. The chitin present in the mushroom DFI
is in an antiparallel α-conformation [50] as there is observed a split of the amide I vibration band at
1655 cm−1, identical to the reference crustacean chitin (Figure 2). These results confirmed that the
glycosaminoglycans of DFI from A. bisporus were in highly acetylated form. The ratio of intensities
of the bands at ~1379 and ~2920 cm−1 has been suggested as the crystallinity index for chitin and
chitosan [51]. The crystallinity index of the DFI chitin was similar to that of the reference chitin (1.07 vs.
1.12, respectively) and higher than that observed for the reference chitosan (0.78). The crystallinity
index obtained mushroom DFI was higher than that obtained by Wu et al. [27], this being probably
due to the preparation method used by these authors (1M NaOH at 95 ◦C during 30 min followed by
2% acetic acid at 95 ◦C during 6 h). A clear spectrum of the glucan in DFI could not be observed, due
to the overlapping of chitin bands and the lack of unique bands in β-glucans when compared to chitin
(Figure 3). This composition of dietary fiber is similar to that previously described [52], although in our
work the amount of glucosamine was lower, and this can be related with different times after harvesting
of the mushrooms [53] or to different A. bisporus strains used [54], nevertheless the chitin content of
the A. bisporus obtained in this work is in agreement with previous works [27,48,49,55]. Although the
relative abundance of the different sugars in the mushroom DFI is similar to that observed for the
original mushroom there was a decrease in the relative abundance of fucose (−60%), galactose (−70%),
and glucuronic acid (−60%). The other sugars present increased their relative abundance by 10% for
glucose, 70% for xylose and 30% for mannose. Galacturonic acid was not detected in the original
mushrooms but was present in most of the DFI obtained, and the relative abundance of glucosamine
was on average the same as that found in the original mushroom dietary fiber.
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Figure 2. FTIR spectra of the DFI obtained in treatment nº 4 and of the reference polysaccharides chitin,
chitosan and curdlan.
 
Figure 3. Dietary fiber ingredient obtained for the treatment nº 4. CNaOH = 0.419 M; CH2O2 = 3.9% and
T = 2.81 h.
3.4. Protein, Fat, Ash Content and Energy
Protein was the second most abundant component of the mushroom DFI, ranging from 11 to 40%
(Table 1). The yield of protein obtained varied between a minimum of 0.081% of the mushroom fresh
weight to 0.88%, representing between 6.7% and 73% of the original mushroom protein content. Only
T had a significant effect on the yield of protein from the mushroom. There was observed an increase
in the amount of protein recovered in the DFI with increasing T, nevertheless, the model (Table 3) is
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not enough to explain the variations observed in the amount of protein recovered in the DFI (R2 = 0.33)
during the chemical treatment of the mushroom material. Lower T assure lower amounts of protein in
the DFI. This higher recovery of protein in the ingredient with increasing T was probably due to the
denaturation of protein during the treatment in alkaline solution [56], to the crosslinking of protein
due to the hydrogen peroxide treatment [57] or due to the alkaline conditions employed leading to the
formation of lysinoalanine crosslinks [58].
The fat recovered in the mushroom DFI varied between a minimum of 0.016% of the mushroom
fresh weight, to 0.057%, representing between 4.9% and 17.4% of the original mushroom fat content.
There is observed an increase in the amount of fat recovered in the DFI with the increasing T and
increasing CNaOH being observed a significant interaction between these two factors. This higher
recovery of fat in the final product was probably due to the precipitation or adsorption of fatty acids
released from triglycerides during the alkaline treatment, as also higher CNaOH and increasing T
resulted in higher amounts of fat recovered.
The caloric values were calculated for each mushroom DFI produced under the different conditions
employed and ranged from 261 to 316 kcal on a dry basis (Table 1). As can be observed, and as expected,
the DFI with a higher amount of dietary fiber presented the lower caloric values.
3.5. Colour of Mushroom DFI
The mushroom DFI presented a white/yellowish color depending on the treatment conditions
(Table 4).
Table 4. Yield, water and oil retention capacity and color parameters a obtained for the different runs
used for the optimization process.





1 91.0 −0.113 11.39 15.2 11.3
2 89.3 0.320 15.71 18.5 12.0
3 82.1 1.100 17.68 18.5 11.3
4 90.6 −0.470 13.41 21.3 18.9
5 87.4 0.337 18.49 16.3 15.7
6 90.5 −0.467 18.88 8.5 7.8
7 90.3 −0.360 15.24 11.3 10.8
8 75.8 2.930 17.75 9.3 7.0
9 86.9 0.787 21.52 11.4 12.6
10 84.7 1.517 20.37 9.9 10.4
11 81.3 1.037 20.18 11.5 11.5
12 81.0 2.507 22.95 9.2 8.4
13 93.8 −2.623 16.37 10.6 7.4
14 88.2 −0.080 22.72 9.6 7.8
15 89.4 −0.497 22.94 5.9 7.7
16 88.9 −0.677 23.61 4.2 7.7
17 91.9 −0.224 22.34 5.7 7.9
18 89.5 −0.304 22.61 4.7 6.0
19 88.8 −0.273 22.52 6.2 6.9
20 89.1 −0.443 23.51 8.8 6.1
a L* defines lightness, a* denotes the red (+)/green (−) value and b* the yellow (+)/blue (−) value.
In theory, the perfect colorless white (white point) has the values L* = 100, a* = 0, b* = 0, therefore,
processing conditions rendering DFI with values close to these theoretical values will allow to obtain
DFI with a white color. Lightness (L*) was significantly affected by the three factors, being also observed
a significant interaction between T and CH2O2 and between CH2O2 and CNaOH (Table 2). Taking all
these effects into account, for obtaining a DFI with a high L* value, the optimum CH2O2 . level is 0
and aiming having a DFI with higher fiber values (Section 3.2), the CNaOH level should be 1.682 and
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the level for the treatment time factor should be −1 (predicted L* = 103.79; 88.90 to 118.18). For the
a* value (red-green coordinate of the color space), all factors, either linear or quadratic effects were
significant. In addition, there was observed a significant interaction between all factors (Table 2). There
are several combinations of independent variables (T, CH2O2 , CNaOH) that allow to obtain the desired
value of a* = 0 as there is observed a significant interaction between all factors (Table 2). Optimum
values for a* for factor T − 1, important for obtaining high fiber percentage in the DFI, can be obtained
with the following combination: levels of CH2O2 of 1 and of CNaOH of 1 (predicted a* value of 0.785 and
prediction interval of −5.760 to 7.330). For the b* value (yellow-blue coordinate of the color space), the
linear terms of T and CNaOH and all quadratic terms of the factors had a significant effect (Table 2).
Additionally, there was observed a significant interaction between T and CH2O2 and CH2O2 and CNaOH
(Table 2). For the desired value of b*, all factors should remain at the lower level yielding a b* value
of 0.131 (95% prediction interval of −2.814 to 3.076). These results show that the method developed
allowed us to obtain a DFI with desirable neutral color values for their application as a food ingredient
(Figure 3).
3.6. Mushroom DFI Water and Oil Retention Capacity
The water retention capacity (WRC) of mushroom DFI is shown in Table 4. WRC ranged from a
minimum of 4.2 g water/g of DFI to a maximum of 21.3 g water/g of DFI. The highest WRC values
obtained for the mushroom DFI are higher than that obtained for dietary fiber concentrates obtained
from orange, peach, artichoke and asparagus, mango peel, sugar beet (10–14 g/g), apple and pear
(6–7 g/g) and much higher than that observed for wheat and oat bran, carrot, and pea dietary fiber
concentrates (3–4 g/g) [59–61] and in the range of that observed for potato fiber (23–25 g/g) [62]. As can
be observed in Figure 4a, the WRC of the mushroom DFI was strongly dependent on T, being observed
a decrease in the WRC with increasing T, whatever the CH2O2 .
For the CH2O2 there was observed a minimum for the WRC at the central value of this factor, with
lower and higher levels showing a positive effect in the WRC of the DFI. For the CNaOH there were
observed to different situations (Figure 4b), for lower treatment times there was observed an increase
in the WRC with increasing CNaOH, the reverse was true for higher treatment times. Keeping the level
of factor T at the minimum, the effect of CNaOH on the WRC of DFI was much more important than
the CH2O2 (Figure 4c). Whatever the CH2O2 the higher WRC was observed for the higher CNaOH. For a
higher WRC of the DFI the optimum CH2O2 level was 1.682, the CNaOH level should be 1.682 and the
level for factor T should be −1.682 (predicted WRC of 36.0 g/g of DFI with a 95% prediction interval of
29.6 to 42.4 g/g).
The oil retention capacity (ORC) of mushroom DFI is shown in Table 4. ORC varied from a
minimum of 6.0 g oil/g of DFI to a maximum of 18.9 g oil/g of DFI. The ORC values obtained for the
mushroom DFI were higher than that obtained for dietary fiber concentrates obtained from apple, pea,
wheat, carrot (1–2.3 g/g) and sugar beet (5 g/g) [59], apple pomace and citrus by-products (0.6–1.8
mL oil/g) [63], unripe banana flour (~2 mL oil/g) [64]; carrot pulp dried at 50 ◦C (~6 mL oil/g) [65]
and asparagus by-products (5.5–8.5 mL oil/g) [66]. As can be observed in Figure 5a, the ORC of the
mushroom DFI was strongly dependent on the CH2O2 and T, being observed the higher value of ORC
for lower T and higher CH2O2 .
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Figure 4. Response surfaces for mushroom DFI water retention capacity (WRC) as a function of: (a) time
and hydrogen peroxide concentration (at sodium hydroxide concentration level of 1.682); (b) time and
sodium hydroxide concentration (at hydrogen peroxide concentration level of 1.682); (c) hydrogen
peroxide concentration and sodium hydroxide concentration (at time level of −1.682).
The same effect was observed for factor CNaOH, for lower T there was observed an increase in the
ORC with increasing CNaOH, the reverse was true for high T (Figure 5b). When the effect of the factors
CNaOH and CH2O2 are represented, there was observed that the maximum ORC was obtained or for
high CNaOH and CH2O2 when the treatment time was at the lower level (Figure 5c) the reversed being
observed for longer treatment times (result not showed). Using the factor levels where the maximum
value is observed (T = −1.682; CH2O2 and CNaOH = 1.682) the predicted value of ORC of the DFI is
35.8 g/g of DFI (95% prediction interval between 30.8 to 40.8 g/g).
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Figure 5. Response surfaces for mushroom DFI oil retention capacity (ORC) as a function of: (a) time
and hydrogen peroxide concentration (at sodium hydroxide concentration level of 1.682); (b) time and
sodium hydroxide concentration (at hydrogen peroxide concentration level of 1.682); (c) hydrogen
peroxide concentration and sodium hydroxide concentration (at time level of −1.682).
3.7. Effect of Mushroom DFI Chemical Composition on the Colour and Functional Properties
To understand the effect of the chemical composition of the mushroom DFI obtained under the
different processing conditions on the color and functional properties of mushroom DFI, the data
obtained was analyzed by principal component analysis (PCA). The first three principal components
obtained explained >70% of the total variance in the original data set. The loadings express how well
the new PCs correlate with the original variables (Figure 6a and Table 2). The first PC, which explains
44.4% of the total variance, correlates positively with total fiber, glucosamine, glucose, xylose, WRC
and ORC and negatively with protein and the b* value. The second PC, which explains 14.6% of the
total variance, correlates positively with galacturonic acid content and negatively with glucuronic acid
content, and PC3, which explains 13.5% of the total variance correlates positively with the a* value and
negatively with lightness (L*). These results show that the WRC and ORC of the DFI are correlated
with the total sugar content of the DFI (Figure 6a) and the b* value, related to the yellowness of the DFI
is correlated with its protein content.
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(a) (b) 
Figure 6. (a) Factor loading plot based on correlations of the mushroom DFI chemical composition,
color characteristics and functional properties projected on the space of PC1 vs. PC3; (b) scores plot of
the mushroom DFI samples projected on the space of PC1 vs. PC3.
The scatter plot of the sample scores on the PC1 and PC3 scores (Figure 6b) shows the formation
of two distinct clusters along the PC1. Samples with positive PC1 scores have a high relative content
of total sugars and also a high WRC and low protein content and were less yellow, the opposite
being true for the samples with negative PC1 scores. The WRC of dietary fibers is dependent on
its structure [62,67] and chemical composition [68,69]. The water retained by dietary fiber material
generally comprise three types of water, retained by three mechanisms: water bound by the hydrophilic
polysaccharides of the fiber, dependent on the chemical composition of the fiber; water held by the
fiber in the fiber matrix, mainly dependent on the pore size distribution of the fiber matrix; and water
associated with fiber other than bound or matrix water, trapped within the cell wall lumen, dependent
on the fiber source, method of preparation and method of measurement. Contrarily the ORC is in part
related to its chemical composition but is more largely a function of the porosity of the fiber structure
rather than the affinity of the fiber molecule for oil [70].
Samples with high scores on PC3 contain a relatively high a* value and lower L* value. As can be
observed in Figure 6b, the group composed by the samples with a high PC1 score, corresponding to
the DFI resulting from the 5 first treatments applied, are subdivided according to PC3 forming two
groups, samples 3 and 5 contain a higher a* and lower L* values when compared to samples 1, 2 and 4.
4. Discussion
The production of a DFI from A. bisporus by-products, besides being a good strategy to reduce
wastes generated in the mushroom agro-industry, can yield a DFI that besides having prebiotic
activity [19,21,22] can also present a range of other very interesting biological activities. Several studies
have shown that A. bisporus polysaccharides show immunostimulatory [71–74], antioxidant [74,75],
antitumor [76–78], anti-inflammatory [7,79] and anti-sepsis activities [80], as well as antinociceptive
inhibition [7,80]. The method developed allowed to concentrate the A. bisporus fiber polysaccharides
up to 2.9 times, with a chemical composition similar to the initial cell wall, and so the biological
activities of these polysaccharides are expected to be enhanced due to the concentration observed
during the production process. In addition, it is expected that the original CGC present in A. bisporus
cell walls is maintained [27,48,49]. CGC has been shown beneficial effects concerning the development
of obesity and associated metabolic diabetes and hepatic steatosis, through a mechanism related to
the restoration of the composition and/or the activity of gut bacteria, namely, bacteria from clostridial
cluster XIVa [81]. Furthermore, CGC has potential beneficial effects concerning the development
of atherosclerosis, mainly related to improving the antioxidant status [11,12]. On the other hand,
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chitin consumption can reduce triglyceride and cholesterol levels in liver and increase excretion of
triglycerides in feces [13] and reduce cholesterol levels [14], and linear β-(1→3)-glucans have shown
hypoglycemic activity accompanied by promotion of metabolism and inhibition of inflammation,
through suppressing SGLT-1 expression and possibly associated with alteration of gut microbiota [15].
Nevertheless, to be acceptable, a DFI added to a food product must perform in a satisfactorily as a
food ingredient [82], namely be bland in taste, color, and odor. Besides the well-established nutritional
benefits of adding dietary fiber ingredients to food products, the use of DFI can also have important
technological advantages [59]. Of the various technological benefits, the increases in the water retention
capacity (WRC) and oil retention capacity (ORC) of foods are one of the main advantages of using
DFIs [59,83]. Both WRC and ORC can increase the technological yield of food. WRC of DFIs can be
advantageous in sauces and soups, but also for their textural properties, enhancing the flow properties
and avoiding lump formation in powdered mixes (e.g., ready-to-eat sauces, mixes of spices, flavoring
agents). ORC can be exploited in foods (cooked meat products) to enhance their retention of fat that
is normally lost during cooking, being also beneficial for flavor retention [59]. The WRC can have a
nutritional interest as well, as increase in water retention has been related to an increase in orocaecal
transit time. The water-holding capacity of dietary fiber has been proposed to be valuable in the diet to
alter stool bulking [84]. Increased stool weight can cause shorter gut transit times limiting the exposure
of the gut to secondary bile acids and other toxins [85,86].
The use of a sodium hydroxide concentration of 0.419 mol/L and hydrogen peroxide of 3.9%
during 2.81 h, at room temperature, allow to obtain the highest yield of DFI (1.22% in relation to
the fresh weight) with one of the highest dietary fiber (63.7 g/100 g) and lower protein (12.0 g/100
g) contents and highest WRC (21.3 g/g of DFI) and ORC (18.9 g/f of DFI). In addition, the chromatic
characteristics of the DFI obtained show that it has a good lightness (L* = 90.6) and neutral (white)
color (a* = −0.470 and b* = 13.71).
The by-products of A. bisporus production can be successfully used for the production of a DFI
using a simple method at room temperature and using food-grade materials, being a good strategy to
reduce wastes in the mushroom agro-industry. Due to the simplicity and the efficiency shown in the
production of A. bisporus DFI, there are no anticipated problems in applying this technology to other
abundant mushrooms wastes as those derived from the production of Lentinus edodes and the oyster
mushroom (Pleurotus ostreatus).
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Table 2. Factor-variable correlations (factor loadings), based on correlations.
Factor 1 Factor 2 Factor 3
Total
Sugars 0.946 −0.167 −0.054
GlcNH2 0.861 0.326 −0.059
Glc 0.825 −0.463 −0.065
Xyl 0.837 0.376 −0.061
Man 0.607 0.551 0.219
GalA 0.358 0.686 0.037
GlcA 0.458 −0.801 0.063
Fuc −0.819 0.213 0.166
Fat −0.000 −0.284 −0.501
Ash −0.484 −0.383 0.004
Protein −0.938 0.002 −0.129
WRC 0.801 −0.030 0.192
ORC 0.652 −0.083 0.205
L* 0.068 0.090 −0.924
a* −0.072 −0.226 0.922
b* −0.717 0.311 0.151
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Abstract: Water soluble polysaccharides (WSP) were isolated from Lentinus edodes fruiting bodies.
The mushrooms were previously subjected to various processing techniques which included blanching,
boiling, and fermenting with lactic acid bacteria. Therefore, the impact of processing on the
content and biological activities of WSP was established. Non-processed fruiting bodies contained
10.70 ± 0.09 mg/g fw. Boiling caused ~12% decrease in the amount of WSP, while blanched and
fermented mushrooms showed ~6% decline. Fourier transform infrared spectroscopy analysis
(FTIR) confirmed the presence of β-glycosidic links, whereas due to size exclusion chromatography
216 kDa and 11 kDa molecules were detected. WSP exhibited antioxidant potential in FRAP (ferric
ion reducing antioxidant power) and ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid))
assays. Cytotoxic properties were determined on MCF-7 and T47D human breast cell lines using
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) test. Both biological activities
decreased as the result of boiling and fermenting.
Keywords: polysaccharides; Lentinus edodes; antioxidant; cytotoxicity; processing; mushrooms; LAB
(lactic acid bacteria); fermenting
1. Introduction
Among thousands of mushrooms only about 20 species are cultivated commercially for culinary
purposes. Japanese mushroom Lentinus edodes, commonly known as Shiitake, is cultivated for both its
culinary and medicinal applications [1]. It has been reported that consumption of edible mushrooms
provides a significant health improvement as they are low in calories, sodium, fat and cholesterol,
but rich in proteins, carbohydrates, fibre, vitamins and minerals [2–4]. Commonly consumed mushroom
species exposed to a source of ultraviolet (UV) radiation can generate nutritionally relevant amounts
of vitamin D [5]. Providing considerable amount of iron and well absorbed proteins they are often
called “the meat of forest” [2]. Mushrooms are rich in immunomodulating compounds which, unlike
traditional chemical drugs, do not cause any harmful effect or allergic reactions and put no additional
stress on the body [6,7].
Out of all mushroom-derived substances, polysaccharides are known to have the most potent
antitumor, antioxidative and immunomodulating properties [6,8,9] but their biological activities differ
greatly depending on the structural and physical features [10]. For example, both in vitro and in vivo
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antitumor activities of mushroom extracts arise from the presence of β-glucans, especially containing
β-1,3 bounds in the polysaccharide chain [2,11]. Studies confirmed that lentinan, the high molecular
weight polysaccharide β-1,3-d-glucan with β-1,6-glucopiranoside branches extracted from Lentinus
edodes fruiting bodies not only has immunomodulating properties but also can suppress the growth of
cancer cells and induce them to apoptosis [10,12,13]. However, the details of molecular mechanisms
of these processes remain unclear [14,15]. Chen et al. [16] stated that among eight studied species of
medicinal mushrooms, Lentinus edodes polysaccharides showed the strongest scavenging activity for
hydroxyl radicals and were able to inhibit the proliferation of MCF-7 tumor cells. Antibacterial and
antifungal properties of Shiitake extracts have also been reported [4,17].
As edible mushrooms are characterized by a short shelf life, 1–3 days at room temperature,
they should be consumed directly after harvesting because their nutritional value is then the best then.
Additionally, most of mushroom species need to be processed before the consumption. In the literature
there are some information about the influence of processing like cooking, baking, drying or freezing
on the contents of health promoting compounds [18,19] but little is known about the effect of these
processes on mushroom-derived polysaccharides antioxidant and antiproliferative activities [20].
Contemporary consumers are more aware of what they eat and drink, they more often choose
home made products or those without any artificial stabilizers. Noticing this tendency the aim of this
article was to verify the impact of some processing methods on the content, chemical composition,
antioxidant and antiproliferative activity of water soluble polysaccharides (WSP) obtained from
Lentinus edodes. The processes that were chosen are easy to conduct and commonly used at home,
including boiling, blanching and fermenting with lactic acid bacteria (Lactobacillus plantarum).
2. Materials and Methods
2.1. Biological Material
Lentinus edodes fruiting bodies were provided by a private producer (AgRoN, Ząbki, Poland).
Harvested mushrooms were from the same crop and were transported in five kg plastic trays. Fresh
fruiting bodies were stored at 5 ◦C up to five hours before the analysis.
The bacterial strain used in the experiment (Lactobacillus plantarum IBB76) was obtained from IBB
Central Collection of Strains (Warsaw, Poland). This strain was used previously in fermentation of
mushrooms [21–23].
2.2. Processing of Mushrooms
Fruiting bodies were divided into four portions. The first one was blanched for five minutes in
citric acid solution (0.5% w/v) at 95 ◦C. The second portion was boiled in water for fifteen minutes at
100 ◦C. The third group was blanched as above and fermented with lactic acid bacteria strain, as in the
previous study [23]. The last portion (control group) was not processed. All the four portions were
lyophilized (Alpha 1–2 LD plus, Christ, Germany) prior the extraction of polysaccharides.
2.3. Extraction of Water Soluble Polysaccharides (WSP)
Lyophilized fruiting bodies were milled into fine powder, extracted with ethanol (80 ◦C, 1 h) and
centrifuged. Insoluble part was rinsed with alcohol and subjected to water extraction (115 ◦C, 1 h).
The obtained water extract was concentred and mixed with 2-propanol to precipitate polysaccharides.
Precipitates were then washed three times with alcohol, lyophilized and weighed. The extraction was
carried out in triplicate and extraction yields were calculated.
2.4. Chemical Characteristics of Polysaccharides
The extracted WSP were redissolved in water and subjected to three colorimetric assays.
Total carbohydrate content was determined with the phenol–sulfuric acid method [24]. Protein
content was determined with Bradford reagent [25] and total phenolics content was quantified with
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Phenol-Cicalteau reagent [26]. Glucose, bovine albumin and gallic acid (respectively) were used to
construct calibration curves.
Fourier transform infrared spectra of the samples were recorded on Nicolet NXR 9650 spectrometer
(Thermo, Waltham, MA, USA) equipped with an ATR (attenuated total reflection) module. The samples
were scanned within the range of 400–4000 cm−1.
Gel permeation chromatography (GPC) was employed to determine the molecular weight.
The analysis was conducted according to the methodology described by Malinowska et al. [27]. Briefly,
the samples were dissolved in NaN3 water solution and applied to the following TSK-GEL columns:
G5000PWXL, G3000PWXL andG2500PWXL (Tosoh, Tokyo, Japan). Samples were detected with a
Refracto Monitor IV refractive index detector (LDC Analytical, Riviera Beach, FL, USA) and compared
with pullulans standards.
2.5. Antioxidant Assays
ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) radical scavenging activity assay
was conducted according to Re et al. [28]. The samples (25 μL) were mixed with ABTS + solution (975
μL) and measured at 734 nm after 15 min. Ferric reducing antioxidant power (FRAP) analysis was done
according to the methodology of Benzie and Strain [29]. FRAP reagent (1900 μL) was added to the
samples (100 μL) and after 90 min of incubation the absorbance was measured at 593 nm. The results
of both antioxidant assays were compared with calibration curves made with Trolox and expressed as
micromoles of Trolox equivalent (TE) per 1 g of mushroom dry weight.
2.6. Cytotoxic Properties
The MCF-7 adenocarcinoma, cell line was obtained from the American Type Culture Collection
(ATCC) cat. no. HTB-22. The T47D ductal, epithelial cancer cell line was obtained from the
European Collection of Authenticated Cell Cultures (ECACC) no. 85102201. These two human breast
cancer cell lines were grown at standard conditions (37 ◦C, 5% CO2, 95% humidity) in RPMI 1640
medium (Sigma) supplemented with 10% fetal bovine serum (FBS, Sigma), 100 U/mL penicillin (Polfa,
Poland) and 100 μg/mL streptomycin (Polfa, Warsaw, Poland). For MCF-7 cells 50 μg/mL of bovine
insulin (Sigma) was also added. Cytotoxicity effect of tested WSP was measured with a quantitative
colorimetric toxicity MTT assay based on the transformation of yellow, soluble tetrazolium salts
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) to purple-blue insoluble formazan by
mitochondrial succinate dehydrogenase of living, metabolically active cells [30,31].
T47D and MCF-7 cells (100 μL/well) were seeded on 96-well plates at concentrations of 3 × 105
cells/mL and 2 × 105 cells/mL, respectively. After 24 h incubation at standard conditions, when cells in
each well reached 75–80% confluence, the growth medium was replaced with WSP dilutions in RPMI
1640 with 2% FBS. The concentrations ranged from 25 μg/mL to 250 μg/mL. Cells were incubated with
polysaccharides for 24 h, followed by addition of 25 μL of MTT (Sigma) solution (5 mg/mL in PBS) per
well. After 3 h incubation at 37 ◦C formazan crystals were solubilized with 100 μL of lysis buffer (10%
SDS in 0.01 M HCl) per well. Plates were incubated overnight at standard conditions. The absorbance
was read at 540 nm with a plate reader (680 XR, Bio-Rad), and the mean value for each concentrations
was calculated. The percentage of viable cells were calculated from the absorbance.
2.7. Statistical Analysis
The measurements were done in triplicate and results were expressed as the mean ± standard
deviation. The collected data were evaluated using analysis of variance ANOVA with a level of
significance set at p < 0.05. The LSD test was performed to assess statistically different results. Different
letters on graphs and tables (a, b, c, etc.) show significant differences among the data according to LSD
test (p < 0.05).
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3. Results and Discussion
3.1. The Content of Water Soluble Polysaccharides
As shown in Table 1, mushrooms belonging to the control group contained 96.9 ± 0.8 mg/g dw
of WSP. Blanching did not cause statistically relevant changes, whereas boiling led to the increase
in the amount (112.0 ± 2.0 mg/g dw). The observed increase in the case of boiled fruiting bodies is
with agreement with the previous study conducted on Hypsizygus marmoreus fungi [32] or button
mushroom [22]. The reason for this could be the leaking of easy soluble substances into the brine
and changing the ratio between high and low weight molecular weight compounds. Blanched and
fermented mushrooms contained the lowest quantity of WSP (86.7 ± 3.1 mg/g dw).
Table 1. The content of the isolated water soluble polysaccharides (WSPs).
Treatment
WSP Content in Dried Fruiting Bodies WSP Content in Fresh Fruiting Bodies
(mg/g dw) (mg/g fw)
Control 96.9 ± 0.8 b 10.70 ± 0.09 c
Blanched 95.3 ± 4.1 b 10.75 ± 0.22 c
Boiled 112.0 ± 2.0 c 9.40 ± 0.20 a
Blanched and Fermented 86.7 ± 3.1 a 10.07 ± 0.21 b
The results were also expressed in mg per g of fresh weight in order to consider the loss of the
mass. As can be seen, the highest drop (~12%) was observed in the case of boiled fruiting bodies and
slight decrease (~6%) in the case of blanched and fermented samples. Similar results were noticed.
Boiling of mushrooms may lead to the changes in their mycelial structure and therefore facilitate the
extraction of water soluble polysaccharides [32].
3.2. Chemical Characteristics of Water Soluble Polysaccharides
In the isolated WSPs the level of carbohydrate, protein and phenolics were determined (Table 2).
Polysaccharides extracted from non-processed mushrooms contained 72.35 ± 3.77% of carbohydrate,
4.90 ± 0.46% of protein and 0.59 ± 0.02% of phenolic compounds. Previous research demonstrated a
similar quantity of carbohydrate in L. edodes polysaccharides which ranged from 72% [33] to 78% [34].
Other authors who used different extraction method reported higher quantity of carbohydrate (87%),
lower amount of protein (~3.5%) and no phenolic compounds [35]. In accordance with the presented
results, previous studies have demonstrated similar content of protein but twice higher amount of
phenolics [34]. Mushrooms are highly abundant in phenolics and these compounds have tendencies
to bind to polysaccharides with hydrogen or even covalent bounds [36,37]. According to research
phenolic antioxidants are released from polysaccharidic matrix by probiotic bacteria and then are
absorbed into bloodstream [38].
Table 2. Chemical composition of the isolated WSPs.
Treatment
Carbohydrate Content Protein Content Total Phenolics Content
(% dw) (% dw) (mg Gallic Acid Equivalent per 100 g)
Control 72.35 ± 3.77 a 4.90 ± 0.46 c 0.59 ± 0.02 d
Blanched 79.67 ± 3.45 b 4.03 ± 0.28 b 0.49 ± 0.04 c
Boiled 71.21 ± 3.29 a 5.12 ± 0.25 c 0.45 ± 0.01 b
Blanched and Fermented 93.00 ± 3.59 c 2.30 ± 0.35 a 0.25 ± 0.02 a
The processing of mushrooms caused various changes in chemical composition. Blanching in
citric acid solution resulted in higher carbohydrate content (79.67 ± 3.45%) along with lower protein
(4.03 ± 0.28%) and phenolics content (0.49 ± 0.04%). Interestingly, boiling for 15 min affected only
(negatively) protein quantity when compared with control samples. The most evident changes
were observed in the case of blanching and fermenting, where significant decreases of phenolics
and protein (0.25 ± 0.02% and 2.30 ± 0.35%, respectively) were noticed. In contrast, the level of
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carbohydrate markedly rose reaching 93.00 ± 3.59%. These data is in accordance with previous
experiment conducted on Agaricus bisporus [22]. The loss of protein and phenolics during lactic acid
fermentation of mushrooms can be attributed to enzymes that are produced by bacteria: proteases
degrading protein moieties [39] and esterases which release phenolic compounds [40]. Additionally,
aqua-thermal processing may cause solubilization or even degradation of low molecular weight
phenolics [41].
Fourier transform infrared spectroscopy enables us to detect functional groups which are present
in a sample and is often used in the analysis of plant and fungi based polysaccharides [42–44]. FTIR
coupled with a ATR accessory a is rapid and non-destructive tool which does not require sample
preparation [45]. FTIR analysis may be useful in determination of polymers purity as well as for the
detection of the type of glycosidic bond [46]. FTIR analysis of the isolated WSP is presented in Figure 1.
The obtained spectra shows bands which are commonly present in polysaccharides mushroom origin.
Broad bands at 3000–3500 cm−1 and 2800–3000 cm−1 are associated with stretching vibrations of O-H,
N-H and C-H, respectively. Two signals at ~1645 cm−1 (Amide I) and ~1535 cm−1 (Amide II) indicate
the presence of protein. They are result of C =O stretching vibrations (Amide I) and bending vibrations
of N-H groups (Amide II) and were reported previously in L. edodes β-glucans [47]. Interestingly,
Amide II band is barely visible in WSP isolated from blanched and fermented mushrooms. This is in
accordance with the observed sharp drop in protein content shown due to Bradford assay. The signal at
~1520 cm−1 can be attributed to C-C stretching of aromatic ring and suggests the presence of phenolic
compounds [48]. This signal is the weakest in the case of WSP obtained from blanched and fermented
mushrooms and may confirm the significant loss in phenolics. In the region of 1300–1450 cm−1 there
are signals which can be assigned to bending vibrations of O-H, C-O-H and CH2 [49], whereas intense
peaks between 950–1190 cm−1 are due to stretching vibrations of C-O-C, C-O-H, C-C [50]. FTIR
analysis allowed to identify the type of glycosidic bonds dominating in the samples. Spectra showed
absorbance at ~890 cm−1 which is indicative of β-glucans [51,52].
Figure 1. FTIR spectra of WSP.
In order to establish molecular weight of the extracted polysaccharides, size exclusion
chromatography was used (Figure 2). All the tested WSP gave intense signals at ~18.8 mL. These sharp
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peaks correspond to molecules of 216.3 kDa. This finding was also reported by Chen et al. [53] who
isolated proteoglycan from L. edodes, having the molecular weight of 220 kDa and capable of scavenging
free radicals. It is also consistent with the previous research in which 200 kDa polysaccharide (showing
immunomodulating activities) was obtained from L. edodes water extract [54]. However, this study
was unable to demonstrate the presence of larger molecules exceeding 600 kDa as was earlier reported
by other authors [55,56]. Chromatogram of the control sample also contains the peak at 22.6 mL. It can
be attributed to the smaller compound having the molecular weight of 11 kDa. This peak is removed
due to the processing and a possible explanation for this might be that this compound was solubilized
and extracted during blanching or boiling.
Figure 2. Size exclusion chromatography of WSP.
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3.3. Antioxidant Potential
Mushrooms are rich in low molecular weight antioxidants, mainly phenolic acids. Such compounds
are mainly present in free form and can be easily extracted with both water and organic solvents.
However, some antioxidants bind to larger molecules and become less or non-extractable [57]. These
compounds are often bound to mushroom derived polysaccharides and affect their antioxidant
capacities. All the isolated WSP exhibited antioxidant activity in both assays (Figure 3). The highest
antioxidant parameters were noticed in the case of the control samples (23.53 ± 0.30 μmoles of TE/g dw
for ABTS and 12.29± 0.87μmoles of TE/g dw for FRAP). Antioxidant activity of L. edodes polysaccharides
was reported before and this study confirms earlier findings [16,35,58]. Blanching caused a significant
drop in FRAP test (7.59 ± 0.75 μmoles of TE/g dw), while no relevant change in ABTS parameter was
noticed. Boiling resulted in the decrease of ABTS activity (20.83 ± 1.24 μmoles of TE/g dw), whereas no
further change in the case of FRAP test was observed. The most profound changes caused blanching
and fermenting (7.78 ± 1.50 μmoles of TE/g dw for ABTS and 3.56 ± 0.33 μmoles of TE/g dw for FRAP).
The results clearly showed that aqua-thermal processing may have negative impact on antioxidant
parameters of polysaccharides. Previous findings showed that antioxidant activity of polysaccharides
is related to total phenolics and protein content [59–61]. In this study, a high correlation was observed
between ABTS values and total phenolics (R = 0.93) as well as protein content (R = 0.85). In the
case of the FRAP parameter, the correlation coefficients were similar to ABTS (R = 0.96 and R = 0.82,
respectively). Therefore, the reason for the drop in antioxidant capacity is very likely caused by
the removal of phenolics and protein. Further studies should be carried out to isolate and identify
antioxidant compounds which are bound to polysaccharidic matrix by covalent bonds [57].
Figure 3. Antioxidant capacity of WSP.
3.4. Cytotoxic Properties of WSP
It has been reported that many mushroom polysaccharides show direct cytotoxicity to cancer
cells [62]. To determine the response of cells to water soluble mushroom polysaccharides (WSP) we
used MTT assay that measures the reduction in cell viability when exposed to cytotoxic substances.
The control T47D and MCF-7 cells viability was assessed as 100%. Our results showed a dose
dependent cytotoxic effect of crude polysaccharide extract from Lentinus edodes on MCF-7 cells
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(Figure 4a). The control, a not processed WSP sample, caused a 73% and 41.7 ± 4.7% decrease of
MCF-7 cell viability after treatment with 50 and 250 μg/mL concentration respectively. The processing
of Lentinus edodes fruiting bodies particularly blanching and blanching with further fermentation
had suppressed cytotoxic activity of applied WSP. After incubation with the highest polysaccharides
concentration MCF-7 cells viability reached 74.0 ± 5.7% and 82.5 ± 3.5%, respectively. Boiling in water
changed cytotoxic properties of polysaccharides in the least degree. MCF-7 cells viability after treating
with (250 μg/mL) WSP from boiled mushrooms was 57.9 ± 5.8% [63]. Israilides et.al. achieved a 50%
reduction in viability of MCF-7 cells, however the time of incubation with 73 ± 14 μg/mL of water
extract from Lentinus edodes took 48 h. Moreover, it is known that whole mushroom extracts contain
a lot of substances other than polysaccharides with very well documented direct cytotoxic activities
achieved 50% reduction in viability of MCF-7 cells, however, the time of incubation with 73 ± 14 μg/mL
of water extract from Lentinus edodes took 48 h. It is known that whole mushroom extracts contain a lot
of substances other than polysaccharides with very well documented direct cytotoxic activities [64].
Figure 4. Cytotoxic effect of water soluble polysaccharides (WSP) from blanched, boiled, blanched and
fermented Lentinus edodes on MCF-7 (a) and T47D (b) cell lines.
In the cell line T47D (Figure 4b), we have assessed no significant sensitivity to polysaccharides
fractions from processed and control (Lentinus edodes fruiting bodies) mushrooms. Viability of T47D
cells treated with maximal WSP concentration was consecutively 87.2 ± 4.5% for blanched, 84.9 ± 0.6%
for blanched with further fermentation and 83.7 ± 1.8% for control sample. Interestingly boiling in
water have led to complete loss of WSP antiproliferative activity (cells viability was 97.0 ± 0.5%).
These observations are consistent with the results of previous studies [23] carried out on
Pleurotus ostreatus fungus where it was stated that hydro-thermal processing of mushrooms cause
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the loss of direct cytotoxic activity of mushroom derived polysaccharides. Similarly other authors
reported that different ways of mushrooms conservation treatment and cooking affect the composition
of nutritional values and their antioxidant properties [18]. To sum up, from both studied breast cancer
cell lines MCF-7 and T47D, the first one seemed to be more sensitive to water soluble polysaccharides.
The strongest antiproliferative activity to MCF-7 cells was stated for water soluble polysaccharides
from non-processed Lentinus edodes fruiting bodies.
4. Conclusions
Mushrooms fruiting bodies are rarely eaten raw and certain processing needs to be applied prior
the consumption. The main purpose of the present paper was to determine the effect of three processing
methods on the content and biological activity of water soluble polysaccharides. The study has shown
that boiling and fermenting with lactic acid bacteria may lead to small decrease in the amount of
polysaccharides. Moreover, all the techniques, namely blanching, boiling and fermenting cause the
decrease in both antioxidant and antiproliferative capacities. However, these processes do not diminish
biological activity completely and polysaccharides still retain their properties to some extent. A natural
progression of this work would be to verify the impact of different processing methods e.g., baking,
frying or microwaves. In addition, further studies should be conducted to understand mechanisms
beyond antiproliferative activities of polysaccharides and residues which are attached to them.
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Featured Application: An updated description of pursued approaches for efficiently resolving the
low bioavailability issue of ellagic acid.
Abstract: Ellagic acid, a polyphenolic compound present in fruit and berries, has recently been the
object of extensive research for its antioxidant activity, which might be useful for the prevention and
treatment of cancer, cardiovascular pathologies, and neurodegenerative disorders. Its protective role
justifies numerous attempts to include it in functional food preparations and in dietary supplements,
and not only to limit the unpleasant collateral effects of chemotherapy. However, ellagic acid
use as a chemopreventive agent has been debated because of its poor bioavailability associated
with low solubility, limited permeability, first pass effect, and interindividual variability in gut
microbial transformations. To overcome these drawbacks, various strategies for oral administration
including solid dispersions, micro and nanoparticles, inclusion complexes, self-emulsifying systems,
and polymorphs were proposed. Here, we listed an updated description of pursued micro and
nanotechnological approaches focusing on the fabrication processes and the features of the obtained
products, as well as on the positive results yielded by in vitro and in vivo studies in comparison
to the raw material. The micro and nanosized formulations here described might be exploited for
pharmaceutical delivery of this active, as well as for the production of nutritional supplements or for
the enrichment of novel foods.
Keywords: ellagic acid; oral administration; bioavailability; microformulations; nanoformulations;
solubility enhancement
1. Introduction
Pomegranate, Punica granatum, is well-known as a traditional medicinal fruit mentioned in the
Old Testament of the Bible, the Qur’an, the Jewish Torah, and the Babylonian Talmud as a sacred
fruit harbinger of fertility, abundance, and luck. Historically and currently, pomegranate has been
used for various purposes [1]. The bioactive compound mainly responsible for the health effects of
pomegranate is ellagic acid (EA), as it represents one of the most potent dietary antioxidants.
EA is a polyphenol compound which derives from ellagitannins (ET), a family of molecules in
which hexahydroxydyphenic acid residues are esterified with glucose or quinic acid. Following a
hydrolytic process, the hexahydroxydyphenic acid group is released, dehydrates and spontaneously
lactonizes, forming EA. Punicalagin isomers are the most representative of total tannins extracted from
pomegranate (Figure 1).
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Figure 1. Hydrolysis of punicalagin (a pomegranate ellagitannin) to produce ellagic acid.
Present also in a large variety of tropical fruit, nuts, berries (strawberries, raspberries, blackberries,
cranberries, goji berries) and in a type of edible mushroom (Fistulina epatica), EA has recently
attracted deep interest, since many research studies showed the role of oxidative stress in different
pathologic conditions such as cancer, diabetes, cardiovascular and autoimmune diseases, obesity,
and neurodegenerative disorders [2–7]. In this regard, EA may be a useful adjunct in Parkinson’s
disease treatment, as it proved to protect dopamine from oxidation and, by reducing inflammation and
oxidative stress, to exert a neuroprotective effect [8]. Besides being able to reduce the pathological
levels of NF-kB, EA may play a beneficial role in diseases associated with CNS inflammation, such as
multiple sclerosis. EA has also been proposed as antidepressant and anxiolytic drug for its capability
to modulate the monoaminergic system and to increase the endogenous levels of brain-derived
neurotrophic factors [6]. In the last decade, several studies investigated EA effects on many types
of cancer, showing its ability to arrest cell cycle progression, modulate pathways linked to cell
viability, and inhibit angiogenesis via inactivating metalloproteinases [9–18]. For example, EA resulted
in inducing apoptosis and modulating gene expression in different colon cancer cell lines at the
concentrations achievable in the intestinal lumen from the diet, suggesting a potential role in cancer
chemoprevention [19]. Moreover, EA may counterbalance the dangerous side effects of antitumoral
drugs such as cisplatin, doxorubicin, and cyclosporine [20–22]. In addition, EA proved to possess
antimicrobial properties inhibiting the growth of methicillin-resistant Staphylococcus aureus and
Salmonella [23]. These properties were explained through the ability of EA of either coupling with
proteins of the bacterial wall or inhibiting gyrase activity, which cleaves the DNA strand during
bacterial replication. Furthermore, EA seemed to counteract the HIV-1 virus replication, by binding
envelope proteins and inhibiting reverse transcriptase [24]. Pomegranate extract has been traditionally
used for treating gastrointestinal bleeding and various types of wounds, due to EA’s ability to promote
blood coagulation by the activation of the Hageman factor (Factor XII) [25]. Moreover, preliminary
results suggest potential anti-inflammatory properties [26,27] and an important role in prevention
of cardiovascular diseases [28–30]. Finally, EA finds application also in cosmetic and nutraceutical
industries, mainly for antiaging and prophylactic purposes respectively [31–33]. An overview of EA
activities is shown in Figure 2.
However, though EA has the potential to become an efficacious agent in the prevention and
therapy of several diseases, as supported by several papers present in the literature, the working
efficacy of EA dietary and therapeutic formulations have been mainly examined at preclinical level.
To date, few clinical studies have been performed to evaluate EA beneficial effects in humans, with
often a limited number of patients, and most of them concern the administration of pomegranate juice
or extract in cancer patient diet or deal with the evaluation of the enhancement of cognitive/functional
recovery after stroke [34,35]. It was suggested that EA’S low water solubility and rapid metabolism
might hinder the progress towards translational research. In our opinion, further studies focused on
the application of micro and nanotechnology could provide more encouraging data, opening the path
to new strategies able to overcome EA’s poor biopharmaceutical characteristics. Hence, the goal of this
review is to provide to scientists, embarking on the research involving EA, a scenario of all pursued
formulation attempts. Therefore, starting from a description of EA bioavailability and solubility,
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a summary of micro and nanosystem-based strategies suitable for improving orally administered EA
efficacy is provided.
2. EA Chemical Structure and Solubility
EA is a chromene-dione derivative (2,3,7,8-tetrahydroxy-chromeno [5,4,3-cde]chromene-
5,10-dione), encompassing both a hydrophilic moiety with 4 hydroxyl groups and 2 lactone groups,
and a planar lipophilic moiety with 2 biphenyl rings. This particular structure has both hydrogen
bonding acceptor (lactone) and donor (–OH) sites (Figure 1). Due to the weak acidic nature of its
four phenolic groups (pKa1 = 5.6 at 37 ◦C), around neutral pH it is mainly deprotonated on positions
8 and 8′, while above pH 9.6 lactone rings open to give a carboxyl derivative [36]. EA low oral
bioavailability is mostly due to its poor water solubility (9.7 μg/mL), which increases with pH, as well
as the antioxidant action [37]. However, in basic solutions, phenolic compounds lack stability as these
molecules, under ionic form, undergo extensive transformations or are converted to quinones as a
result of oxidation. A stability study on pomegranate fruit peel extract demonstrated that EA content
significantly decreases in few weeks regardless of the pH of the solution, due to the hydrolysis of the
ester group with hexahydroxydiphenic acid formation, suggesting that EA should not be stored in
aqueous medium [38]; this aspect reinforces the need to develop novel systems also for EA stabilization.
Prior to facing the route of the development of a new delivery system, the knowledge of solvents,
co-solvents and substances in which EA could be consistently soluble and stable represents an
indispensable step for designing a good formulation. In this regard, with the aim of providing a
useful guidance for further research studies, Table 1 gathers published data concerning EA solubility.
Concerning organic solvents, EA is slightly soluble in methanol, soluble in DMSO and shows maximum
solubility in N-methyl-2-pyrrolidone (NMP), confirming the effect of basic pH on EA dissolution.
An analogous trend is also observable in aqueous solutions, where results implied that the solubility
of EA depends on the pH values of the media. While EA is almost insoluble in acidic media and
distilled water, its water solubility is significantly improved by basic pH. As highlighted further ahead,
one of the mostly exploited vehicles is polyethylene glycol (PEG) 400, as it is endowed with satisfactory
biocompatibility and, at the same time, is miscible with both aqueous and organic solvents. EA
solubility in oils and surfactants is also provided, helpful for developing emulsifying-based techniques.
3. EA Dietary Assumption
In foods and beverages, EA is present in several forms, such as unmodified, glycosylated and/or
acetylated or inside the structure of hydrolysable ET polymers, usually esterified with glucose moieties.
However, only a small fraction of free EA is absorbed in the stomach, since ET are resistant to
acidic pH. ET hydrolysis occurs in the small intestine, leading to the release of EA, which can be
absorbed mainly by passive diffusion, although an in vitro experiment on Caco-2 cells monolayer
model suggested the involvement of a protein-mediated transport [39]. Once reached the systemic
circulation, EA undergoes a massive first pass effect, being transformed in methyl esters, dimethyl
esters or glucuronides, detectable in human plasma from 1 to 5 h after ET ingestion [40]. Meanwhile,
unabsorbed ET and EA fractions are mostly converted to a family of metabolites called urolithins by
colon microflora. Urolithins contain a common structure of dibenzopyranone and are more lipophilic,
showing higher absorption rate across colon epithelium compared to EA, thus resulting 25–80 times
more bioavailable [41]. Naturally, there is huge variability in microbial metabolism of EA among
individuals depending on differences in gut microbiota composition. According to the metabotype
(M-0, M-A and M-B), humans may produce no urolithins, highly active urolithins or less active urolithin,
so that EA consumption may not exert equal health benefits in all subjects [42–44].
EA oral bioavailability was studied in human subjects after 180 mL of pomegranate juice
consumption. In this study, the maximum EA blood concentration (Cmax) was 32 ng/mL which
was rapidly metabolized in the next 4 h, confirming the extremely poor intestinal absorption [41].
Other pharmacokinetic studies supported the hypothesis that higher EA-to-ET ratio in the oral dose
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corresponds to higher EA plasma concentrations, but, intriguingly, no enhancement in bioavailability
was observed increasing the dose of free EA up to 524 mg, suggesting that a saturation condition in the
absorption process was achieved [45]. In addition to these unfavorable conditions, it must be considered
that polyphenols are not consumed in sufficient quantities among population in Western Europe and
developing countries, because of inadequate fruit and vegetable intake, though an increased awareness
of the benefits of a balanced diet is fostering the assumption of dietary supplements [46].
4. Formulation Strategies for Improving EA Oral Bioavailability
The Biopharmaceutics Classification System (BCS) is a scientific framework for classifying drug
substances based on their aqueous solubility and intestinal permeability. It is a drug-development tool
that divides drugs into high/low solubility and permeability classes. Based on its low aqueous solubility
and low permeability (apparent permeability coefficient = 0.13 × 10−6 cm/s [47]), EA is classified as
class IV drug according to the BCS, i.e., endowed with low solubility and low permeability, features
that limit a lot its clinical application. Micro and nanotechnology approaches widely demonstrated
great potential in modifying pharmacokinetic, bioavailability and stability of several drugs, including
phytochemicals used in cancer chemoprevention or in dietary supplements, contributing to preserve
the properties of the active ingredients or to mask bad tastes and odors [48–50]. From a formulation
point of view, a good EA dosage form would grant easier handling, transport and storage, increase its
light resistance, hamper undesirable reactions such as oxidation and hydrolysis, and enhance solubility.
Focusing on preparative methods, features and biological results of the developed EA-loaded
formulations, an exhaustive description of the employed strategies is thereafter presented. The various
approaches were divided according to the kind of the dosage form and reported in Tables 2 and 3
depending on the micro or nanosize of the final product. Moreover, in the final paragraph, examples
of fixed combinations containing EA were also described and discussed.
4.1. Micronized EA (m-EA)
According to Noyes-Whitney law, an effective way to increase dissolution rate and oral absorption
of a substance is the size reduction of powder particles [51]. For this purpose, anti-solvent precipitation
may represent a valid processing technique. In comparison to more popular micro and nanocarriers
that will be discussed in the following sections, this approach presents several advantages, such as easy
realization and rapidity. In addition, the process allows the reduction of organic solvents use and the
one-step processing favors scalability. The anti-solvent precipitation of a poorly water-soluble substance
is simply obtained by dissolving it in a solvent, followed by rapid mixing with a solvent-miscible
anti-solvent. After mixing, the substance precipitates in micro-sized particles, since a supersaturated
solution forms. The critical step of this method is to produce crystal nuclei rapidly, avoiding their
excessive growth. For process optimization, precipitation time and temperature, addition speed of the
solution to the anti-solvent, their volume ratio, drug concentration and stirring intensity are the keys
parameters that have to be checked.
Li et al. set the best conditions to produce m-EA by anti-solvent precipitation with an accurate
preformulative study [52]. An EA solution in NMP (30 mg/mL) was added to water, used as anti-solvent,
at a rate of 30 mL/h with 2 min precipitation time, at 3 ◦C and 2500 rpm stirring. Then, the precipitate
was dispersed in a maltodextrin aqueous solution to have a solid concentration of 1 mg/mL and was
lyophilized. The authors verified that residual NMP (class 2 residual solvent) in the final product was in
agreement with the established International Council for Harmonization of Technical Requirements for
Pharmaceuticals for Human Use (ICH) limit [53]. The m-EA freeze-dried powder, whose mean particle
diameter was 428 nm, in a comparison to raw EA and to a physical mixture of EA in maltodextrin,
showed the fastest dissolution rate. Surely, maltodextrin acted as hydrotrope, but the result could be
attributed exclusively to the high specific surface of the lyophilized powder and to the low crystallinity
of the incorporated EA. All in all EA water dissolution was improved up to 11.67 μg/mL at 37 ◦C.
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In addition, the 2, 2-diphenyl-1-1-pycrylhydrazyl (DPPH)-scavenging activity was higher than that of
not-micronized EA and oral bioavailability in rats increased twice in comparison to raw EA.
In another study, Beshbishy et al. obtained m-EA using the anti-solvent precipitation method by
injecting into deionized water a 10 mg/mL ethanolic solution of EA at a fixed flow rate [54]. m-EA
particles, collected by filtration and vacuum dried, showed modified morphology with respect to the
parent material and appeared as needle-shaped or rod-like structures. In vitro and in vivo experiments,
performed by intraperitoneal injection in mice, showed a significantly improved m-EA activity against
blood parasites as Babesia and Theileria. However, the authors concluded that EA activity requires
further investigations to understand whether EA inhibits parasites grow or causes their death.
A similar approach was performed using supercritical CO2 as anti-solvent. In this procedure a
solution of EA in NMP was sprayed into a vessel where a CO2 stream was continuously flowed under
supercritical conditions. Solution atomization led to a fast mass transfer between supercritical CO2
and the solution itself, which caused supersaturation and subsequent rapid precipitation of EA in the
form of micro-sized particles [55]. The study focused on the influence of process parameters and EA
concentration on size, polydispersity index (PDI) and morphology. Moreover, a co-precipitation with
Eudragit® L 100 was also carried out and, starting from EA:Eudragit® 1:1 weight ratio, a drug loading
(DL) of 49% was achieved. Experimental results showed that EA concentration should be, if possible,
close to saturation, thus allowing obtaining particles in the form of sticks and flowers and with a mean
diameter of about 3 μm. Also, in this case residual NMP was far lower than the mandatory established
limit. m-EA showed higher dissolution rate with respect to raw EA due to the small particle size,
reaching higher concentrations even at pH 1.2. Finally, the coprecipitates with Eudragit® showed the
fastest dissolution rates, probably because the dispersion of EA within the polymer led to smaller
particles and, surprisingly, the presence of the polymer did not delay the pomegranate acid delivery,
possibly since EA particles were obtained in crystalline form, confirming that the product was a solid
dispersion in which the pomegranate acid particles were not encapsulated.
4.2. EA in Spray Dried and Lyophilized Powders
Solid dispersions are semi-crystalline or amorphous dispersions (ASDs) of a molecule in an
inert matrix. ASDs represent a valid alternative for the development of microsystems entrapping
poorly water-soluble molecules. ASDs can be prepared from a solution by spray drying, freeze
drying, co-precipitation, rotary evaporation, film casting, or hot-melt extrusion. In all cases, a suitable
polymeric excipient should have functional groups able to form H-bonds with EA, thus allowing the
formation of metastable amorphous EA dispersions with adequate stability over time.
In this context, a first attempt was made with maltodextrins, a saccharide-based excipient
extensively used in food industry. Using a freeze drying technique, maltodextrin DE5-8 or DE18.5 were
applied to form a solid network around a cloudberry phenolic extract [56]. The amorphous matrices
were prepared starting from a maltodextrin (9% w/w) and a cloudberry extract (1% w/w) aqueous
solution, mixed under slight heating for about 0.5 h to avoid ET degradation. DE5-8 complexed
phenolics in a more efficient way, rationally due to its higher molecular weight. The microencapsulation
improved the extract storage stability to hydrolysis, and also in this case the improvement contribution
of DE5-8 was better than that of DE18.5. Microencapsulation always resulted in a decrease of EA
formation by ET hydrolysis during storage, but the stability was strongly dependent on relative vapor
pressure (RVP). At 66% RVP and 25 ◦C maltodextrin DE5-8 protected phenolics up to 32 days, then the
degradation reactions occurred in a major extent. On the contrary, the antioxidant properties did not
alter during storage either in the extract alone or in the presence of DE5-8, probably because the loss of
original phenolics was compensated by new formed molecules with equal antioxidant activity.
In another study, polymers as the hydrophilic hydroxypropylmethyl cellulose acetate succinate
(HPMCAS), the rather hydrophobic carboxymethyl cellulose acetate butyrate (CMCAB), and the very
hydrophobic cellulose acetate adipate propionate (CAAdP) were compared with polyvinylpyrrolidone
(PVP), taken as reference excipient being widely used in ASD formulations [57]. Mixtures of EA and
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PVP, CMCAB or HPMCAS at different weight ratios (1:9 and 1:3), dissolved in acetone:ethanol (1:4 v/v),
were spray dried with yields of 50%–60%. ASD from CAAdP were instead prepared by co-precipitation
method, due to the limited quantity of polymer available. EA was amorphous up to 25% w/w in solid
dispersions with PVP and HPMCAS, and up to 10% with CMCAB and CAAdP. Consequently, EA-PVP
and EA-HPMCAS reached the highest solution concentration of 1500 and 280 μg/mL, respectively.
In a stability study performed in aqueous buffer (pH 6.8) for 24 h at room temperature (rt), pure EA
showed a degradation degree by lactone ring opening of 20%, while lower values—16% for CMCAB,
14% for CAAdP, 6% for PVP and just 5% for HPMCAS—were found in the ASD samples. Dissolution
rate at pH 6.8 was remarkably superior to that of pure EA, both from PVP and HPMCAS ASDs, while
from CAAdP or CMCAB ASDs it was very slow and did not achieve adequate EA concentration.
As expected, under acidic conditions EA release from PVP was quite fast, whereas from cellulose
esters it was minimal, but this advantage was nullified by crystallization of a large amount of the EA
released from PVP. Since the 1:9 ASDs with HPMCAS effectively stabilized EA against crystallization
and degradation, the authors concluded that this could be considered the most promising formulation.
To prepare an ingredient for functional foods, a fine microdispersed powder containing EA was
obtained by spray drying using low methoxyl pectin, characterized by high biocompatibility, good
palatability, taste, and prebiotic properties [58]. Pectin represents a common natural food additive (E440)
authorized in several food categories [59]. By varying EA:pectin weight ratio, different formulations
were prepared. The best microdispersed powder, obtained with 1:4.5 EA:pectin ratio, showed a mean
particle diameter of about 10 μm and a DL equal to 21%, allowing solubilizing 63 μg/mL of EA in water.
Moreover, the drug loading of EA in the powder remained stable for one year of storage in a desiccator
at 25 ◦C.
Recently, the search for promising systems suitable for dietary supplements enlarged the research
field to other natural polymers, such as alginic acid (ALG) [60]. EA-ALG nanoparticles (NPs) were
prepared by dissolving both EA and ALG at the concentration of 250 μg/mL in an aqueous medium
at pH 8.5. The solution was spray dried and the obtained powder was added to a CaCl2 solution
in order to induce reticulation by ionic gelation. The resulting NPs had a mean diameter of 670 nm
with zeta potential around −27 mV. Thanks to the high degree of EA solubilization in the basic
medium, the encapsulation efficiency (EE) was 50%, much higher than the EE of NPs prepared from
a neutral medium. As rational remark to this procedure performed in basic environment, it may be
highlighted that the possible degradation of EA in alkaline medium during preparation was not taken
into consideration. This EA-ALG system showed a biphasic release profile with a fast phase during the
initial 3 h, justified by EA adsorbed on NPs surface, followed by a sustained, complete release until
8 h. A mice model of epilepsy was used to assess in vivo EA-ALG NPs efficacy as anticonvulsant
and neuroprotective agent by oral treatment every other day for 33 days. Results indicated that EA
contained in this dosage form prevented seizures during the experimental period, and had a more
pronounced effect, compared to free EA, by reducing oxidative stress damage, inhibiting apoptosis
and down-regulating cytokine levels.
4.3. Inclusion Complexes
4.3.1. EA Inclusion in Cyclodextrins (CDs)
CDs are able to form inclusion complexes with a variety of molecules by hosting a guest drug
with suitable polarity and dimension inside their lipophilic cavity, thus modifying its physico-chemical
behavior. Among CDs, hydroxypropyl-β-CD (HP-β-CD) is characterized by better inclusion ability
and higher complex solubility. To investigate the feasibility and the stoichiometry of inclusion
complex formation of EA in HP-β-CD, phase solubility studies were carried out in water at 30 ◦C
for 72 h to reach the equilibrium [61]. The obtained solubility curve of EA showed a linear increase
with HP-β-CD concentration up to 12 mM, followed by a negative deviation from linearity up to
24 mM. This trend belongs to AN type and was explained through the formation of a soluble 1:2
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EA:HP-β-CD inclusion complex with stability constants K1:1 and K1:2 of 201.61 and 18.91 M-1,
respectively. A 15 mM HP-β-CD solution allowed to solubilize 54.40 μg/mL of EA in water at 30 ◦C.
Subsequently, the inclusion complex was prepared by freeze drying a solution of EA:HP-β-CD in
1:2 molar ratio upon its filtration. In a dissolution test performed at pH 6.8 and 37 ◦C, HP-β-CD
released about 55% of the loaded drug in 15 min, more than 5-fold the amount dissolved from pure
EA powder. Furthermore, the anti-inflammatory effect of complexed EA was tested in a rat model
of inflammation. Oral treatment with 10 or 20 mg/kg EA-HP-β-CD resulted more efficacious than
the administration of EA alone or of 10 mg/kg indomethacin as indicated by the measure of paw
edema volume. The feasibility of using β-CDs as complexing agent for EA was also investigated
with less satisfactory results [62]. The complex was less soluble, leading to a total EA concentration
up to 39.14 μg/mL, lower than that obtained in the previous study with HP-β-CD, due to the lower
β-CD solubility.
By following a different preparative procedure, β-CD was again chosen as EA complexing agent
in another study [63]. A saturated aqueous β-CD solution was slowly mixed with 125 mg/mL of
EA ethanolic solution and stirred for 2 h at rt, then the mixture was filtered and finally freeze-dried.
As highlighted by SEM images, the obtained powder was different from those of the pure components
in terms of morphology and dimensions; EE was 35% and in vitro dissolution studies (pH from 6.8 to
7.4) showed a multiphase release profile: a little amount of EA (3%) was released in a slow initial stage
during the first 4–8 h, followed by a rapid phase between 8 and 24 h with 73% of drug released, and by
a final slow phase. The effect of EA-β-CD complexes on proliferation of human liver carcinoma cells
was evaluated by MTT assay and, though the lack of data relating to the treatment of cells with EA
alone do not allow a comparison, a remarkable inhibition was observed.
Another study to increase EA solubility regarded EA complexation with β-CD nanosponges
(NS) [64]. NS are hyper-cross-linked CDs obtainable either from a mixture of CDs, or CDs conjugated
with relevant amounts of linear dextrin. The cross-linking leads to a cage-like structure, where CDs
cavities and nanochannels are strictly connected to form a porous network. Consequently, NS are
able to incorporate drugs both as inclusion and non-inclusion complexes, thus improving the overall
solubilizing ability of the starting CD. In this work theβ-CD NS were obtained using dimethyl carbonate
as a cross-linker. By a solubility study the authors demonstrated that the β-CD NS solubilized EA in
water up to 49.79 μg/mL. The mean particle size of EA-β-CD NS was about 423 nm, PDI was found of
0.409 and the zeta potential equal to −34 mV, thus sufficiently high to produce a stable suspension.
In this regard, it has to be remembered that very low Z-potential values (ζ < 5 mV) usually translates
in particles with high tendency to agglomerate that means physical instability in solution. On the
contrary, increasing the charge associated with the particle i.e., ζ ± 30 mV or higher, usually prevents
particles sticking after collision [65,66].
Moreover, EE was around 69% and, as highlighted by X-ray diffraction, in the polymeric structure
EA was present either in the amorphous form or as a solid-state solution. The release profiles showed
that only about 20% of loaded EA was released after 24 h, suggesting strong retention of EA in the
NS network. A pharmacokinetic study in rabbits indicated that oral administration of EA-β-CD NS
increased EA bioavailability by more than 2-fold if compared to the free EA suspension.
In a more recent work, a useful analysis of the preparation processes and experimental conditions
for obtaining inclusion complexes was reported [67]. Three inclusion methods were considered, i.e.,
stirring-ultrasonic, ultrasonic, and grinding. In the first method, which led to the highest EE (84%),
EA, dissolved in a small amount of ethanol, was added by slowly dripping into HP-β-CD aqueous
solution under stirring, then the mixture was sonicated for 20 min, and finally kept under stirring at
rt for further 18 h. The suspension was filtered, concentrated with rotary evaporator and vacuum
dried to obtain the inclusion compound. Process conditions were optimized by an orthogonal test
design, in which EA:HP-β-CD molar ratio, ethanol concentration, inclusion time and temperature
were considered to be experimental parameters. The experimental design showed that EA:HP-β-CD
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molar ratio of 1:2, ethanol concentration of 60%, inclusion time of 36 h, and inclusion temperature of
20 ◦C were the best conditions.
Recently, Gontijo et al. failed in realizing an effective complexation in HP-β-CD as the first study
did, possibly because in this case the phase solubility studies were performed at rt instead of 30 ◦C [68].
In fact, a linear increase in EA solubilization was achieved only in alkaline solution, where raising
HP-β-CD concentrations up to 300 mM led to a total EA concentration only 2.8-times higher than that
without CD. However, the low stability constant of the complex (K1:1 = 4.5 M-1) resulted in a low
complexation efficiency with an EA:CD stoichiometric ratio equal to 1:45. Concerning the procedure,
the inclusion complex was prepared by spray drying a suspension of EA:CD 1:1 molar ratio in 0.1 M
NaOH solution. Furthermore, also methyl-β-CD was used without success, since no complexing
ability was found either in water or in basic solution. Finally, Caco-2 cells were employed in an in vitro
model of invasive Candida albicans infection to test the bioactivity of EA complexes, but no statistically
significant difference was observed in terms of antifungal activity between free or complexed EA,
suggesting that complexation apparently did not improve antimycotic efficacy.
4.3.2. EA Inclusion in Metalla-Cages
A recent strategy for allowing EA administration in a more bioavailable form consisted of
a self-assembled metallo-supramolecular architecture able to host EA inside three-dimensional
cages [69]. These vectors, engineered via coordination-driven self-assembly, present several advantages.
In particular, the metal-guest interactions are very strong and highly directed, leading to the formation
of a stable rigid complex. In this regard, EA was encapsulated in arene-ruthelium metalla-prism cages
with a yield of about 90% and its anticancer activity was investigated. The cytotoxic effect against A549
human lung cancer cells was significant, overall considering that free EA lacked any activity. In an
attempt to investigate if EA effect was macrophage-mediated, a study on RAW264.7 murine leukemia
monocytes was performed, highlighting that EA encapsulated in metalla-cages exhibited an inhibitory
effect for cancer cells via G-CSF induction and Rantes inhibition at both mRNA and protein levels.
4.4. EA Encapsulated in Polymeric Carriers
4.4.1. Eudragit® Microspheres
EA was proposed as a prophylactic agent for the treatment of inflammatory bowel disease.
Jeong et al. developed microspheres for EA site-specific delivery to the ileum using Eudragit® P-4135,
a copolymer of methacrylic acid, methyl acrylate and methyl methacrylate able to dissolve at pH > 7.2,
which corresponds to the pH of the distal part of the small intestine [70]. The adopted preparation
method was a solvent evaporation process in oil phase using an acetone/light liquid paraffin system.
Different polymer amounts, ranging from 0.5 to 1.5 g, were dissolved in acetone and mixed with
0.5 mg of EA, previously dispersed in the same solvent and sonicated. Then, the resultant solution
was added to light liquid paraffin containing Span 80 (3% v/v), and the emulsion was stirred up to
complete evaporation of acetone. The microspheres, harvested by filtration and washed with hexane
to remove paraffin, yielded an EE ranging from 57 to 99% and a DL from 33 to 36%. Increasing
polymer amounts resulted in higher EE and size increase from 98 to 168 μm. As expected, EA release
was pH-dependent and at pH 6.8 an initial burst effect of about 25% was followed by a sustained
release, with approx. 40% of loaded drug released after 6 h. In this case, the burst effect would not be
critical, as it occurred at the target site, as demonstrated by the negligible EA in vitro release at more
acidic pH. For in vivo studies fluorescein was added to the preparative mixture to accurately measure
microsphere dissolution rate. The obtained microspheres were orally administered to rats and blood
samples were collected every hour. The comparison between collected images of microspheres in
small intestine of euthanized rats and fluorescein plasma concentration evidenced that the plasmatic
peak occurred 3 h after administration, when microspheres reached the ileocaecal junction. Therefore,
this Eudragit®-based system represents an effective vehicle to target EA release to the terminal ileum,
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providing enhanced absorption in the region and thus preventing the variability connected to EA
conversion into urolithins.
4.4.2. Poly (Lactic-Co-Glycolic Acid) (PLGA) and Poly (ε-Caprolactone) (PCL) Nanospheres
Among the various encapsulating polymers, PLGA has been extensively used due to its
biocompatibility, biodegradability, and ability to protect the drug from degradation and in
obtaining sustained drug release [71]. To increase EA bioavailability, PLGA-based formulations
suitable for oral administration were developed [72]. The particles were prepared by using the
emulsion-diffusion-evaporation technique. PLGA was dissolved in ethyl acetate under stirring for
2 h, then EA, previously dissolved in PEG 400, was added, and a fine EA dispersion was obtained.
The dispersion was emulsified in an aqueous phase containing a stabilizer (1% w/v), such as polyvinyl
alcohol (PVA), PVA:chitosan (CS) in 80:20 ratio, or didodecyldimethylammonium bromide (DMAB).
After with stirred the emulsion at 1000 rpm for 3 h, homogenization at 15,000 rpm for 5 min was
performed to obtain a more homogeneous and smaller size distribution. Then, the addition of water
caused the diffusion of the organic solvent into the aqueous phase, and the evaporation of the organic
phase by heating led to EA-polymer precipitation. The use of DMAB yielded smaller particles, while
the other two stabilizers led to bigger sizes and higher PDI, probably due to the increased viscosity
and irregular entanglement associated with the long polymeric chains. The zeta potential was highly
positive for NPs containing DMAB (about +75 mV), equal to +25 mV for the ones with PVA-CS,
and slightly negative for those with PVA. The highest EE (55%) was obtained with PVA-CS, the lowest
with DMAB (42%). Concerning EA release at pH 7.4, all products exhibited a rapid initial release
followed by a slower sustained phase, with PVA NPs being the fastest, because PVA hydrophilic
groups favor water penetration into the NPs compared to the more lipophilic DMAB. However,
the release study was not performed simulating the pH conditions of the whole gastrointestinal tract.
To study the permeability of NPs, an in situ intestinal study was performed on rats based on the close
loop method, even though the disappearance of drug from the luminal side, used for determining
permeation, not always correlates with the rate of absorption of the drug in the systemic circulation.
EA-DMAB NPs showed the highest uptake (87%) in accordance with their smaller size and higher
hydrophobicity. The antioxidant activity was assessed in cell free system and in yeast cell culture model,
confirming the good scavenging activity of the encapsulated pomegranate acid. The same research
group also investigated the feasibility of EA-loaded PCL NPs in comparison to PLGA NPs using the
same emulsion-diffusion-evaporation method, but with an important modification: during the primary
emulsion step EA underwent a rapid precipitation that caused its low entrapment, so the authors added
the stabilizer to the polymer solution to increase EA solubility [22]. As expected, EE increased from
42% to 52% for DMAB-PLGA NPs and from 55% to 62% for PVA-PLGA NPs, not much different from
EE of DMAB-PCL and PVA-PCL NPs (47% and 57% respectively). Since PCL is a slower degrading
polymer compared to PLGA, its release profiles yielded slower release rates. The antioxidant potential
of EA-DMAB NPs was assessed by evaluating their protective action against cyclosporine A-induced
nephrotoxicity in rats: both PLGA- and PCL-based NPs were 3-fold more effective than free EA in
kidney protection, thus indicating the improved bioavailability of the encapsulated EA.
Unfortunately, PLGA NPs major drawback is rapid opsonization, so that their systemic circulation
time is too short. To address this issue, EA was encapsulated in PLGA NPs grafted with poly (ethylene
glycol) (PEG) chains to escape to the reticuloendothelial system [73]. In a proof of principle study,
NPs were prepared by the double emulsion-solvent evaporation method. Two dichloromethane
stock solutions, containing PLGA-PEG and EA respectively, were mixed, added to 200 μL of
phosphate-buffered saline solution (PBS) and sonicated. This primary w/o emulsion was emulsified in
PVA 1% w/v aqueous solution by sonication. Subsequently, this w/o/w emulsion was first diluted with
PVA 1%, then heated for dichloromethane evaporation and finally the obtained NP were dialyzed
and lyophilized. The NP showed a diameter of 175 nm with PDI of 0.14. In vitro biological studies
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on MCF-7 and Hs578T breast cancer cell lines proved a significant activity enhancement of EA in the
encapsulated form, being its IC50 values more than 2-fold lower than those of the free form.
In a further attempt to curb the phagocytic activity, a combination of CS and PEG was considered
to be surface coating material for EA-PLGA NPs [74]. The NPs were prepared by o/w single
emulsion-solvent evaporation method as follows. EA and PLGA were separately dissolved in
chloroform and emulsified with PVA 2% w/v aqueous solution containing 12% w/w CS and 5% w/w
PEG 2 kDa through sonication. The emulsion was stirred overnight up to complete evaporation of
the organic solvent. The coated CS-PEG-PLGA NPs were compared to PLGA NPs and PEG-PLGA
NPs prepared in the same way. EE was always about 65%, while the mean hydrodynamic diameter
was 220 nm for PLGA NPs and CS-PLGA NPs, and 255 nm for CS-PEG-PLGA NPs. As expected,
positive charges were present on the surface of CS-PLGA NPs and CS-PEG-PLGA NPs (ζ = +27 and
ζ = +38 mV, respectively); on the contrary, a negative zeta potential characterized PLGA NPs (ζ =
−10 mV). Release studies, carried out at pH 7.4, showed an initial faster release of about 35% during
the first 10 h, followed by a more controlled release phase, with further 55% of drug released in 24 h.
In vitro anticancer activity against HepG2 hepatocellular carcinoma cells and HCT 116 colorectal
cancer cells revealed a significant cytotoxic effect of EA loaded in CS-PEG-PLGA NP vs. free EA at
every tested dosage (up to 100 μM), suggesting an efficient NPs uptake by the cells. Also Mady et al.
used PCL for successful entrapment of EA through the emulsion-evaporation method [75]. In this
case, EA, dissolved in PEG 200, was mixed with PCL, solubilized in ethyl acetate, and the mixture
was emulsified by homogenization with an aqueous solution containing a stabilizer (PVA, DMAB or
poloxamer 407 ranging from 0.1% to 1% w/v). The resulting o/w emulsion was sonicated for 1 min, then
diluted in water and kept under stirring for 6 h up to complete evaporation of the organic solvent.
The obtained NPs were centrifuged, washed with distilled water to remove unentrapped EA, and
freeze-dried. As previously observed, 1% DMAB yielded the smallest mean NP size (193 nm). In fact,
by creating a positive charge layer around the internal phase, DMAB provided electrostatic repulsion,
while PVA and poloxamer, being uncharged, induced only a steric stabilizing effect. The type of
stabilizer affected also EE and DL. DMAB gave the lowest EE (66.4%–73.5%) and DL (56.8%–63.9%),
whereas PVA provided the highest EE (78.3%–90.3%) and DL (68.1%–78.6%). These differences in EA
entrapment were probably linked to the unequal EA aqueous dissolution granted by the stabilizer.
Release studies at pH 7.4 illustrated the typical two-step profile, with an initial fast release driven by
diffusion for the first 12 h, and a second slow release due to the retarded diffusion of EA from the NPs
inner layers. Finally, the release of EA from DMAB-PCL NPs reached up to 48% of the loaded amount
in 8 days. The anticancer efficacy of EA-PCL NPs tested on HCT-116 colon adenocarcinoma cells was
6.9-fold enhanced in comparison to free EA, meaning that encapsulated EA was significantly superior
in reducing HCT-116 cell survival. Moreover, a pharmacokinetic study by oral administration in rabbits
showed that the nano-sized formulation improved the relative EA bioavailability by 3.6 times.
4.4.3. Chitosan Micro/Nanospheres
CS is a polysaccharide obtained by partial deacetylation of chitin, endowed by important features
from the biomedical point of view. It is mucoadhesive, non-toxic, biocompatible, biodegradable
and exerts slight antimicrobial properties. CS is a weak base (pKa value ~6.5) positively charged at
physiologic pH. In a study by Arulmozhi et al., EA-CS NP were prepared by ionic gelation method
using sodium tripolyphosphate (TPP) as gelating agent, with CS to TPP ratio of 4:1. CS was dissolved in
1% v/v acetic acid under magnetic stirring overnight and the final pH was adjusted to 5.0 [76]. Different
EA amounts (25, 50, 100 mg) dissolved in DMSO (0.5% v/v) were added to the CS solution, and finally
an equal volume of 1 mg/mL TPP solution was added dropwise under mild stirring. The mixture was
kept under stirring till NPs formation. The lowest EA amount added led to the highest EE and DL, of
94% and 33% respectively. Spherical NP were obtained with a mean diameter of 176 nm and a slightly
positive zeta potential (ζ = +4 mV), which could be due to the adsorption of EA on the particle surface,
thus masking CS positive groups. As usually, the EA release showed a two-step profile, where 55% of
138
Appl. Sci. 2020, 10, 3353
loaded EA was rapidly released during the first 8 h and the remaining 20% was released more slowly
until 48 h. Finally, EA-CS NPs were investigated as anticancer agents and proved higher cytotoxicity
than free EA on KB human oral cancer cell line at almost all the tested doses. Successively, in another
study by Gopalakrishnan et al., EA-CS NPs were been investigated as anti-hemorrhagic agents [77].
Also in this case, the NPs were prepared by ionic gelation procedure with 1:12 EA:CS ratio. They sized
around 80 nm, being 50% their maximum EE. Release studies showed an EA fast dissolution (84% in
12 h), suitable for clotting purposes. In fact, EA-CS NPs yielded a significantly faster clotting time
when compared to free EA, void CS NPs, and an EA:CS physical mixture.
A recent study by Ding et al. focused on the preparation of EA microspheres based on CS
and sodium alginate as coating materials [78]. CS-alginate microparticles (MPs) were prepared by
ionotropic gelation. The polycationic CS and Ca2+ were added to the EA alginate solution, thus a
polyelectrolyte complex coating formed; MPs were further stabilized with 2% glutaraldehyde solution.
SEM images revealed a mean size of 4.36 μm, with some EA crystals on the surface, while EE was
around 30%. Regarding dissolution profiles, they reflected the structure of the MPs, because EA
was quickly released at 0–3 h and 6–24 h, while it was slowly released from 3 to 6 h because of the
necessary deconstruction of the strong coating, suggesting the effective dispersion of EA inside the
MPs. Therefore, this formulation seems to be more suitable if a sustained release is desired. Finally,
in vitro experiments on 3T3-L1 adipocytes showed a consistent inhibition of adipogenic differentiation
by entrapped EA vs. EA alone, suggesting its possible use in obesity treatment.
Figure 2. An overview of different ellagic acid’s activities versus human diseases.
4.4.4. Zein Nanocapsules
Among the various formulations that have been designed to ameliorate EA bioavailability,
only one attempt concerns nanocapsules (NCs). NCs, because of their hollow structure, display
large surface-to-volume ratio, low density, short solid-state drug diffusion length, and good surface
permeability. On the other hand, NCs present some disadvantages, such as weak mechanical properties
and complex production procedures. Recently, EA has been successfully encapsulated into NCs made
of zein, a group of water insoluble proteins (prolamins) extracted from corn gluten meal [79]. Ruan et al.
developed a system, characterized by EA and a sacrifice template to form the core and by an outer
film of zein mixed with a plasticizer to increase film flexibility. NCs were prepared by antisolvent
coprecipitation in water using Na2CO3 as core-forming template. Firstly, EA was dissolved in 0.1 M
NaOH solution and mixed with Na2CO3 aqueous solution (1% w/w). EA-Na2CO3 cores were formed
by coprecipitation in 70% ethanol, then an ethanolic solution of triethyl citrate and zein was added to
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the core suspension, and finally the mixture was poured in distilled water to induce NCs precipitation
and Na2CO3 diffusion outwards. Spherical NCs with an average diameter of 72 nm were obtained. EA
content (326 mg/g) resulted much higher than that of NPs prepared without Na2CO3. Surprisingly,
not remarkable differences were observed in the release behavior between solid and hollow NPs. Both
formulations did not show a burst effect, achieving a well-controlled release. An in vitro permeability
study on Caco-2 cells showed improved transporting ability of EA NCs compared to pure EA or solid
zein NPs, because EA, either when free or present on NPs surface, tended to bind DNA and proteins,
causing accumulation inside the cells. In addition, the superior anti-inflammatory activity of orally
administered EA NCs was confirmed in a rat model and explained by pharmacokinetic experiments
showing AUC 2.5 and 8.7 times higher than the ones of EA solid NPs and pure EA, respectively.
4.5. Dendrimers
Dendrimers are branched polymers characterized by a tree-like structure of globular shape of
nanometric dimension endowed with inner cavities, able to host lipophilic drugs, and a peripheral
shell rich in functionalized groups [80,81]. Among various typologies of dendrimers, the well-known
polyamidoamine dendrimers (PAMAM) and branched polyethyleneimine polymers (b-PEI) are
in vitro well-performant, but mainly because of their extremely cationic inner framework and poor
biodegradability, they can exert hemolytic effect, which hindered their clinical translation. To reduce
dendrimers cytotoxicity in the study by Alfei et al., PAMAM dendrimers were avoided and EA has
been physically encapsulated into cationic dendrimers characterized by an uncharged polyester-based
hydrolysable inner core peripherally esterified with a selection of four different amino acids [58].
Histidine, lysine, N-methyl-glycine and N, N-dimethylglycine were chosen to provide the carrier with
primary, secondary, tertiary protonable amino groups and with the guanidine residue that is known to
promote cellular up-take. Two dendrimers, one hydrophilic and one encompassing in the structure a
C-18 chain that provides an amphiphilic character, were employed to encapsulate EA. Dendrimers
were dissolved in MeOH and EA was added obtaining a conspicuous suspension maintained at acidic
pH under magnetic stirring at room temperature for 48 h. The non-complexed EA was removed
by filtration and the final EA dendrimer nanodispersions were brought to a constant weight under
vacuum. The values of DL were of 46% (hydrophilic) and 53% (amphiphilic). NPs mean dimension
was of 70 nm for both compounds while EA water solubility increased up to 1.7 mg/mL in the case of
the amphiphilic dendrimer and up to 4.8 mg/mL in the case of the hydrophilic one.
4.6. Peptide Microtubes
In the last decade, there has been an increased focus on biomaterial fabrication, of which peptide
micro and nanotubes provide a good example. These ordered structures origin from a dipeptide,
usually L-diphenylalanine (FF), by self-assembling. Six FF units form cyclic hexamers, which can
further be stacked to produce narrow channels with a diameter of approximately 10 Å. Various
peptides can be used as building blocks, thereby these vehicles can be tailored according to the desired
application [82]. In a study by Barnaby et al., EA was encapsulated by the self-assembling of the
synthetic precursor bolaamphiphile bis (N-amido threonine)-1, 5-pentane dicarboxylate, with a pentyl
chain between the head groups of the two aminoacids, according to the following procedure [83]. First,
the bolaamphilile solution was allowed to assemble for 2–3 weeks with a higher yield at pH 6, then EA
was added at a concentration of 0.06 mM, which maximizes EE, as at elevated concentrations EA forms
discotic liquid crystal assemblies upon aggregation, while lower EA amounts efficiently insert into
the nanotubes by capillarity. The self-assembled EA-loaded nanostructure had an average diameter
ranging from 0.5 to 1 μm with an EE of about 80%. EA release was affected by pH, as expected, with
about 50% of loaded acid released within 2 h at pH 6 and 7. EA antibacterial property was assessed
in vitro against Gram-positive S. aureus and Gram-negative E. coli, and in both cases EA-loaded
microtubes were significantly more efficacious than free EA. That was an unexpected result, since EA
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alone did not exert any action against S. aureus, but probably the explanation relies on the antibacterial
activity of threonine itself.
4.7. Functionalized Graphene Oxide (GO) Carriers
GO is prepared by chemical oxidation of graphite and represent a promising pharmaceutical
material due to its small size, biocompatibility, possible functionalization, and low cost. GO offers
interesting opportunities for loading and delivering aromatic molecules such as flavonoids via simple
physisorption [84]. To further improve GO aqueous solubility, it was covalently functionalized with
hydrophilic excipients such as poloxamer F38, Tween 80 and maltodextrin through an esterification
reaction. In a study by Kakran et al., EA loading was carried out by mixing 0.5 mg/mL functionalized
GO aqueous solution with 50 mg/mL EA in 0.01 M NaOH solution [85]. After stirring overnight at rt,
undissolved EA was removed by centrifugation, while the small amount of free dissolved EA was
separated by dialysis. Therefore, EA was loaded by simple mixing, due to adsorption supported by
hydrogen bonding, π-π stacking and hydrophobic interactions between the acid and the aromatic
regions of graphene sheets [85]. Tween 80-GO exhibited the highest DL, with about 1.22 g of EA per g
of excipient, as probably the poloxamer hindered GO surface with its higher molecular dimensions,
differently Tween 80-GO exhibited a larger area available for the drug attachment. Release studies
showed not differences among the three GO derivatives, probably due to the stronger hydrophobic
interactions and hydrogen bonding between EA and the carriers, in any case an increasing release was
observed raising pH values, which was attributed to the increased hydrophilicity and solubility of EA
at higher pH. In vitro cytotoxic activity against MCF7 human breast cancer cells and HT29 human
adenocarcinoma cells was found to be higher than the one of free EA, while the antioxidant property
of EA-GO formulations was similar to that of EA alone, proving no interference of the carriers on EA
scavenging activity as confirmed by DPPH assay.
4.8. Lipid-Based Carriers
4.8.1. Solid Lipid Nanoparticles (SLNs)
SLNs are colloidal delivery systems based on a high melting point lipid core coated by surfactants.
In recent years, SLNs have been considered to be promising delivery systems due to the ease of
manufacturing processes, scale up capability, biocompatibility and also biodegradability of formulation
constituents [86]. SLNs also have some disadvantages, such as low drug loading efficiency and the
possibility of drug expulsion due to its crystallization during storage [87]. Besides the initial burst
release of drug which usually occurs represent an additional concern with these formulations [88].
These systems were proposed as carriers for improving the anticancer activity of EA against prostate
cancer by Hajipour et al. [89]. EA-loaded SLNs were prepared by the homogenization method as
follows. EA was added after dissolution in DMSO to the melted lipid phase, consisting of Precirol® and
Tween 80, then the aqueous phase with poloxamer 407 was added dropwise at the same temperature
under high speed homogenization. Finally, the obtained nanoemulsion was cooled for NP solidification.
Tween 80 seemed to increase EA encapsulation, while the poloxamer at higher concentrations yielded
unsuitable sizes. The optimal formulation showed an average diameter around 100 nm with a narrow
size distribution (PDI = 0.28) and a negative zeta potential (ζ = −20 mV). The EE was about 89% and
DL 36%. Release studies performed at pH 7.4 demonstrated a noteworthy initial burst effect due to the
drug present on or close to the surface, followed by a sustained release phase. Like polymer-based
particulate systems, SLNs often lack uniformity of distribution of the drug in the nanostructure, which
can explain the initial burst effect. In vitro biological studies revealed that EA loaded in SLNs was
more efficacious than free EA on PC3 human prostate cancer cells, being the IC50 values of 61 and
82 μM, respectively.
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4.8.2. Liposomes (LPs)
With the aim of producing an effective EA dietary supplement, a formulation based on
phospholipids was developed by Murugan et al. [90]. EA and hydrogenated soy phosphatidylcholine
(HSPC) in 1 to 4 molar ratio were dissolved in dichloromethane and refluxed at a temperature not
exceeding 60 ◦C for 2 h. The solution was concentrated and then n-hexane was added for inducing
the precipitation of the EA-LPs by anti-solvent method with a yield of encapsulation of 89% w/w.
The resulting EE was around 29% and SEM images showed that EA was intercalated in the spherical
lipid layer and that EA-LPs had a mean diameter ranging from 1 to 3 μm. In an in vivo CCl4-induced
hepatic damage model, rats orally treated with EA-LPs exhibited a remarkably reduced antioxidant
liver damage from oxidative stress. The same effect was obtained only with a double amount of free
EA. Moreover, a pharmacokinetic study on the rats confirmed the enhancement of bioavailability
exerted by the complexation as the AUC value resulted increased by 2.8-fold if compared to free
EA administration.
With the aim of developing a nutritional support during chemotherapy with cyclophosphamide,
a recent study by Stojiljković et al. evaluated the protective effect of EA encapsulated into nanoliposomes,
in a cyclophosphamide-induced rat liver-damage model [91]. EA was incubated overnight with a
suspension of LPs in 1:10 ratio, obtaining an EE equal to 60%. Stability studies were performed at
37 ◦C at different pH (from 4.5 to 9.9) or in the presence of metal ions. During the 3-h study, EA in the
encapsulated form always resulted less degraded, whereas free EA showed higher chelating ability,
thus indicating the effectiveness of encapsulation. Subsequently, the loaded liposomes were essayed
in a cyclophosphamide-induced rat liver-damage model. The animals were treated for 5 days either
with free or encapsulated EA, and only on the third day cyclophosphamide administration occurred.
The authors determined serum liver-damage parameters, oxidative tissue damage parameters, and
morphological changes of liver cells through histopathological observations. The results indicated that
EA nanoliposome formulation could represent an efficacious tool in adjuvant cancer chemotherapy.
4.8.3. Self-Emulsifying Delivery Systems (SNEDDS)
Among the several approaches that were suggested to achieve better EA oral bioavailability,
SNEDDS represent an attractive opportunity. SNEDDS are isotropic mixtures of active molecules,
oils, surfactants, and coemulsifiers or solubilizers able to form an o/w nanoemulsion. Once in the
gastrointestinal fluid, the fine droplet dispersion enhances water solubility of lipophilic molecules, thus
providing more effective absorption. Though SNEDDS are not suitable for exerting controlled release,
they demonstrated high potential in increasing oral bioavailability of several therapeutic agents, such
as curcumin [92]. However, the poor palatability of the components and low compatibility with
other excipients might be the major drawbacks in case of oral delivery. In this context, Avachat et al.
developed a formulation containing EA starting from a mixture of EA and soy lecithin at 1:1 molar
ratio [93]. This preliminary step was necessary to facilitate the incorporation of a larger amount of EA
in the lipid phase and to increase its solubility. The EE was 95% and the water and n-octanol solubilities
of complexed EA at 25 ◦C increased by about 3 and 6 times, respectively. Well-formulated SNEDDS
should disperse in a few seconds under gentle stirring. Therefore, after a preliminary screening,
the optimized composition was selected with the help of ternary phase diagrams. The final formulation
included EA PL, glyceryl triacetate 40% v/v as oil, polyoxyl 40 hydrogenated castor oil 40% v/v as
surfactant, PEG 400 20% v/v as co-surfactant. To prevent EA oxidation, tocopherol was added in
the oil phase. This composition led to the smallest mean diameter (106 nm, PDI of 0.3388) and to a
negative zeta potential (ζ = −13 mV). As expected, EA release from SNEDDS was very fast at pH
6.8 (nearly 95% after 1 h), and a bit slower at pH 1.2, but this largest amount of dissolved EA may
strongly increase gastrointestinal absorption. To support the hypothesis of a potential enhancement of
oral bioavailability, an ex vivo permeability study was also carried out, which confirmed the good
permeation of the SNEDDS through rat stomach and intestine.
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In a more recent work by Wang et al., EA was entrapped in SNEDDS made of food-grade
components to prepare a highly biocompatible formulation suitable for nutraceuticals, performing
the procedure previously described [94]. Firstly, a preliminary study investigated the solubility of EA
in different oils, surfactants, and co-surfactants, then ternary diagrams were constructed. The best
formulation was selected on the basis of the weight of water added dropwise to the mixed ingredients
without causing turbidity, and the best formula corresponded to EA 2.5 mg/mL, PEG 400 45% v/v
as co-surfactant, Tween 80 45% v/v as surfactant, and caprylic/capric triacylglycerols 10% v/v as oil.
This mixture was able to load EA in a concentration 250 times higher than its aqueous solubility and to
release it completely within 1 h at pH 6.8. In addition, the authors developed a pharmacokinetic study
on rats to evaluate in vivo oral bioavailability of EA in SNEDDS and the AUC value of the emulsified
EA was 6.6 times higher than the one of the EA suspension.
An issue associated with SNEDDS is the possibility for the dissolved molecule to undergo
precipitation if administered in high dose [95]. Therefore, a slight but important modification consists of
adding a precipitation inhibitor, such as PVP or HPMC, capable of increasing drug loading and stability
over time. On this purpose a supersaturable self-nanoemulsifying drug delivery system (S-SNEDDS)
containing EA was developed by Zheng et al. [96]. As usual, according to the results of solubility studies,
those vehicles highly mixable with EA were chosen for formulation optimization through ternary
phase diagrams. The final formulation consisted of Tween 80, PEG 400 and ethyl oleate at the ratio of
67.5/22.5/10% w/w, which can be fully diluted with water without phase separation. In addition, to avoid
EA precipitation during storage, 0.5% PVP K30 was added. DL was equal to 4 mg/g, while EA S-SNEDS
droplet mean diameter was 45 nm and the zeta potential was negative (ζ = −23 mV). The dissolution
profiles were characterized by a slightly less rapid release, compared to EA-SNEDDS, since the complete
delivery at pH 6.8 was reached after 4 h. Finally, in vitro and in vivo antioxidant activity was studied by
DPPH assay or by detection of malondialdehyde, superoxide dismutase and glutathione in mice liver.
The results indicated that the antioxidant ability of EA was noticeably improved by the S-SNEDDS vs.
EA suspension, but it was of a lesser extent compared to vitamin C.
4.9. EA Formulations in Fixed Combination with Other Bioactive Molecules
With the aim to prevent or treat diseases associated with increased oxidative stress such as
hyperglycemia, obesity, atherosclerosis, the industry of nutritional supplement has rapidly and greatly
expanded over recent decades [97]. In a study by Ratnam et al., EA was combined with Coenzyme
Q10 (CoQ10) in a PLGA nanoparticulate formulation to prevent hyperlipidemia [98]. The NP were
prepared by emulsion-diffusion-evaporation method, dissolving PLGA and CoQ10 in ethyl acetate,
and EA in PEG 400. The two solutions were mixed and emulsified in 1% PVA aqueous solution.
The mean particle size obtained was around 259 nm with EE of 70% for EA and of 72% for CoQ10. In an
in vivo experiment, rats were fed with a high fat diet and daily administered with oral suspension of
free drugs or once in three days with EA-CoQ10 NP. The effects on reducing glucose and triglyceride
levels were similar, but only EA-CoQ10 NP exerted a prolonged control on cholesterol levels for up to
2 weeks after treatment suspension.
With the aim at decreasing the risk of chemotherapy complications, further investigation
concerning co-delivery systems involved EA and chemotherapy drugs, such as paclitaxel (PTX),
for a combined anticancer therapy [99]. The idea of combining these actives was based on the
evidence that PTX resistance relies on the NF-kB-dependent pathway, while EA hinders NF-kB.
The two molecules were formulated with the temperature-sensitive amphiphilic copolymer poly
(N-isopropylacrylamide-PEG acrylate), stable under physiological conditions, being its lower critical
solution temperature higher than 37 ◦C. The NP were loaded directly by using the dialysis method
at different temperatures. Several formulations were prepared, but the best one, in terms of EE and
efficacy, contained the copolymer, PTX and EA in 20:1:1 weight ratio. The mixture was solubilized
in DMF and dialyzed against deionized water, in which the copolymer self-assembled, developing
core-shell nanoparticles. Since the drugs molecular weight is lower than the dialysis membrane cut-off
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(12 kDa), a slight loss of EA and PTX was unavoidable. To limit this phenomenon and to achieve a
high EE, the loading reaction was performed at 4 ◦C and an EE of 92% for PTX and of 98% for EA
were achieved. After completion of the dialysis, the solution was filtered and lyophilized. NP size
was below 200 nm and the release was well-controlled, as only the 8% of both drugs was released
after 2 h, while the 61% of PTX and the 88% of EA were released after 48 h. In vitro cytotoxicity tests
were performed against MCF-7 breast cell line. After 48 h PTX/EA-loaded NP showed slightly higher
cytotoxicity compared to free PTX, deriving from an improved cellular uptake. However, further
studies would be needed to assess an eventual synergism between the two loaded drugs.






N-methyl-2-pyrrolidone 25 37 ◦C [36]
DMSO 2.5 37 ◦C [36]
Pyridine 2.0 37 ◦C [36]
Methanol (671 ± 17) × 10−3 37 ◦C [36]
Ethanol 1.02 ± 0.04 25 ◦C [96]
Cosolvents
PEG 200 4.178 25 ◦C [94]
PEG 400 11.0 ± 0.5 25 ◦C [96]
Propylene glycol 2.1 ± 0.1 25 ◦C [96]
Oils
Palmester 3575 1 0.030 25 ◦C [94]
Cottonseed oil 0.005 25 ◦C [94]
Soybean oil 0.29 ± 0.01 25 ◦C [95]
Castor oil 1.63 ± 0.07 25 ◦C [96]
Oleic acid 0.29 ± 0.01 25 ◦C [96]
Ethyl oleate 2.34 ± 0.06 25 ◦C [96]
Surfactants
Tween 20 1.605 25 ◦C [94]
Sucrose esters 0.115 25 ◦C [94]
Isopropyl myristate 1.94 ± 0.07 25 ◦C [96]
Cremophor RH40 2 2.5 ± 0.1 25 ◦C [96]
Tween 80 3.5 ± 0.1 25 ◦C [96]
Lecithin 0.085 ± 0.004 25 ◦C [96]
Poloxamer F68 0.036 ± 0.002 25 ◦C [96]
Aqueous
Solutions
Phosphate buffer pH 7.4 (33 ± 16) × 10−3 37 ◦C [36]
Phosphate buffer pH 6.8 (11.1 ± 0.4) × 10−3 25 ◦C [96]
Acetate buffer pH 4.5 (6.9 ± 0.3) × 10−3 25 ◦C [96]
Distilled water (8.2 ± 0.4) × 10−3 25 ◦C [96]
HCl 0.1 M in water (1.03 ± 0.06) × 10−3 25 ◦C [96]
1 Caprylic/capric triacylglycerols 2 Polyoxyl 40 hydrogenated castor oil.
In a multiple drug co-delivery study by Fahmy et al., fluvastatin (FLV), alpha lipoic acid (ALA)
and EA were chosen for their anticancer properties [100]. As dosage form, nanostructured lipid
carriers (NLCs) were taken into consideration. NLCs are a relatively new generation delivery system,
developed to overcome SLNs drawbacks such as low payload, crystallization of the lipid matrix, and
drug expulsion during storage. In fact, NLCs, being composed of both solid and liquid lipids, do not
undergo crystallization, allowing higher drug loading and consequent better bioavailability of low
soluble drugs. Furthermore, NLCs are composed of highly biocompatible and biodegradable lipids, so
they have a wider range of applications. As an example, NLCs are useful nutraceutical delivery systems
with high drug loading, stability, capability in increasing bioavailability of bioactive compounds
and consumer acceptability. In addition, they may provide controlled release of the encapsulated
materials [101]. In this work, NLCs were prepared by hot emulsification–ultrasonication method
starting from 1% almond oil, 3% glyceryl dibehenate, 0.5% L-α-phosphatidylcholine phospholipid,
0.25% FLV, 0.02% EA and 0.3% ALA. The mixture was melted heating up to 50 ◦C in chloroform:ethyl
acetate 1:1. To this lipid phase 1% Gelucire® 44/14 aqueous solution was added and the resultant
emulsion was sonicated, cooled down and collected by ultracentrifugation. The NPs had a mean particle
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size of 85 nm (PDI = 0.58) and a negative zeta potential (ζ = −25 mV). The EE was 98% for FLV, 92% for
ALA, and 96% for EA. The release rate was rather slow after an initial burst effect. The formulation
was evaluated for its in vitro cytoxicity against PC3 prostate carcinoma cells. The co-delivery of FLV,
ALA and EA from NLCs always provided better results in comparison with free drugs both when
administered individually and mixed together, with significant differences in terms of cell survival,
caspase-3 expression and incidence of apoptosis.
In another interesting study, Abd Elwakil et al. focused on the preparation of an inhalable
spray dried powder for targeted co-delivery of EA and doxorubicin (DOX) to lung carcinoma [102].
This system consisted of nanocomposites comprised of drug-loaded NP and excipients like sugars just
to reach the micro-range size necessary to ensure deposition in deep lung tissue. Once at the alveolar
surface, the carbohydrate fraction rapidly dissolves, releasing the NP components apt to be internalized
by the cancer cells. NP matrix was composed of lactoferrin (Lf), a cationic glycoprotein chosen for
its ability to bind transferrin receptors overexpressed on cancer cells, and chondroitin sulfate (ChS),
a polyanionic glycosaminoglycan able to bind hyaluronic acid CD44 receptors. The first step of this
procedure was the nanocrystallization of raw EA via antisolvent precipitation in order to increase EA
incorporation in the hydrophilic matrix. A methanolic EA solution was added in a 1:10 volume ratio
to an aqueous phase containing 0.5% w/v poloxamer F188 as a stabilizer at 4 ◦C and the mixture was
stirred for 15 min. The resulting EA nanocrystals had an average size of 148 nm (PDI of 0.185) and an
aqueous solubility 33.3-fold higher than raw EA. The loaded Lf-ChS NPs exploited the polyelectrolyte
electrostatic complexation. DOX dissolved in distilled water was dropped gradually into 2% w/v ChS
solution containing lyophilized nano-sized EA; this dispersion was added by controlled dripping to
2% w/v Lf solution, at a suitable pH to allow formation and stabilization of NPs. The resulting product
was harvested by centrifugation. The loaded NPs showed a size of around 192 nm and a negative
zeta potential (ζ = −27 mV). The EE was 91% for DOX and 96% for EA. The in vitro anticancer efficacy
was tested against A495 human lung cancer cell line. Co-encapsulated DOX and EA Lf–ChS NPs
enhanced the potency of the drug co-administrated in mixture, as demonstrated by the significant
reduction of IC50 value by 3.8-fold compared with combined free drug solution. This system was not
expensive, scalable, and made of natural and highly biocompatible components, characteristics that
make it potentially useful for preparation of EA-enriched foods.
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5. Conclusions
In recent decades, a growing interest in the administration of polyphenolic compounds for
prevention of several diseases has arisen, since epidemiological studies have revealed a correlation
between dietary habits and disease risks. In particular, EA exerts various health-promoting
activities, suggesting that it may play an important role in dietary supplements. Furthermore,
a few research studies proved that EA is endowed with a wide spectrum of therapeutic effects
against oxidation-linked chronic illnesses such as, above all, diabetes, cancer, neurodegenerative
disorders, and cardiovascular diseases. Unfortunately, EA presents unsuitable biopharmaceutical
features, including poor bioavailability and interindividual variability that hamper its successful
employment in prophylaxis and disease treatment. To date, on the market, EA is present in beverages,
capsules, and tablets, which obviously do not overcome the problems associated with low oral
EA intake; furthermore liquid formulation submits it to fast degradation. From this background,
in order to address the many drawbacks associated with EA in vivo absorption, strategies mainly
consisting of micro and nanotechnology approaches were designed and performed. The obtained
EA formulations demonstrated modifying its release and improving its solubility, stability during
storage, and bioavailability in animal models. However, from the evaluation of the various developed
formulations, some considerations may be made. For example, approaches starting from basic EA
solutions lead to higher EA content, but the preparation timing may represent a crucial factor as
undesirable reactions such as oxidation and hydrolysis may occur. As a matter of fact, the choice of a
proper vehicle for dissolving EA is challenging, because EA results rather insoluble in most common
solvents. The attempt of reducing the size of EA powder through anti-solvent precipitation could be a
recommended preliminary step as reported by different authors. Regarding micro and nanosystems
preparative methods, encapsulation in biodegradable PLGA or PCL micro and nanospheres represents
a valid route when effective EA protection, long circulation and controlled release are required, as,
despite an initial burst effect, these systems provided a sustained release over one week. Thanks
to its biocompatibility, chitosan was also extensively used, providing a rather fast EA release (50%
within 8 h). Concerning lipid carriers, self-emulsifying systems are the most investigated ones, since
they were usually endowed with high EA loading capacity and gastrointestinal release within 1 h.
Although in the work of Wang et al. food-grade excipients were used, the effects of surfactants
concentration on intestinal epithelial integrity has to be taken into consideration. In this regard, it is
of great importance to develop formulations with residual organic solvents or surfactants below the
recommended maximum levels indicated by regulatory agencies. The most recent, innovative, and
highly biocompatible EA formulations consisted of pectin spray dried dispersion, cyclodextrin-based
nanosponges, zein nanocapsules, chitosan/alginate microspheres, lactoferrin/chondroitin sulfate
nanoparticles, and supersaturatable self-microemulsifying delivery systems. With these promising
advances, novel and more effective strategies could be applied for allowing extensive investigations
on EA in vivo beneficial effects. In this regard, in the last pharmacokinetic study in humans, it was
reported that after pomegranate extracts consumption, the key factors hampering EA effectiveness are:
its low solubility at the gastric pH, its bounding to intestinal epithelium, the saturable transcellular
transport and the interindividual variability to produce urolithins. All these drawbacks may be
overcome at least to a large extent by applying micro or nanocarrier-based approaches, suggesting that
future pharmacokinetic studies will provide more encouraging results if they are performed by using
an optimized pomegranate acid delivery system.
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Featured Application: The review aims to provide guidance on the definitions and regulation of
products containing botanical ingredients, which are at present quite complex.
Abstract: In recent decades, the interest in products containing botanicals and claiming “functional”
properties has increased exponentially. Functional foods, novel foods and food supplements have
a special impact on the consumers, who show significant expectation for their well-being. Food
supplements with botanical ingredients are the food area that has witnessed the greatest development,
in terms of the number of available products, budget, and consumer acceptability. This review refers
to and discusses some open points, such as: (1) the definitions and regulation of products containing
botanicals; (2) the difficulty in obtaining nutritional and functional claims (botanical ingredients
obtaining claims in the EU are listed and summarized); (3) the safety aspects of these products; and (4)
the poor harmonization between international legislations. The availability of these “new” products
can positively influence the well-being of the population, but it is essential to provide the consumers
with the necessary recommendations to guide them in their purchase and use.
Keywords: botanicals; food supplements; nutritional claims; functional food
1. Introduction
The sentence “Let thy food be thy medicine and medicine be thy food”, commonly attributed
to Hippocrates (400 BC), indicates the importance that nutrition has always had in the concept of
health and prevention of disease. This relationship has obviously undergone changes and historical
recurrences with an evolution parallel to that of human civilization with its variable habits in social
behavior and diet. More than 2500 years after Hippocrates’ claim, the concept of diet has evolved
to include aspects based on research in the field of nutrition and on knowledge relating to active
molecules contained in foods with potential benefit to human health.
The vegetables entered massively in the diet of humans with the Agricultural Revolution that
occurred about 12,000 years ago. Cereals, only rarely consumed in the Paleolithic era, have become
the basis of human nutrition with milk derivatives [1]. However, considering the use of plants for
their healing properties, archaeological excavations place their use up to 60,000 years ago. These were
plants not commonly consumed as food: poppy (opium), ephedra and cannabis.
The possible placement of the plants among food and products with therapeutic properties is
therefore ancient history and reappears, with its contradictions, in the current legislation, as described
below. The aim of this review was the clarification and relative discussion of the most critical aspects
regarding products containing botanicals, in order to promote the correct use of plant food supplements
among consumers.
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2. Definitions and Regulation
There is no internationally shared definition of the term “botanical”. However, it is possible to cite
what was defined by European Food Safety Authority (EFSA) in its guidelines published in 2009 [2].
The term botanical includes whole, fragmented or cut plants, plant parts, fungi and lichens. The term
botanical preparations include all preparations obtained from botanicals by various processes, such as
pressing, squeezing, extraction, fractionation, distillation, concentration, drying up and fermentation.
A similar definition is reported by a group of food and beverage producers: “botanicals are fresh or dried
plants, plant parts or plants’ isolated or collective chemical components, extracted in water, ethanol,
or other organic solvents, plus essential oils, oleoresins, and other extractives used for flavoring,
fragrance, functional health benefits, medicine, or other uses” [3].
Based on the definitions listed above, it is clear that botanicals include numerous possible
ingredients with extremely variable composition and characteristics. First of all, the presence and
concentration of active molecules can vary greatly, with possible effects on the beneficial effect expected
on the consumers’ health.
Hundreds of plants are ingredients commonly used in the food industry as such or derivatives,
or food additives (flavorings, colorings, preservatives, etc.), and botanicals can be included in different
types of products regulated by the food law as illustrated in Figure 1.
Figure 1. Categories of food containing botanicals.
2.1. Fruits and Vegetables
Fruits and vegetables have been included in the diet of humans since ancient times; they can
be consumed as such or as household or industrial derivatives (jams, juice, purée, etc.). Fruits and
vegetables are included in the EC Regulation N. 178/2002, which defines any unprocessed or processed
substances or product designed for human consumption [4]. Generally speaking, consumers prefer
products from the geographical area of belonging, but with the increasing globalization it is possible to
expand the choice to imported products.
2.2. Enriched or Functional Food
Although there is no international agreement, according to the consensus document on “Scientific
Concepts of Functional Foods in Europe” of the European Commission Concerted Action on Functional
Food Science in Europe (FUFOSE), functional food is usually considered a product to which one or
more ingredients have been added (or more rarely subtracted) with a positive consequence on the
functionality of human organs or systems [5]. It is, therefore, a food that has not only the function of
providing calories and nutrients but intends to carry out a favorable action on the consumer’s health.
This effect must be reached with the quantity of food normally consumed, it must be in “traditional”
form (and not in pharmaceutical form) and must guarantee the safety of the subjects taking the
product, even if they present common pathologies. As an example, the prebiotic ingredients are
frequently added to food; they are soluble fibers capable to promote the growth of the positive intestinal
microbiota; among others, the most important fibers in this field are inulin and fructo-oligosaccharides
(from chicory or Jerusalem artichoke). Further details will be reported in Section 4.1.2.
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2.3. Novel Food and Traditional Food from Third Countries
At the European level the regulation of new food, or novel food, was amended in 2015
(EU Regulation 2015/2283). Compared to the previous regulations, the definition of this products was
maintained: “novel food means any food that was not used for human consumption to a significant
degree within the Union before 15 May 1997”. Some of the categories listed in novel food include
botanicals: (1) food consisting of, isolated from or produced from microorganisms, fungi or algae;
(2) food consisting of, isolated from or produced from plants or their parts. Novel food category also
includes products obtained with new technologies. Before marketing them, appropriate documentation
must be provided in order to demonstrate their safety. Examples of novel food include: new sources of
vitamin K (menaquinone) or some extracts from existing food (Antarctic krill oil rich in phospholipids
from Euphausia superba) [6].
The aforementioned regulation has introduced a new authorization procedure for “traditional
foods deriving from Third Countries”, where a food with proven tradition of safe use in a third country
for at least 25 years is included. Compared to the novel food procedure, this new category must present
less documentation for their approval. Examples of foods belonging to this category are the dried
aerial parts from Hoodia parviflora N.E.Br. (hoodia) and seeds from Salvia hispanica L. (chia) [6].
2.4. Food/Dietary Supplements
Botanicals are widely used in the formulation of food (or dietary in US) supplements, that can be
defined as “products intended to supplement the common diet and which constitute a concentrated
source of nutrients, such as vitamins and minerals, or other substances having a nutritional or
physiological effect, in particular, but not exclusively, amino acids, essential fatty acids, fibers and
extracts of vegetable origin, both single- and multi-compound, in pre-dosed forms” [7]. The role of
food supplements is limited to correcting nutritional deficiencies, maintaining the recommended intake
of some essential nutrients and supporting specific nutritional needs such as pregnancy, breastfeeding
and menopause. They must not show therapeutic activity or significantly modify the physiological
functions [8]. Among the most frequently botanical ingredients used in food supplements, there are
Ginkgo biloba L. (ginkgo), Oenothera biennis L. (evening primrose), Cynara scolymus L. (artichoke) and
Panax ginseng C.A. Meyer (ginseng) [9].
2.5. Other Categories
Botanicals can be regulated by drug law. In fact, their use can enter into conventional medicine, or,
as in some European countries (e.g., Germany), in “Traditional Herbal Medicinal Products (THMPs)”.
THMPs must guarantee their safety in the expected conditions of use and their biological activity/efficacy
must be plausible on the basis of a chronic use and of available experience [10].
Botanicals can also be ingredients of products belonging to the category of medical devices; among
others: (1) ophthalmic solutions containing chamomile (Matricaria recutita L.), calendula (Calendula
officinalis L.), cornflower (Centaurea cyanus L.), etc.; (2) some liquids used in contact lens care, which
include arabinogalactans and plant extracts; (3) some solutions used for oral hygiene containing mainly
chamomile, aloe (Aloe vera (L.) Burm.f.) and marshmallow (Althaea officinalis L.). Since this chapter
is about food, only examples of the use of botanicals in functional foods and food supplements will
be described.
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3. Claims
One of the most interesting aspects associated with functional food and food supplements is the
possibility to boast on the label their health properties, the so-called “claims”.
The European Commission allows health claims when they can be supported by the scientific
literature and if they can be understood by consumers. In the EU, the European Food Safety Authority
(EFSA) is in charge of evaluating the scientific evidence [11] and provides the guidelines, which
describes in detail the studies required for the approval of nutritional/physiological claims [2,12].
There are two types of health sentences, those related to art. 13, and those relating to art. 14 of the
European Regulation 1924/2006. Article 13 claims refer to: (1) growth, development and functions
of the body; (2) psychological and behavioral functions; (3) slimming or weight control. Article 14
claims are associated with: (1) a reduction of risk factors in the development of diseases; (2) support of
normal children’s development and health. Table 1 lists the most important health claims allowed for
vegetable/botanical ingredients in the EU [13].
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4. Botanicals in Functional Foods
Some botanical derivatives have been successfully included in functional food for their healthy
properties. Among others, soluble and insoluble fibers, beta glucans and phytosterols/phytostanols
deserve a more in-depth description.
4.1. Soluble and Insoluble Fibers
The beneficial properties of dietary fiber intake have been known for a long time and have been
publicized since the 1920s. Over the years, the importance of fiber for human health has been fluctuating
to be re-evaluated in the second half of the 20th century [14]. With the progress of knowledge, dietary
fiber has been classified in various ways; the first subdivision concerns the difference between fiber,
which are soluble or insoluble in aqueous medium. In addition to the obvious difference in “chemical”
behavior, the solubility (or less) of the fiber in water greatly conditions the activity on humans’ health.
Insoluble fiber acts mainly on the intestinal transit, while the soluble fibers mediate beneficial properties
based on different biological mechanisms.
4.1.1. Insoluble Fiber
Insoluble fiber includes mainly cellulose, hemicellulose and lignin, and it is characterized by
its “inertia” at the level of human organism. In other words, it does not undergo any metabolic
modification during the transit in the gastro-intestinal tract. Products containing insoluble fiber from
different plant sources can use the health claim “the fiber contributes: (1) to normal bowel function;
or (2) to increase faecal bulk; or (3) to an acceleration of intestinal transit” (see barley, oat, rye, sugar
beet, and wheat fiber in Table 1). Insoluble fiber increases fecal bulk, that leads to a speeding of
intestinal transit with the consequent beneficial effects (elimination of waste containing toxic molecules,
less contact of fecal waste with the intestinal mucosa, etc.). These effects have been recognized as
protective factors versus some cancers including the colon cancer.
4.1.2. Prebiotic Fibers
The prebiotic fibers fall into the category of soluble fibers. The definition of the term “prebiotic”
has undergone a certain number of changes since the 1990s, a period in which they were identified as
beneficial ingredients of the human diet. In agreement with the International Scientific Association for
Prebiotics and Probiotics, a prebiotic fiber is “a substrate, that is selectively used by host microorganisms
conferring a health benefit” [15]. Similarly, the Food and Agriculture Organization of the United
Nations (FAO) published the following definition in 2008: “a nonviable food component that confers a
health benefit on the host associated with modulation of the microbiota” [16].
In recent decades, the awareness of the critical role played by the intestinal microbiota on human
health has progressively grown. Studies to support this knowledge have stimulated the formulation of
food products capable to contribute to the modulation of microbiota towards positive bacterial strains
(mainly lactic bacteria) at the expense of pathogenic ones. These foods, mostly milk-based, contain
particular strains of live bacteria (probiotics) or soluble fibers capable of promoting their growth.
In functional foods, the most commonly used prebiotic fibers are: inulin, fructo-oligosaccharides (FOS)
and galacto-oligosaccharides (GOS); the latter are mostly included in products for infants. Inulin is a
linear polymer of 2-60 fructose molecules linked by β-(2-1)-bonds.
The nature of chemical bonds prevents inulin from the usual digestion of caloric sugars. FOS are
similar to inulin for chemical bonds, but the number of units ranges between 2 and 10 [17]. Inulin and
FOS are storage carbohydrates contained in several plants; the most important sources are chicory,
sugar beet, leeks, asparagus, and Jerusalem artichokes. Inulin and FOS reach the colon undigested
where they are fermented by the “positive” microbiota. A health claim for “native chicory inulin” is
allowed in EU; it states that “chicory inulin contributes to normal bowel function by increasing stool
frequency”. This claim must be associated with those products, providing at least a daily intake of 12 g
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of inulin, as a non-fractionated mixture of monosaccharides (<10%), disaccharide, inulin-type fructans
and inulin, with an average of polymerization > 9 (see Table 1).
Although from animal origin, galacto-oligosaccharides (GOS) are considered here to describe the
possible healthy effect due to prebiotic fiber. GOS are oligosaccharides containing 2-10 molecules of
galactose and one molecule of glucose. The purity and degree of polymerization largely influence
the prebiotic properties of these oligosaccharides, as shown in clinical studies [18,19]. GOS are
widely used in lactating formulas to improve the microbiota colonization and modulate the intestinal
disorders such as colic. The effects of GOS added to infant formulas were evaluated in a randomized,
double-blind, controlled, parallel-group clinical trial including healthy term infants [20]. Three groups
were considered: breastfed, formula-fed, and GOS-supplemented formula-fed infants. The effects of
supplemented formula were assessed considering four bacterial targets: Bifidobacterium, Lactobacillus,
Clostridium, and Escherichia coli. The effect of the prebiotic-supplemented formula was very close to that
of breast-feeding in stimulating Bifidobacterium and Lactobacillus growth and in inhibiting Clostridium
growth. The whole result was a significantly lower incidence of colic [20].
4.1.3. Beta-Glucans
Beta-glucans are soluble fibers contained in cereals, such as barley, oat, rye, wheat and some
mushrooms [21]. They are linear polymers of glucose linked by β-(1-4) and β-(1-3) bounds. Two claims
for beta-glucans received positive opinion by EFSA and were included in the list of wordings allowed
in the EU (Table 1) [22].
The first claim is “consumption of beta-glucans from oats or barley as part of a meal contributes
to the reduction of the blood glucose rise after that meal” (Table 1). In fact, beta-glucans modulate the
post-prandial glycemic response by increasing the meal bolus viscosity, with a consequent delayed
absorption of nutrients (including glucose) in the small intestine [23].
On the basis of intervention studies performed in healthy subjects, EFSA concluded that quantities
of about 4 g of beta-glucans/30 g of available carbohydrates are capable to decrease the post-prandial
glycemic response without modifying the insulin release [22]. The claim must be associated with the
recommendation to use beta glucans during meals.
The EFSA received from the European Commission a second request for an opinion regarding the
claim associating beta-glucans with the positive modulation of normal blood cholesterol levels [24].
On the basis of a certain number of randomized-controlled trials in adults with normal or mildly
increased cholesterolemia, the EFSA Panel formulated the following wording “regular consumption
of beta-glucans contributes to the maintenance of normal blood cholesterol levels”. The beneficial
effect is linked to a daily consumption of 3 g of beta-glucans in one or more servings. The proposed
mechanism of action is based on the fact that dietary beta-glucan forms, in the small intestine, a viscous
mixture that reduces the intestinal absorption of dietary cholesterol and the re-uptake of bile acids.
As a consequence, new bile acids are synthetized from circulating cholesterol [25].
4.2. Phytosterols/Phytostanols
Phytosterols and phytostanols are compounds of plant origin, which are commonly part of the
human diet. Phytosterols can be transformed in phytostanols by hydrogenation and both class of
molecules can be esterified with fatty acids from vegetable origin to the corresponding esters [26,27].
Phytosterols and phytostanols are structurally similar to cholesterol, apart from their side chain.
The most common phytosterols and phytostanols are sitosterol, sitostanol, campesterol, campestanol,
stigmasterol and brassicasterol [26].
In the EU, the use of phytosterols, phytostanols and their esters in foods refers to the Regulation
(EC) No. 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel
foods/novel food ingredients.
These molecules reduce the intestinal absorption of cholesterol and, as a consequence, cause
a decrease in blood cholesterol levels. For this property, phytosterols and phytostanols, in free or
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esterified form, can be added to foods for their properties to maintain normal (claim under Art. 13) or
reduce blood cholesterol levels (claim under Art. 14). The first wording is allowed for food providing
0.8 g of plant sterols/stanols with the daily dose and the second for daily doses ranging from 1.5 to 3 g.
Doses of 1.5–2.4 g/day are associated with a cholesterol level reduction of 7–10%, while 2.4–3 g/day can
produce a decrease of 10–12.5% [28].
5. Botanicals in Food Supplements
The category of food/dietary supplements is that in which the presence of ingredients from plant
origin is more frequent (botanicals). Food supplements containing plants or derivatives have found an
increasing diffusion and acceptance by the consumers, which consider the word “natural” synonymous
with “non-chemical” and for association with safe. This belief explains the success of these products
and therefore their consistent market presence.
The plants contained in food supplements are many and most of them derive from the tradition
of use, that is the preparation of infusions or decoctions. The same plants have been then used by the
industries to prepare extracts, in order to enrich the products in active molecules and enhance the
expected positive properties. Supplements may contain a single plant ingredient or a mixture of them.
It is clear that the greater the number of botanicals present in the finished product, the greater the
problems in the correct use by the consumer and in the quality control especially when the product is
already on sale.
Another critical aspect derives from the fact that there is no harmonization at the international
level (even in Europe) as regards the lists of plants allowed in food supplements. Many countries of
the European Union, but also of other continents, have published positive and/or negative lists of
botanical ingredients, which are allowed or prohibited in food/dietary supplements. Unfortunately,
there is few correlations between them.
The inconsistent situation of the European market of products with botanical ingredients (presence
both in products regulated by food or drug laws, see Section 2) leads to several consequences, including
the difficulty in discriminating “healthy” or “therapeutic” information for the same plant used in
different product classes. As the researchers well know, the dose makes the difference, but discriminating
the dose with physiological effects from the one that is suitable for clinical applications is a complex
objective even for plants of more ancient tradition. These difficulties were reflected in the very small
number of claims approved by EFSA in the field of botanicals.
To boast a nutritional or health claim as a guide for the consumer, it is necessary to refer to
the European Regulation n. 1924/2006, according to which: "Scientific substantiation should be the
main aspect to be taken into account for the use of nutrition and health claims and the food business
operators using claims should justify them”. To obtain authorization to associate a nutrition/health
claim with a botanical in EU, the manufacturer must submit a dossier to EFSA, which evaluates the
scientific evidence of the studies provided and publishes the relative opinion. The guidelines provided
by EFSA [2,8] describe in detail the studies required for the approval of nutritional/physiological claims.
The guidelines published by EFSA, although extremely well-articulated, have nevertheless led to
immediate difficulties in the creation of a dossier that could meet all the listed requirements. Among
the most critical and important aspects:
(a) speaking of dietary supplements, food industries cannot claim any therapeutic effect, but only
physiological ones; as a consequence, apart from few exceptions, it is very difficult to prove a healthy
activity that aims to maintain homeostasis or reducing disease risk factors in the long term;
(b) to obtain statistical significance, it is necessary to recruit a very large “healthy” population
that is willing to take a certain product for very long periods. All this is economically unsustainable,
and the results could still be affected by the dietary habits (and not only) of the subjects considered;
(c) it seems unreasonable that the tradition of use has been accepted for traditional medicine drugs
and not for food supplements.
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Considering the list of claims listed in Table 1, only one case can be clearly associated with
food supplements: Monascus purpureus (red yeast rice); in the remaining cases, claims are related to
ingredients generally used in all foods.
Red Yeast Rice (RYR) is a rice fermented by the red yeast Monascus purpureus, which contain a
certain number of active polyketides named monacolins, that are secondary metabolites deriving from
the fermentation process [29]. The most abundant active molecule is monacolin K.
RYR obtained the approval of the claim: “Monacolin K from red yeast rice contributes to the
maintenance of normal blood cholesterol levels” [30]. This wording was supported by two randomized
controlled studies, where RYR preparations providing 10 mg of monacolin K (with the daily dose)
were responsible of a reduction of blood Low-Density Lipoprotein- cholesterol (LDL-cholesterol) level
in subjects suffering from hypercholesterolemia. EFSA considered also the fact that the effect of pure
monacolin K (chemically identical to the drug lovastatin) on blood LDL-cholesterol concentration was
well known and based on the inhibition of HMG-CoA (3-Hydroxy-3-Methyl-Glutaryl-Coenzyme A)
reductase [31].
6. Safety Aspects
This chapter deals with food, the safety of which should be able to be taken for granted. Actually,
when botanicals are food supplement ingredients, some distinction has to be made. Compared to
common or functional food, food supplements containing botanicals have no or little role from the
nutritional point of view, as these do not contribute significantly to the intake of calories and nutrients.
In fact, normally these products do not contain caloric nutrients (sugars, fats and proteins) and
the presence of vitamins and minerals (not mandatory) covers, with a few exceptions, very limited
percentages of the recommended daily dose. On the other hands, food supplements with botanicals
are frequently promoted for their possible healthy properties, leading the consumer to prolonged use
over time. Furthermore, as mentioned above, the growing popularity among consumers of “natural
products” has led to an increasing number of producers and thousands of food supplements on
the international market, without certainties relating their composition, activity and safety. While
biological activity may be at least partly based on the “tradition of use”, the risk/benefit assessment
still remains orphaned of sufficiently reliable scientific data.
Botanicals, especially if in their extract form, can have biological effects which, in relation to
the dose and quality of the ingredient, can be functional, therapeutic and also toxic [32]. Different
factors could be involved in the incidence of adverse effects such as the quality of the raw botanical
material, the presence of environmental contaminants, the specific technological process applied
(extraction and concentration), misidentifications of the plant ingredients, adulterations, counterfeits.
The phytochemical fingerprint of a botanical can vary significantly, when the biological variability or
the different processes applied are considered. Different factors (extractant solvent, the temperature and
time, the time from harvesting, etc.) can modulate the quality of botanical ingredients, with consequent
changes in the relative abundance of active molecules present in the final product. Consumer’s age
and gender, unsuitable use of botanical food supplements, genetic factors and specific pathological or
physiological conditions are further possible sources of unexpected adverse reactions.
Confirming the particularity of the supplements with respect to usual food, there are cases in
which limits on the content of molecules naturally present in botanicals are regulated by national and
international directives. The established values must also be indicated on the label, such as in the case
of bitter orange (Citrus aurantium L.) for which it is necessary to declare the content of synephrine and
other active amines with the daily dose (Figure 2). Limits are established for molecules that can lead to
unwanted side effects at high levels and therefore for which safe daily doses for consumers need to be
“standardized”.
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Figure 2. Active amines of Citrus aurantium L. regulated for their content in food supplements.
6.1. Adverse Events
Even in the case of adverse events, supplements containing botanicals show specific characteristics.
Excluding the accidental presence of toxic xenobiotics, the adverse events associated with common foods
are mostly due to allergies and intolerances, which concern restricted groups of at-risk populations.
On the contrary, in the case of supplements with botanicals, the consumer must be informed that
adverse events can occur. Moreover, pregnant, lactating women and children should avoid food
supplements or strictly follow the doctor’s/pediatrician’s indications.
Since botanicals are “natural”, the average consumer considers them safe and rarely communicates
their use to doctors in the case of short- or long-term therapy. This point is probably the most
important factor leading to unexpected adverse effects. Botanicals could modify the efficacy of other
molecules (pharmaceutical drugs or other dietetic compounds) reducing or increasing their plasmatic
concentration. To give an example of the possible adverse events to supplements containing botanicals,
the case of RYR is described here.
6.2. The Case of RYR
As described previously (see Section 5), in 2011 RYR received a positive opinion for the claim
supporting the reduction of LDL-cholesterol plasma level, if the daily intake of monacolin K was 10 mg.
In 2018, the EFSA was asked a second time in relation to RYR, with the request being to evaluate
the safety of the monacolins contained in it and to provide advice on the daily dose of monacolins
that does not give rise to concerns for harmful effects [33]. Since the lactonic form of monacolin K
has the same chemical structure of lovastatin (a pharmaceutical drug), the EFSA, after consulting the
scientific material provided, concluded that the intake of 10 mg of monacolin K with a food supplement
would lead to the intake of a therapeutic dose. Moreover, the evaluation of the data presented showed
that several adverse events were reported following the consumption of RYR. These adverse events
involved musculoskeletal system (the most severe clinical event associated was rhabdomyolysis) and
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liver. The clinical symptoms appeared after consumption of RYR, with an intake of 3–10 mg/day of
monacolin K.
Two problems have therefore been highlighted for RYR:
1. the dose of monacolin K required to boast the claim about the LDL-cholesterol reduction
corresponded to the lower therapeutic dose of the drug lovastatin, chemically identical to the
lactonic form of monacolin K. This fact is not acceptable due to the legal definition of a dietary
supplement, which must not show pharmacological activity.
2. EFSA “was unable to identify a dietary intake of monacolins from RYR that does not give rise
to concerns about harmful effects to health, for the general population, and as appropriate,
for vulnerable subgroups of the population” [33]. This fact makes uncertain the marketing of
RYR as food supplement, products that do not require medical supervision.
7. Conclusions
Since the last century, a progressive lengthening of the average life of the population has been
observed; this social phenomenon is in itself a positive fact, but inevitably entails an increase in the
occurrence of chronic-generative diseases more frequent in elderly: cardiovascular diseases, tumors,
dementias, etc. At the same time, new data on the role of nutrition in human health has stimulated
important international researches and industrial activities:
1. the tables of nutritional requirements (RDA) have been prepared which, with some differences,
indicate to consumers all over the world the quantity of calories and nutrients necessary to
maintain health;
2. the possible protective role of some components present in foods (antioxidants are the most
popular) against the chronic-degenerative diseases described above has been highlighted.
These premises explain the great interest of the food industry for products that present, in addition
to nutritional ingredients (proteins, carbohydrates and fats), new “functional” properties, which
have special impact on the consumer. In this area, particular interest has been paid to ingredients
of vegetable origin, the botanicals. Most products containing botanicals are regulated by food law:
fruits and vegetables, functional foods, novel foods, traditional foods from third countries, and food
supplements. Some botanical ingredients have received positive opinion by EFSA to support their
health claims; fibers, beta glucans and phytosterols/phytostanols are among the most known functional
ingredients. Food supplements with botanical ingredients are the sector that has witnessed the greatest
development, in terms of both the number of products on the market and consumer acceptability.
The availability of these “new” functional products can positively influence the well-being of the
population, but it is essential to provide the consumer with the necessary information to guide him in
the purchase and use of food supplements.
The difficulties in demonstrating scientifically the supposed physiological/healthy properties
of botanicals are the reasons of the limited number of claims approved by EFSA. In addition, safety
aspects should be considered in relation to the high number of products available on the market and
their growing popularity among consumers: among other things, the quality of raw materials, possible
adulterations, presence of active molecules regulated by national/international directives and factors
associated with consumers (age, gender, concomitant diseases/drugs). These factors can contribute to
adverse effects occurring, underlying the need for tools and intervention to promote consumers safety.
In conclusion, this review provides an overview on the actual knowledge about products containing
botanicals aimed to promote consumers’ wellbeing. The main purpose is to provide useful information
to consumers in order to guide their choices. In fact, although much progress has been made in the
field of botanicals, there is still a lack of data, information, and guidelines to ensure the suitable use of
these products.
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Abstract: The Cucurbita genus, a member of Cucurbitaceae family, also known as cucurbits, is
native to the Americas. Genus members, like Cucurbita pepo and Cucurbita maxima, have been used
for centuries in folk medicine for treating gastrointestinal diseases and intestinal parasites. These
pharmacological effects are mainly attributed to their phytochemical composition. Indeed, Cucurbita
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species are a natural source of carotenoids, tocopherols, phenols, terpenoids, saponins, sterols, fatty
acids, functional carbohydrates, and polysaccharides, that beyond exerting remarkable biological
effects, have also been increasingly exploited for biotechnological applications. In this article, we
specifically cover the habitat, cultivation, phytochemical composition, and food preservative abilities
of Cucurbita plants.
Keywords: Cucurbita plants; cucurbits; pumpkin; phytochemical composition; food industry
1. Introduction
Natural products are a rich source of chemical diversity that has boosted pharmaceutical industry
over the centuries [1,2]. Plants and herbs have been applied in both prevention and treatment of
human disorders since ancient times [3–5]. Indeed, many investigations on herbs and plants have
been conducted, and their efficacy proved as a compelling source of antioxidant, antimicrobial,
anti-inflammatory [6], anticancer and neuroprotective agents [7,8].
The Cucurbitaceae (pumpkin) family contains many species as human foods. This family frames
a huge gathering with roughly 130 genera and 800 species. Cucurbitaceae plants are commonly known
as cucurbits, extensively cultivated in tropical and subtropical countries. Cucurbit species include
pumpkins, squashes, gourds and melons [9]. In addition, it is an economically important family with
a rootage of various valuable products, such as edible vegetables, fruits, seed, seed oils, and drugs.
Indeed, they include a large variety of vegetables, often used through various forms for cooking,
pickling, salad, dessert fruits, candied, confectionary, etc. In addition, Cucurbita products have a high
nutritional value, being also an important source of vitamins, and widely used in culinary for biscuits,
bread, desserts, soup and beverages production [10–12].
Overall, this article aims to provide an update on the Cucurbita plants sources, as well as historical
culinary usage, habitat and cultivation, phytochemical composition and industrial purposes.
2. Cucurbita Plants: An Historical Culinary Usage
Cucurbita plants were first explained by Linnaeus in the middle of the eighteen century and are
among the earliest known plants that have been grown by mankind. Primarily, they are classified by
their shape or harvest season (summer or winter), although there are both female and male types.
The male flowers produce pollen and the female ones produce the fruit. Cucurbita species have
bristly and prickly stems and leaves. Broadly, leaves are large, occasionally lobed or spotted, and
spiraled clinging tendrils are frequently given at the leaf axils. Both leaves and stems can be rough or
prickly. Yellow or orange trumpet shaped flowers develop into variously shaped, sized, marked, and
colored fruits [13]. However, these plants are also cultivated for their edible and ornamental fruit, also
having therapeutic and wholesome advantages. The juvenile natural products are often expended
as a vegetable, but some assortments of natural products are used with beautiful purposes in the
Halloween party. They can be consumed as raw or cooked, and also for animal feed, but due to their
high nutraceutical value, Cucurbita plants have been widely used in many countries as constituents of
many commercial products. For instance, in Indian cuisine, squashes (ghia) are traditionally cooked
with seafood, such as prawns. French people use marrows (courges) as a gratin. In Italy, many
of regional dishes are prepared from squashes. Japanese people use Cucurbita moschata Duchesne
pumpkins (kabocha) for preparation of different Japanese foods. C. moschata fruits can be round, oblate,
oval, oblong, or pear-shaped, variously ribbed, 15–60 cm in diameter, and weigh up to 45 kg. In African
countries soup is prepared from squash, and soft alcoholic drinks are made from Cucurbita ficifolia
Bouché. C. ficifolia fruits are oblong with a diameter of 20 cm, weighs 5 kg to 6 kg, and its skin can vary
from light or dark green to cream-colored.
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Specifically, the commercially produced pumpkin is mainly used for production of pumpkin pie,
bread, biscuits, cheesecake, desserts, donuts, granola, ice cream, lasagna dishes, pancakes, pudding,
pumpkin butter, salads, soups, and stuffing. The seeds, wealthy in oil, likewise are used in Mexico,
with nectar to make pastries, known as palanquetas. Blossom buds and blooms are used in Mexico
to cook quesadillas. Indeed, Cucurbita products contain carbohydrates, protein and are also rich in
vitamin C, pyridoxin (B6) and riboflavin (B2). The content of fat is negligible. Fruit and root of Cucurbita
foetidissima Kunth is also rich in saponin, which can be used as soap, shampoo and bleach [10–12,14].
3. Habitat and Cultivation of Cucurbita Plants
3.1. Habitat
The Cucurbita genus is native to the Americas. Archaeological observations have explained that,
for more than 8000 years, Cucurbita domestication has moved from the southern parts of Canada to
Argentina and Chile [10–12,14]. Five species of the genus, namely Cucurbita argyrosperma C.Huber,
C. ficifolia, C. moschata, Cucurbita maxima Duchesne, and Cucurbita pepo L. were habituated and cultivated
in several areas of North and South America [15–17]. C. pepo is considered as one of the most seasoned
and developed varieties, by Mexican archeological evidence of 7000 BC. Along these lines, it was
extensively developed through aboriginal people through Central, North America and Mexico, earlier
the landing of Europeans. C. pepo is local to Northern Mexico and Southwestern and eastern USA [18].
C. pepo fruits can be oval, cylindrical, flattened, globular, scalloped, fusiform, and/or tapering to a
curved or straight neck on one or both ends. They can be up to 5 times longer than wide and their
weight varies from 30 g to 50 kg. The skin can be smooth, warty, wrinkled, furrowed, or/and have
shallow to deep longitudinal ridges. Often there is more than one color to the soft to hard skin: white,
yellow, light to dark green, nearly black, cream, and/or orange. Subsequently, Cucurbita species were
cultivated in all tropical, subtropical and temperate regions of the planet and are now considered as
one of the valuable foods for most of the world’s inhabitants [12,19].
Cucurbita species also show diverse habitat use, growing in terrestrial and wetland environments,




In general, Cucurbita species prefer warm weather. Temperatures of 18–27 ◦C are ideal for
maximum crop production. So, a long warm season is important to obtain a quality production.
For seed germination, soil temperatures above 16 ◦C are essential and it takes about 14 days for the crop
to leaves at this temperature, and it was also reported that when soil temperature rises to 20 ◦C seed
emerge within a week [21]. Cucurbita species requires a continuous water supply, but overwatering also
lead to crop spoiling. Uniform moisture supply is, therefore, important during the growing season of
the crop. C. argyrosperma is generally cultivated in regions with little arid climate with proper watering
or in regions with a distinct rainy season [22]. C. ficifolia grows in specific environmental parameters,
such as not in a high frost condition, but it prefers heavy rain agricultural systems [23]. C. maxima are
mainly grown in regions with temperate climate, and exceptionally grown in warm and moist area [24].
The shape of C. maxima fruit can be an elongated cylinder, oval, flattened, globular, heart-shaped,
and/or tapering to a curved neck on one or both ends. The length (from 5.8 cm to 71.6 cm), width
(from 11.2 cm to 48.6 cm) and weight (usually ranging from 0.3 kg to 50 kg, some pumpkins can grow
over 90 kg) is very variable. The skin can be smooth, warty, wrinkled, or/and have shallow to deep
longitudinal ridges. Often there is more than one color on the soft to hard skin: red, white, gray, black,
green, cream, and/or orange. C. moschata is reported mainly from regions with low altitude, hot climate
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and high humidity [25,26]. C. pepo can adapt to different ecological conditions, but prefers low altitude
and warm/humid places [27].
3.2.2. Soil
Cucurbita spp. can be grown in a wide range of soil varieties, but favors well-drained fertile
ground [22]. A well-drained soil is preferred, and the crop roots can penetrate up to a meter deep into
the soil. The ideal soil pH is in the range of 6.0 to 6.5, but the crop can withstand both slightly acidic
and alkaline soils. In areas with low soil pH, the application of lime or dolomite is essential to allow
better uptake of nutrients. Well-drained loamy fertile soils or sandy loam soils are good for commercial
cultivation. However, heavier soils (clay) can also be used as long as drainage is adequate.
3.2.3. Propagation and Planting Method
Cultivated Cucurbita spp. are usually propagated by planting seeds in the ground. Sometimes,
seeds are germinated in small pots and seedlings are transplanted to the field when climatic and
edaphic factors are favorable [22]. Transplant seedling are often used to establish an early season crop
or when using permanent beds [21]. It has been reported that Cucurbita species that are developed
from transplanted seedling have luxuriant growth, larger fruit size and significantly higher seed yield
compared to direct sowing method [28,29]. Commercially cultivated varieties are sometimes grown with
traditional crops, like maize, beans or even in vegetable gardens along with other species. Plant density
affects fruit size, yield and its number per plant. Napier [21] reported that in C. maxima and C. moschata
higher plant densities resulted in smaller fruit size, higher total yield and fewer fruit per plant.
3.2.4. Irrigation
The first irrigation is important just after planting, and subsequent irrigation is given at a weekly
basis or depending upon growth of the plant and soil condition. Waterlogging should be avoided
throughout the cultivation process. However, in the absence of rain, the crop should be regularly
watered. Irrigation is vital during flowering, fruit set and fruit fill, but should be minimized at the time
of fruit maturity. Various types of irrigation methods are practiced in Cucurbita species cultivation,
such as furrow, drip and overhead irrigation. Furrow irrigation needs the type of soil which passes
water to reach laterally, without penetrating very deep into the soil, and drip irrigation is practiced in
permanent bed systems which help to minimize weeds in the field [21].
3.2.5. Fertilizer
Proper fertilizer application is essential for Cucurbita species cultivation, but the excessive use of
nitrogen fertilizer, early in the growing period, results in huge foliage growth, delayed fruit set and
lower crop yield [21,30–32]. For C. maxima production, mineral fertilizers are used, which consists of
NPK-nitrogen (N), phosphorous (P) and potassium (K)-applied either manually or with sub-soiled
in a row. A nitrogen side-dressing in the form of urea, is also applied about two weeks after crop
emergence [33]. In case of C. maxima, the recommended amounts of fertilizers are about 150 kg
nitrogen/ha, 95 kg phosphorus/ha, 80 kg potassium/ha and 10 kg gypsum/ha [33]. Bannayan et al. [34]
reported that, in C. pepo, the optimum nitrogen rate not only can increase crop growth, but can also
boost up its resistance to higher temperatures.
3.2.6. Pest and Disease Management
Cucurbita species are very prone to pests and diseases, and some pathogens attack this economically
important crop. Thus, it is important to protect them to obtain a good quality and high commercial yield
Cucurbita. Several notorious fungal pathogens are associated with Cucurbita species, e.g., Cladosporium
cucumerinum which causes a scab or gummosis [35], while Choanephora cucurbitarum causes fruit rot of
C. pepo [36]. This disease, also known as “wet rot” and “blossom end rot”, can spoil many blossoms
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and fruit during prolonged damp weather. Pseudoperonospora cubensis is an unusual organism of
downy mildew Cucurbita species, mainly cucumbers, melons, squashes, gourds and watermelons [37].
Phytophthora capsici causes blight and mostly infect the seedlings, vines, leaves, and fruits of Cucurbita
plants [38]. Cucurbits powdery mildew, caused by Erysiphe cichoracearum, is the most critical disease
of cultivated Cucurbita spp. [39,40]. Fusarium oxysporum is a soil borne fungal pathogen that causes a
damping off and wilt disorder [41]. Powdery mildew is caused by Sphaerotheca fuliginea, which forms
pads of whitish mycelium on upper and under leaf sides, petioles, and stems [42]. Important bacterial
diseases of Cucurbita species are across leaf spot evoked by Pseudomonas syringae pv. Lachrymans [43,44].
Bacterial wilt occurs in Cucurbita species infected with Erwinia tracheiphila. This pathogenic bacterium
is imparted with striped (Acalymma vittatum) and spotted (Diabrotica undecimpunctata) cucumber
beetles [45]. Several viral variants have also been identified, causing many problems to the crops due
to the rate of disease expansion, asperity of infection and difficulty in controlling the diseases. The
most important viral variants are clover yellow vein virus (CYVV), papaya ringspot virus Type W (PRSV),
squash mosaic virus (SqMV), tobacco tingspot virus (TRSV), tomato ringspot virus (ToRSV), watermelon
mosaic virus (WMV), and zucchini yellow mosaic virus (ZYMV) [22,46,47]. Many insects invade Cucurbita
species, e.g., aphid species (Myzus persicae and Aphis gossypii) and beetle species (A. vittatum and
D. undecimpunctata), which causes significant crop losses. Proper crop rotation is the best way to
minimize pests and diseases. Thus, the application of appropriate fungicide, like copper oxychloride,
bravo, cupravit, dithane, and dichlorophen, at specific doses can control fungal pathogens of Cucurbita
species. However, the control of viral diseases is difficult. The breeding of disease resistant varieties by
the hybridization technique or the application of innovative methods to promote resistant varieties
is an additional way to control viral diseases. C. pepo cultivar contains unique transgenic forms that
show resistance to viruses like WMV and ZYMV [22].
4. Cucurbita Plants Phytochemical Composition
Twenty-eight Cucurbita species are named in the literature [48,49], but some of them could just be
hybrids or synonyms [49]. The relative lack of studies on some Cucurbita species may be linked to
their rarity and endemic aspect, as is the case of Cucurbita okeechobeensis (Small) L.H.Bailey [50], also
considered as an endangered species that must be protected [50,51]. The potential toxicity of the wild
species may also be a limiting factor [52].
Edible kinds of pumpkins and squashes, like C. ficifolia, C. maxima, C. moschata and C. pepo can
be a natural source of some bioactive components. Indeed, these species are rich in tocopherols and
carotenoids, especially the seeds and the fruit peel, respectively [53]. Generally, it is complicated
to make a straight qualitative or quantitative distinction between the species, because of the high
variability within a single species depending either on their subsequent varieties or environmental
effects and ripening stage. This aspect is also true for other phytochemicals. Depending on the
edible part, Cucurbita species are found to be very rich in compounds with nutritious value, especially
carbohydrates, proteins, minerals (Table 1), fatty acids (Table 2) and amino acids [53].
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Table 2. Seed fatty acid composition of some common Cucurbita spp. *.
Fatty acid (%) Cucurbita moschata Cucurbita pepo Cucurbita maxima References
Myristic acid (C14:0) ND 0.1–0.23 0.16
[53,55,58–62,64]
Palmitic acid (C16:0) 12.78–20.74 9.5–14.5 10.84–15.97
Palmitoleic (C16:1n7) NQ 0.58 NQ
Heptadecanoic acid (C17:0) ND ND 0.18
Stearic acid (C18:0) 7.33–7.47 03.1–8.67 4.68–11.2
Vaccenic acid (C18:1n7) NQ 01.8 NQ
Oleic acid (C18:1n9) 22.66–31.34 21.0–46.9 14.83–44.11
Linoleic acid (C18:2) 35.72–48.52 0.17–60.8 34.77–56.60
Linolenic (C18:3) ND ND–0.68 0.24
Arachidic acid (C20:0) ND 0.39 0.36
Gadoleic acid (C20:1n–9) ND 00.1–1.14 0.07
Arachidonic acid (C20:4) NQ 00.5 0.41
Behenic acid (C22:00) ND 0.37 0.09
Saturated 20.11 18.69–19.35 17.47–21.07
Mono-unsaturated 31.34 32.40 14.90–44.12
Poly-unsaturated 35.72 36.40 34.78–56.84
Total unsaturated 67.06 7.6–80.65 71.74–78.90
* Results expressed in dry base of seeds; ND: Not detected; NQ: Not quantified.
The content of carbohydrates is highly variable within each species and edible parts, starting from
2.62% to 48.40% on dry basis. In general, the seeds and peels are richer than flesh, and C. maxima and
C. pepo were described as containing higher levels of carbohydrates when compared to C. moschata.
The mineral contents of Cucurbita fit the recommended daily intake values of FAO in various essential
elements. In addition, it seems to be far from the upper limits [65], when the values are converted on
a fresh matter basis. Seeds contain high amount of proteins and fats, ranging from 14.3% to 38.0%
and 21.9% to 54.9%, respectively. In contrast, fruit seems to have relatively low and variable levels of
proteins (0.20% to 23.95%), and a very low content of lipids (0.04% to 6.57%). Cucurbita, especially
the seed parts, can also be a good source of amino acids [53]. Indeed, among the 20 amino acids
which constitute the human proteins, 17 are present in Cucurbita, including the 8 + 1 essential amino
acids [53,55]. In addition, Fang, Li, Niu, and Tseng [66] discovered for the first time a new amino acid
in C. moschata, named as cucurbitine.
4.1. Carotenoids and Tocopherols in Cucurbita
Carotenoids are present in high amount in the fruit of these plants and their hybrids, α- and
β- carotene; ζ-carotene; neoxanthin; violaxanthin; lutein; zeaxanthin; taraxanthin; luteoxanthin;
auroxanthine; neurosporene; flavoxanthin; 5,6,5′,6′-diepoxy-β-carotene; phytofluene; α-cryptoxanthin;
and β-cryptoxanthin [53,67–70]. The total carotenoid content varies in range from 234.21 μg/g to
404.98 μg/g in C. moschata fruit [71], and 171.9 μg/g to 461.9 μg/g in C. pepo fruit [61]. The concentration
of carotenoids is much higher (10 fold higher) in the peel of C. moschata than flesh [57]. Azizah et al. [72]
investigated the effect of different baking procedure on β-carotene and lycopene contents of C. moschata.
It was observed that boiling led to a 4 and 40-fold increase in β-carotene and lycopene contents,
respectively. There are also several reports on carotenoid content of several Cucurbita plants, such as
landrace pumpkins (C. moschata) [71], C. moschata and C. pepo [73,74], and C. maxima [75]. A summary
of the major carotenoids found in Cucurbita species is given in Table 3.
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Table 3. Content of major carotenoid present in the edible flesh of Cucurbita spp. varieties *.








Acorn Table 0.15 2.1 1.8
[70]
Acorn Tay Bell 0.17 0.94 0.37
Tonda Padana
(Americano) 0.12 2.3 1.5
Carneval di Venezia 0.03 0.06 ND
Melonette Jaspée Vende 0.05 1.3 0.43
Acorn Table ND 0.36 0.09
[74]
Table King Bush ND 0.09 0.02
Thelma Sander’s Sweet
Potato ND 0.06 0.01
Fordhook Acorn ND 0.04 0.01
PI 314806 ND ND ND
Sweet Lightning NQ 0.7 0.13 [76]
Cucurbita maxima
Uchiki Kuri 1.4 2.5 3
[70]
Flat White Boer 7.5 6.2 7.5
Umber Cup 0.79 3.7 11
Hyvita 0.99 2.5 17
Buen Gusto 1 3.3 6.3
Gelber Zentner ND 2.2 0.8
Mini Green Hubbard 0.42 1.4 5.6
Autumn Cup 0.8 5.2 2.7
Imperial Elite 1.1 7.4 7.1
Snow Delite 1.5 6.4 1.6
Walfish 0.9 4.3 3.9
Japan 117 1 7.2 1.8
Bambino NQ 4.2 NQ
[77]
Amazonka NQ 13.1 NQ
Justynka F1 NQ 13.1 NQ
Karowita NQ 4.2 NQ
Otylia F1 NQ 0.6 NQ
Bischofsmütze NQ 0.5 0.03
[76]
Golden Nuggets NQ 1.9 2.6
Halloween NQ 0.8 0.87
Hokkaido I NQ 0.27 3.6
Hokkaido II NQ 7.1 6.1
Cucurbita moschata
Burpee Butterbush 0.98 3.1 0.08
[70]Long Island Cheese 5.9 7 0.14
Mousquée de Provence 2.8 4.9 1.1
Martinica 1.6 5.4 0.41
Butterbush 1.5 1.5 0.09
[74]
Ponca Butternut 0.21 0.03 0.06
Waltham Butternut 0.3 0.38 0.12
Sucrine DuBerry 0.26 0.21 0.03
PI 458728 0.04 0.06 0.03
Tennessee Sweet Potato ND 0.2 0.03
Muscade de Provence 1.1 0.9 NQ [76]
Butternuts 0.06 1.14 0.14
* Results expressed in dry base of edible flesh part; NQ: Not quantified; ND: Not detected.
Edible Cucurbita seeds are also rich in vitamin E (49.49 μg/g to 92.59 μg/g); γ-tocopherol is more
abundant than α-tocopherol [53,62]. The amounts of α-, β-, γ- and δ-tocopherol from the cold pressed
oil extracted from six samples of pumpkin seeds (C. pepo) from Serbia were reported by Rabrenović
et al. [78], which were in the range of 38.03 to 64.11 mg/100 g oil. C. maxima var. béjaoui seed oil was
found as a rich source of tocopherols, where δ-tocopherol was the dominant tocopherol with 42% of
the total [64]. However, for C. pepo seed oils, γ-tocopherol was stated as the remarkably abundant
tocopherol (13–21%) compared to α- and δ-tocopherols [79].
4.2. Phenolic Compounds in Cucurbita
Table 4 presents the main phenolic compounds found in Cucurbita species and their structures.
C. moschata fruit seems to have a low total phenolic content in comparison with other fruits [57].
No flavonoids were found in either the fruit nor seeds of C. moschata in the study of Eleiwa et al. [80].
However, Li et al. [81] have previously discovered five novel phenolic glycosides from C. moschata
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seeds, named cucurbitosides A–E. Other new phenolic glycosides were discovered later from the same
source [81,82]. In another work, Li et al. [83] isolated eight different cucurbitoside compounds (F–M).





Protocatechuic acid 3,4-Dihydroxybenzoic acid C7H6O4





Caffeic acid 3,4-Dihydroxycinnamic acid C9H8O4
Syringic acid 3,5-Dimethoxy-4-hydroxybenzoic acid C9H10O5





























* The data were collected from the Phenol-Explorer database which is an online comprehensive database on
polyphenol contents in foods, http://phenol-explorer.eu/ (Accessed on 09.12.2018).
A study by Yang et al. [84] showed no flavonoid content (detection limit: 0.05 mg/100 g) in
either the immature or mature fruits of C. maxima. Only the shoots and buds showed positive results.
However, in accordance with [85], the total flavonoid and phenolic contents of this species were
determined as approximately 2.7 mg quercetin equivalent/g extract and 8.8 mg gallic acid equivalent
(GAE)/g extract, respectively. Sreeramulu and Raghunath [86] reported that average total phenolic
content of C. maxima was 46.43 mg GAE/100 g. In another study, C. maxima was analyzed for its
flavonoid content, and kaempferol was found to be the only flavonoid present in this species at a
concentration of 371.0 mg/kg of dry weight [87].
C. pepo was also found to have low polyphenol content. However, Iswaldi et al. [88] have reported
for the first time a list of 34 polyphenols, including a variety of flavonoids in the C. pepo fruit, in addition
to other unknown polar compounds. Also, the C. pepo flowers may contain considerable amounts of
phenolic compounds. A total polyphenol content ranging from 0.054 to 0.297 μg GAE/μg dry biomass
has been reported to be dependent on the extraction conditions and flower sex [89]. Andjelkovic et
al. [90] studied the phenolic content of six pumpkin (C. pepo) seed oils and identified the following
compounds: tyrosol, luteolin, ferulic acid, vanillic acid, and vanillin. Among them, tyrosol was the
most abundant compound, ranging from 1.58 mg/kg to 17.69 mg/kg.
Five major compounds in C. ficifolia fruit aqueous extract were identified by Jessica et al. [91] as:
p-coumaric acid, p-hydroxybenzoic acid, salicin, stigmast-7,2,2-dien-3-ol and stigmast-7-en-3-ol. On the
other hand, Peričin et al. [92] assessed the phenolic acids content of C. pepo seeds. p-Hydroxybenzoic
acid was found to be the prevailing phenolic acid, with 34.72%, 51.80%, and 67.38% of the total phenolic
acids content in whole dehulled seed, hulls, and kernels, respectively. Aside from p-hydroxybenzoic
acid, the most dominant phenolic substances can be listed in a decreasing order of quantity as
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follows: caffeic, ferulic, and vanillic acids in whole dehulled seeds. Trans-sinapic and protocatechuic
acids, and p-hydroxybenzaldehyde were the abundant phenolic acids presented in kernels of hulled
pumpkin variety; the hulls comprised p-hydroxybenzaldehyde, vanillic, and protocatechuic acids with
considerable amounts.
4.3. Terpenoids, Saponins and Sterols in Cucurbita
Badr et al. [55] have demonstrated the existence of calotropoleanly ester and cholesterol in C. pepo
fruit, and Younis et al. [62] also represented the cholesterol content in seeds (<0.2 to 3 mg/100 g). These
plant parts were also reported as containing more β-sitosterol (383.89 mg/kg fresh weight) than those
of C. moschata and C. maxima (277.58 mg/kg and 235.16 mg/kg fresh weight, respectively) [53]. Dubois
et al. [93] have reported that, besides cucurbitacins, a new triterpenoid saponin, foetidissimoside A
(3,28-bidesmosidic triterpenoid saponin) is also present in C. foetidissima roots. Ten years later, Gaidi
et al. [94] discovered the foetidissimoside B in the same source. Also, Matus et al. [95] extracted
sterols from seeds, and the most abundant were Δ7.22.25-stigmastatrienol, β-sitosterol, spinasterol and
Δ7.25-stigmastadienol [61].
Cucurbitacin is a triterpenoid [96] with a bitter taste, isolated from members of the Cucurbitaceae
family, and there are more than 18 types of cucurbitacin in the nature. Cucurbitacins are a group of
distinctive highly oxygenated triterpenoid substances, having tetracyclic triterpenes with a cucurbitane
skeleton. Figure 1 details the structure of 19-(10→9β)-abeo-10α-lanost-5-ene. They are cucurbitane
triterpenes with double bonds between C4 and C5, a hydroxyl at C16, C20 and C25 and a ketone at
C11 and C22 [20]. These compounds are well-recognized for their bitterness and toxicity [97].
 
Figure 1. Principal structure of cucurbitacins (19-(10→9β)-abeo-10α-lanost-5-ene).
Cucurbitacins are randomly divided into 12 groups, specifically cucurbitacins A–T, varying in
their oxygen functionalities at different positions. The chemical structures of a few cucurbitacins (A, B,
C, and D) are presented in Figure 2, and the cucurbitacin composition in different Cucurbita species is
summarized in Table 5.
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Figure 2. Structure of different cucurbitacin: (a) Cucurbitacin A, (b) Cucurbitacin B, (c) Cucurbitacin C
and (d) Cucurbitacin D.
Table 5. Cucurbitacin content of Cucurbita spp. (mg/g fresh weight) *.
Species Plant Part B D E I References
Cucurbita maxima
Radicles 0.1–1 Tr 0.01–0.1 ND [98]
Cotyledons 0.1–1 0.01–0.1 0.01–0.1 ND
Leaf, fruit, root <0.02 <0.02 <0.02 <0.02 [48]
Cucurbita andreana
Leaf 0.15 0.12 ND ND
[48]Fruit 2.78 0.42 ND ND
Root 0.58 0.51 ND ND
Cucurbita. andreana × C. maxima Fruit 1.17 0.09 ND ND [99]
Cucurbita mixta Pang. Cotyledons 0.01–0.1 ND ND ND [98]
Cucurbita pepo
Radicles Tr ND 0.1–1 Tr [98]
Cotyledons 0.1–1 0.01–0.1 0.01–0.1 ND
Fruits ND ND 3.1 ND
[52]Flesh at the stem end ND ND 7.2 ND
Fruit—central portion ND ND 2.7 ND
Fruit ND ND 0.6 ND [100]
Fruit ND ND 1.12 ND [101]
Cucurbita texana Gray
Leaf ND ND Tr Tr
[48]Fruit ND ND 0.07 0.367
Root ND ND 0.18 0.08
Cucurbita texana × C. pepo Fruit ND ND 0.23 0.09 [99]
Cucurbita martinezii Bailey
Leaf ND ND 0.42 0.25
[48]Fruit ND ND 0.36 0.45
Root ND ND 0.23 0.65
Cucurbita lundelliana Bailey
Leaf 0.47 0.12 ND ND
[48]Fruit 0.63 0.15 ND ND
Root 0.53 0.29 ND ND
Cucurbita foetidissima Root ND ND 0.28 1.72 [99]
* Tr.: Trace, ND: Not detected.
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Seedlings of the pumpkin C. maxima have been reported to involve high amounts of cucurbitacin
B and small amounts of cucurbitacin D and E in radicles and cotyledons [98]. Eighteen Cucurbita plants
species were analyzed for their cucurbitacin contents. Bitter species having comparatively high contents
of cucurbitacins B and D and no detectable cucurbitacins E and I were identified as Cucurbita andreana
Naudin, Cucurbita ecuadorensis Cutler & Whitaker, Cucurbita radicans Naudin, Cucurbita lundelliana
L.H.Bailey, C. argyrosperma and Cucurbita pedatifolia L.H.Bailey. The other group of wild, bitter
species having relatively large amounts of cucurbitacins E and I were Cucurbita cylindrata L.H.Bailey,
C. foetidissima, C. martinezii, C. okeechobeensis, and Cucurbita palmata S.Watson, Cucurbita pepo var. texana
(Scheele) D.S.Decker was found to contain nearly all cucurbitacins as cucurbitacin E-glycoside. However,
no cucurbitacin could be identified in domesticated and sweet species, including C. ficifolia, C. maxima,
C. moschata, and C. pepo [48]. The same group of investigators also determined the cucurbitacin and
cucurbitacin glycoside content in fruits of two Cucurbita plant hybrids (C. andreana × C. maxima and
C. texana × C. pepo), as well as in C. foetidissima roots. As a result, C. andreana × C. maxima fruits
contained cucurbitacins B and D, whereas C. texana × C. pepo fruits and C. foetidissima roots presented
cucurbitacins E and I [99]. With regards to C. andreana fruits extract, it was chromatographically
fractionated, and cucurbitacins B, D, E and I, as well as cucurbitacin E and I aglycones and cucurbitacin
B, E, and I glucosides were detected in this species [102]. C. pepo comprises the most investigated
Cucurbita plant for its cucurbitacin content. In an earlier study, cucurbitacin E was detected as a
primary bitter component in seedling C. pepo radicles, whereas cucurbitacins B and I were found in
trace amounts in the same tissue. On the other hand, cotyledons of this species were found to include
cucurbitacin D and E in moderate and low concentrations, respectively [103]. Freeze-dried samples
of Blackjack cultivar of C. pepo were analyzed by two research teams in different years. Ferguson et
al. [101] found 1.12 mg cucurbitacin E-glycoside/g fresh weight, whereas Hutt and Herrington [100]
detected 0.6 mg cucurbitacin E-glycoside/g fresh weight. Wang et al. [104] investigated C. pepo cv
dayangua for its phytochemical content, and cucurbitacin L and cucurbitacin K were isolated at
concentrations of 2.13 mg/kg dry matter and 2.67 mg/kg dry matter, respectively. In a very recent study,
cucurbitacin C and E glycosides in C. pepo fruit were reported for the first time. The corresponding
concentrations of compounds were 105 μg/g fresh fruit for cucurbitacin C and 438 μg/g fresh fruit
cucurbitacin E. The authors also demonstrated that gamma irradiation did not affect the cucurbitacins
concentration, when compared to non-irradiated control group [105].
From a biological point of view, it has been demonstrated that cucurbitacins exert several
bioactivities, such as antitumor, anti-inflammatory, anti-atherosclerotic, antidiabetic effects [106]. There
is a large body of evidence suggesting that cucurbitacins hold very high orders of cytotoxicity towards
a vast quantity of malignancies. Seed and fruit portions of few cucurbits are found to exhibit purgative,
emetic and anthelmintic activities due to presence of cucurbitacin triterpenoids [107,108]. Jayaprakasam
et al.[109] isolated cucurbitacins B, D, E, and I from C. andreana fruits and evaluated their effects at a
level of growth suppression of human breast (MCF-7), colon (HCT-116), lung (NCI-H460), and central
nervous system (CNS) (SF-268) tumor cell lines; cyclooxygenase-1 (COX-1) and cyclooxygenase-2
(COX-2) enzymes; and even on lipid peroxidation. All isolated cucurbitacins were able to abate the
proliferation of investigated cancer cell lines in varying percentages. Among them, cucurbitacin B
exhibited more than 80% proliferation inhibitory activity. Additionally, cucurbitacins B, D, E, and
I inhibited COX-2 enzyme, an enzyme responsible for inflammation, by 32%, 29%, 35%, and 27%,
respectively, at a concentration of 100 mg/mL. A cucurbitacin derivative, with a cucurbitacin D-like
structure, was separated from the methanolic extract of C. pepo seeds and revealed to have antiulcer
activity in a dose-dependent manner [110].
In contrast to their biological activities, cucurbitacins have toxic effects in mammalians. According
to Le Roux et al. [111], 353 poisoning cases linked to C. pepo cucurbitacins were reported to French
Poison Control Centers between 1 January 2012 and 12 December 2016. In 1980s, various human
poisoning cases were stated due to the consumption of commercially produced zucchini (C. pepo) in
Australia. The most common developed characteristic symptoms evidenced by exposed individuals
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include a bitter taste in the mouth, abdominal pain, diarrhea and rarely, collapse [101]. Pfab et al. [112]
reported that, 81 symptomatic cases were registered to Poison Information Centre (PIC) Munich
between 2002 to 2015. The primary symptom was colitis with bloody diarrhea after zucchini (C. pepo)
consumption. As the authors stated, cucurbitacins, the responsible toxins of poisonings, are not often
identified in cultivated fruits, but some fruits spontaneously produced them. In an in vivo experiment,
mice were fed with C. pepo fruit of two cultivars, ‘Blackjack’ and ‘Straightneck’, and an accession of the
bitter species, C. texana. As a result, mice having the diet with 1% C. texana, containing cucurbitacins E
glycoside and I, exhibited poor growth, severe diarrhea, anemia and 40% mortality. When the C. texana
percentage increased to 10 or 20%, mortality rate reached 100% within a few days. However, no
detectable cucurbitacins in C. pepo cultivars were identified and, animals fed up to 20% freeze-dried
squash in their diets displayed no toxicity-related symptoms [113].
4.4. Functional Carbohydrates and Polysaccharides in Cucurbita
C. moschata fruit is a rich source of polysaccharides, with a useful biological benefit, i.e.,
cytoprotective and antioxidative activities [114,115], that can reach 16.2% in dry matter, under optimised
conditions [116]. Xia and Wang [117] reported high amounts of D-chiro-inositol, a hypoglycaemic
molecule, in C. ficifolia fruit (without seeds). In addition to D-chiro-inositol, the plant was found to be
rich in other carbohydrates, like myo-inositol, fagopyritols and sucrose [117].
4.5. Fatty Acids of the Oil of Cucurbita Seeds
Seeds of Cucurbita species are also rich in fat (around 45%) and a variety of fatty acids, such as
saturated, unsaturated (around 55% of the oil), and conjugated fatty acids (CFA) [118,119], therefore,
may be considered as a source of molecules with high pharmacological potential and health benefits.
Specifically, CFA are polyunsaturated fatty acids containing conjugated double bonds with positional
and geometric isomers, and have several beneficial effects [120].
4.6. Other
C. ficifolia can also be considered a safe source of proteinases, with a high potential to be used
for bioactive peptides production [121,122]. Other enzymes, like peroxidases can be obtained from
C. moschata [123]. No alkaloids were found in neither the fruit nor seeds of C. moschata [80]. In contrast,
Chonoko and Rufai [124] have represented alkaloid contents both in the back peels and seeds of
C. pepo. Elinge et al. [56] also reported the presence of phytate (35.06 mg/100 g), oxalate (0.02 mg/100 g),
hydrocyanic acid (0.22 mg/100 g) and nitrate (2.27 mg/100 g) as antinutrient compounds in C. pepo seeds.
5. Cucurbita Plants for Industrial Purposes: Key Role as a Food Preservative
Three main pumpkin varieties, including C. pepo, C. maxima, and C. moschata, are considered
both as nutritional and medicinal foods in many countries [125]. Some biological activities are
reported in pumpkins, among them antimicrobial activity [126,127]. The reason why this plant
show antimicrobial applications is related to its high vitamins content (mainly A and C), phenolic
compounds, minerals, dietary fiber, amino acids and other advantageous compounds to humans.
Indeed, antioxidant, antibacterial and intestinal antiparasitic activities are also part of the active function
of this crop [125,128]. Pumpkin extracts are rich in steroids, flavonoids, tannins, alkaloids and saponins,
showing momentous antimicrobial and antifungal activity against some microorganisms [124,129].
Based on Muruganantham et al. [130] study, the ethyl acetate extract of C. maxima flowers has
meaningful antifungal and antibacterial activity against some microorganisms, like Escherichia coli,
Salmonella typhi, Bacillus cereus, Enterobacter faecalis, Candida albicans, and Curvularia lunata. Nonetheless,
the antioxidant and antimicrobial effects of pumpkin seeds have also been reported. The extracted
oil from pumpkin seeds chiefly contains fatty acids, among them linoleic, oleic, palmitic and stearic
acids. In addition, the oil is also full of tocopherols (δ-tocopherol, γ-tocopherol, β-tocopherol and
carotenoids, like lutein and β-carotene), characterized by displaying strong antioxidant effects. It is
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worth noting that pumpkin seeds oil can preserve lipids by having selenium, tocopherol, enzymes,
hormones and vitamins. Adeel et al. [126] stated that pumpkin seed oil exhibits high antibacterial
activity against Staphylococcus aureus, and pumpkin seeds are also able to markedly inhibit Rhodotorula
rubra and C. albicans growth at 0.5 mg/mL and 1.0 mg/mL, respectively [129]. Other research showed
that Bacillus subtilis, S. aureus, E. coli and Klebsiella pneumonia are easily affected by the antibacterial
properties of the methanolic extract from seed oil at 1.0 mg/mL, 2.0 mg/mL, 2.0 mg/mL and 3.0 mg/mL,
respectively [127]. Moreover, the authors stated that the antibacterial activity is not the only property
of the oil, since it also exerts a remarkable antifungal activity against R. rubra and C. albicans, at
concentrations of 0.5 mg/mL and 1.0 mg/mL, respectively. It has even been stated that there is a high
susceptibility of R. rubra to the seeds’ oil. Still, researchers have stressed that 1.0 mg/mL of pumpkin oil
seeds was effective against Penicillium chrysogenum and Aspergillus parasiticus, and 2.0 mg/mL against
A. flavus [127].
Pumpkin rinds and leaves contain some special bioactive proteins, which have shown preservative
effects. For example, pumpkin leaves contain the PR-5 antifungal protein [131], highly homologous
to thaumatin. In addition, the antimicrobial activity of this protein, besides the synergistic effect of
nikkomycin against C. albicans development, has been proved. Moreover, the growth and survival of
the phytopathogenic bacteria Erwinia amylovora, Phytophthora infestans and Pseudomonas solanacearum is
prohibited by a ribosome-inactivating protein purified from C. moschata [132]. Black pumpkin seeds
have another component, named cucurmoschin and identified as an antifungal peptide abundant
in glycine, arginine, and glutamate residues. Additionally, Park and et al. [133] found two novel
antifungal proteins (Pr-1 and Pr-2) from pumpkin rinds that showed strong in vitro antifungal activity
against Botrytis cinerea, Colletotrichum coccodes, Fusarium solani, F. oxysporum, and Trichoderma harzianum
at 10–20 μM.
6. Conclusions and Future Perspectives
Overall, Cucurbita species have chemical components with an intriguing impact in health
promotion. Several squash and pumpkin species are a natural and rich source of potential bioactive
compounds, such as carotenoids, tocopherols, phenols, terpenoids, saponins, sterols, fatty acids,
functional carbohydrates and polysaccharides. Of these triterpenoids, cucurbitacins are particularly
noteworthy for their multiple marked abilities. The presence of active phytochemicals in Cucurbitaceae
species makes them a great matrix to be further exploited for both preventive and therapeutic purposes,
beyond biotechnological applications. For an emphasis on Cucurbita plants’ pharmacological potential,
please refer to other review [134].
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